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CHAPTER 1: UNANCHORED UBIQUITIN CHAINS, REVISITED
1.1. Introduction
Ubiquitin (Ub) is a highly conserved 76-residue protein that facilitates the complex posttranslational modification of protein function, fate, and binding partners within the eukaryotic cell
[1-3]. “Ubiquitination” refers to the ATP-dependent conjugation of a Ub molecule onto a substrate
protein via an isopeptide bond between the C-terminal carboxylic group of a Ub and the ε-amine
of a lysine residue within the substrate [1]. The cellular machinery that brings about this
conjugation usually consists of three main components: a ubiquitin-activating enzyme (E1), a
ubiquitin-conjugating enzyme (E2), and a ubiquitin ligase (E3). A protein that has accepted a
single Ub molecule is said to be mono-ubiquitinated; additional ubiquitination can result in a multiubiquitinated protein decorated with individual Ub molecules (figure 1.1A).
Following a mono-ubiquitination event, the conjugated Ub can also be ubiquitinated itself,
forming a polymeric chain (figures 1.1A, B). A single Ub molecule harbors seven lysine residues
(Lys6, Lys11, Lys27, Lys29, Lys33, Lys48, and Lys63) that serve as Ub acceptor sites, spread
over the surface of the protein and pointing in distinct directions. In addition, an eighth
ubiquitination site exists at the N-terminal methionine (Met1) [1]. Poly-Ub chains are typically
characterized by the Lys or Met residue used for chain elongation and can be composed of
homogenous linkages (e.g., a tri-Ub chain with only Lys48 linkages; figure 1.1B) or multiple
linkage types can exist in mixed-linkage (multiple linkage types within a continuous chain; figure
1.1C) or branched chains (a Ub chain attached to a second, previously formed chain, resembling
branches in a tree; figure 1.1D). Linkage type also determines the conformation and flexibility of
the chain – while Met1- and Lys63-linked chains adopt open conformations with more space
between Ub molecules, Lys6-, Lys11-, and Lys48-linked poly-Ub are more compact. The Lys48and Lys63-linked chains diagrammed in figure 1.1B illustrate the basic difference between
compact and open conformations. The shape of a Ub chain affects its binding partners, as some
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Figure 1.1. The ubiquitination process. A) Outline of the ubiquitination process. With the assistance of E1,
E2, and E3 enzymes, mono-ubiquitin is conjugated onto a substrate as a post-translational modification.
Additional mono-ubiquitination can occur on a different lysine residue of the same substrate, yielding multiubiquitination; or, the same mono-ubiquitination can be extended with additional moieties, yielding polyubiquitination. Ubiquitination is reversed by deubiquitinases (DUBs) that remove one or more Ub molecules
at a time. B) Elongation to form poly-ubiquitin chains can occur at one or more of a ubiquitin molecule's 8
different acceptor sites (seven lysines and the N-terminal methionine) which allow for unique chains with
distinct physical structures and downstream functions. Chains can be homogenous, containing only one type
of linkage (i.e. Lys48- or Lys63-linked chains) (B); mixed, containing multiple types of linkages in a single chain
(C); or branched, containing ubiquitin molecules that have been modified at multiple sites (D).

proteins are attracted by the pockets created by specific linkage types [4, 5]. This binding
landscape gains even greater complexity through mixed-linkage and branched chains, and
through additional post-translational modifications to Ub, including phosphorylation [6, 7]. Two
poly-Ub chains that contain the same linkage types can behave in unique ways, depending on
the arrangement of those linkages, the chains’ proximity to post-translational modifiers that act
upon them, and accessibility to Ub-binding proteins attracted to certain chain types [3].
The composition of a poly-Ub chain and the context of its attachment to a substrate can
trigger different outcomes in the cell. Several Ub chains function as signals to target proteins to
the 26S proteasome. Lys48-linked chains are the most abundant linkage with this role, although
Lys11-, Lys29-, and in some cases Lys63-linked chains, have also been implicated in this
functional degradation pathway [8-10]. Branched Lys11/Lys48-linked Ub chains have recently
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emerged as an enhanced degradation signal vital to both cell-cycle regulation and quality control
of aggregation-prone proteins [11, 12], and Lys48/Lys63-linked, branched chains are an
additional degradation signal that associates with the proteasome [13]. In addition to proteasomal
degradation, mono-Ub and Lys63-linked chains have been shown to target plasma membrane
proteins to lysosomes for degradation [14].
Outside of degradation, ubiquitination has been shown to play a role in recruiting proteins
to participate in signaling pathways, altering localization by attracting trafficking factors, and even
controlling the conformation and activity of the substrate itself [1-3, 15]. These non-degradation
pathway functions are typically associated with mono-Ub, Met1- and Lys63-linked chains.
Furthermore, many chains induce non-degradative regulation of protein activity through more
indirect means. Met1-, mixed Lys11/Lys63-, Lys63-, and Lys48-linked chains can regulate
signaling through inhibitor degradation, proteasomal processing, allosteric activation, and
recruitment of upstream activating enzymes [1-3, 15]. Table 1.1 in the appendix describes
functions of poly-Ub chains of each linkage type and the ubiquitinating and deubiquitinating
enzymes reported to build and disassemble them.
Decades of research have been dedicated to the study of ubiquitination, yet we have only
begun to understand its countless functions in the cell and the players that direct Ub’s roles. What
determines which proteins are ubiquitinated, and with what type of chain? One determinant of
substrate specificity is the particular E2 and E3 involved. A mono-ubiquitination event is initiated
when the E1 activating enzyme hydrolyzes ATP and forms a thioester bond with Ub. The Ub is
then passed to an E2 conjugase through a transthiolation reaction. An E3 ligase then facilitates
the formation of an isopeptide bond between Ub and a lysine in its target protein. How this final
step happens depends on the type of E3, which is classified into one of three families based on
its domains and transfer mechanisms: RING E3s, HECT E3s, and RBR E3s. RING (Really
Interesting New Gene) E3s, the most abundant type, serve as a scaffold to enable the direct
transfer of Ub from the E2 to the target protein. HECT (Homologous to the E6AP Carboxyl
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Terminus) E3s transfer Ub in two steps: first, a transthiolation reaction moves the Ub molecule
from the E2 to the E3, before passing it to the substrate. RBR (RING-BetweenRING-RING) E3s
also work in multiple steps: a RING domain recruits a Ub-charged E2, a RING-like domain forms
a thioester bond with the Ub, and the Ub is subsequently transferred to the substrate. While the
human genome contains only two E1 Ub-activating enzymes, there are ~40 E2 conjugases and
more than 600 E3 ligases that can confer substrate and linkage specificity. HECT and RBR E3s
each determine the types of Ub linkages they create, while RING E3s depend on their cooperating
E2 to impart that specificity. [1, 2, 6, 16, 17].
Once a Ub chain has been formed on a substrate, it can be removed or edited by
deubiquitinating enzymes (DUB). Humans have ~100 DUBs, some of which have preferences for
chain type, length, and location, while others are promiscuous in those regards. DUBs are divided
into seven families: Ub-specific proteases (USPs), Ub C-terminal hydrolases (UCHs), ovarian
tumor proteases (OTUs), Josephins, JAB1/MPN/MOV34 metalloenzymes (JAMMs), the motif
interacting with Ub-containing novel DUBs (MINDYs), and zinc finger with UFM1-specific
peptidase domain proteins (ZUFSPs). USPs, UCHs, OTUs, Joephins, MINDYs, and ZUFSPs are
cysteine proteases, whereas JAMMs are zinc metalloproteases [15, 18-20]. The significance of
DUBs is evident from the beginning of a Ub molecule’s existence, as Ub genes are transcribed
as tandem repeats (UBB and UBC) or as ribosomal fusion proteins (UBA52 and RPS7A) that
require processing by DUBs before they can be used as mono-Ub for substrate ubiquitination [1,
20]. DUBs also serve as negative regulators of Ub signaling; for example, a protein with a Lys48linked tetra-Ub chain attached as a proteasomal targeting signal can be spared of degradation by
a DUB that removes that chain [15, 21]. The 26S proteasome itself contains and is closely
associated with DUBs that recognize Ub chains and remove them from degradation-bound
proteins to be reused for novel ubiquitination events [15, 22, 23]. Finally, DUBs participate in polyUb editing to change the length or composition of the chain, thus modifying the substrate protein’s
fate or participation in specific pathways. Some DUBs partner with E3 ligases to attach new Ub
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molecules, and there is even a DUBs that has E3 ligase domains itself, the NF- κB modulator A20
[24].
DUBs can disassemble chains one molecule at a time (e.g., UCH37 [25]), or they can
remove the entire chain at once (figure 1.1A, bottom left), resulting in unanchored, or free, polyUb that is not attached to a substrate protein. An example of the latter type, USP14, removes en
bloc poly-Ub chains from multi-poly-ubiquitinated cyclin B (a cell cycle regulator) until only one
chain remains attached, reducing cyclin B’s interaction with the proteasome and thus effectively
inhibiting its degradation in vitro [26]. Another DUB, the proteasome resident Poh1, is a zincdependent metalloprotease that cleaves poly-Ub from substrates as they are being degraded,
saving the chain from degradation, and yielding an unanchored poly-Ub [27].
Unanchored Ub chains make their first appearance in the cell at the time of Ub gene
transcription, as human UBB and UBC encode three and nine tandem repeats Ub, respectively.
Transcription of these genes results in linear, unanchored poly-Ub that is processed by DUBs that
have zinc-finger ubiquitin binding domains (Znf-UBPs) that specifically recognize the chains’ free
C-termini, including USP3, USP4, and USP16 [15]. In mammals, UBB and UBC transcription is
upregulated during cellular stress when increased signaling requires an ample supply of Ub.
Unanchored poly-Ub can also be assembled anew by specialized E2/E3 pairs in vitro and in cells.
This type of production is seen when the E3 TRIM6 and the E2 UbE2K generate unanchored,
Lys48-linked Ub chains that activate an IFN signaling component [28].
To date, not much is known about free Ub chains. They are commonly thought of as toxic,
and their rapid disassembly is thought to be essential to cellular health and Ub homeostasis,
based on findings from the studies described below. However, untethered Ub chains are also
directly implicated in specific pathways, including NF-κB, so their presence in the cell is clearly
important. Yeast and in vitro studies suggested that unanchored poly-Ub inhibits the proteasome
and is toxic, while Drosophila studies more recently indicated that they are tolerated in an intact,
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multi-cellular organism. For the remainder of this review, we examine the details and complexities
of the unanchored Ub chain.
1.2. Toxicity of unanchored chains
Much of our knowledge of unanchored poly-Ub arose from research on the best-known
DUB that processes it, USP5. Mammalian USP5 (also known as isopeptidase T) was first purified
from reticulocytes in 1985 [29] and later characterized as an enzyme that preferentially
disassembles poly-Ub species after they are removed from ubiquitinated substrates at the 26S
proteasome [30]. It specifically recognizes the free C-terminal diglycine motif of untethered polyUb and removes Ub monomers sequentially, from the chain’s proximal end [31]. Kinetic assays
revealed that Ub, itself, can modulate USP5 activity in vitro: low Ub concentrations activate USP5,
while partial inhibition is observed at higher Ub concentrations [32]. It has since been established
that USP5 contains four Ub-binding domains that cooperate to recognize and process multiple
types of unanchored poly-Ub, with a preference for Lys48-linked chains [33]. Its ZnF-UBP domain
governs its specificity for untethered chains, with a specialized pocket that recognizes the
unencumbered C-terminus of the proximal Ub [34]. In the fruit fly, Drosophila melanogaster USP5
knockdown or null mutation is developmentally lethal [35-38]. One proposed purpose for USP5 is
to maintain a pool of available mono-Ub by cleaving untethered poly-Ub; when USP5 cannot
perform this function, perhaps the cell lacks the building blocks necessary for normal
ubiquitination. However, toxicity from RNAi knockdown of USP5 is not alleviated by overexpression of mono-Ub in Drosophila [38]; thus, toxicity arising from reduced or absent activity of
USP5 cannot be explained solely by a disruption of mono-Ub supply, and may involve
dysregulation of specific ubiquitinated substrates [1, 5, 39-41].
When Ub is properly folded, several hydrophobic amino acid residues converge to form a
hydrophobic patch that serves as the interaction site for many Ub-binding domains [39, 42]. It is
through this hydrophobic patch that substrate-conjugated poly-Ub binds S5a, a subunit of the
regulatory compartment of the 26S proteasome, allowing proteasomal DUBs to detach the chain
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and enhancing the degradation of the targeted protein [39, 42]. Could unanchored Ub chains
directly cause toxicity by binding to the proteasome in lieu of ubiquitinated substrates, interrupting
normal proteolysis? Using reconstituted reticulocyte proteasome complexes to study USP5
function in vitro, Hadari et al. determined that USP5 stimulates the proteolysis of polyubiquitinated substrates [30]. If unanchored Ub chains can outcompete ubiquitinated substrates
at the proteasome and hinder normal proteolysis, the authors suggested that USP5 prevents this
by quickly disassembling chains--as soon as they are removed from their substrates--thus
enhancing proteolysis by removing competition [30]. In this study, the authors did not perform
binding assays to assess competition between unanchored chains and ubiquitinated substrates
at the proteasome, instead focusing on the effect of USP5 on in vitro proteolysis and inferring a
corresponding effect from unprocessed poly-Ub.
In follow-up studies, Piotrowski et al. synthesized Lys48-linked, untethered poly-Ub chains
of various lengths (from Ub2 to Ub8) and examined their effects on in vitro proteasomal function
[43]. They found that Ub chain length dictates the magnitude of proteasomal inhibition and the
chain’s affinity for the proteasome: longer chains are more likely to bind and more strongly inhibit
the proteasome [43]. Later, Thrower et al. identified Ub4 as the minimum signal for efficient
proteasomal degradation in vitro and showed that unanchored chains compete with ubiquitinated
substrates to bind to purified, mammalian proteasome, again in an in vitro setting [8].
Yeast studies support the notion that unanchored poly-Ub may inhibit proteasomal activity.
When Amerik et al. deleted the UBP14 gene encoding the USP5 orthologue in S. cerevisiae
(baker's yeast) cells, they observed accumulation of unanchored Ub chains and inhibition of the
Ub-dependent, proteasomal degradation of MATα2, L-βgal, and Ub–P-βgal, reporter proteins
used to study Ub-dependent protein turnover [44]. Reasoning that free Ub chains may be the
culprits hampering proteasomal degradation, they expressed in wild-type yeast cells a Ub mutant
lacking the C-terminal glycine residues required for Ub’s conjugation onto other proteins and its
recognition by UBP14. This mutant, Ub∆GG, can be ubiquitinated, allowing for the creation of an
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unanchored, UBP14-resistant poly-Ub chain with the mutant Ub molecule at the end [44]. (Similar
mutants that lack an intact C-terminal “GG” motif are used in studies described below; although
the precise amino acid mutations vary, the effect is the same, and all such mutants are referred
to as “Ub∆GG” throughout this manuscript.) Yeast cells expressing Ub∆GG mutants suffer growth
defects, sensitivity to environmental stressors, and a reduction in overall protein degradation in
pulse chases [45, 46]. The presence of unanchored, Ub∆GG chains coincided with reduced
proteolysis of MATα2 and Ub–P-βgal, again indicating proteasomal dysfunction, in this case in
vivo, in a single cellular organism [44].
Moving beyond purified proteasomes and yeast studies, Dayal et al. linked USP5 to
unanchored chain disassembly in a mammalian cellular system [47]. From a screen of DUBs
affecting the activity of the tumor suppressor p53 in cultured, ARN8 human melanoma cells, they
found that knockdown of USP5 stabilizes and activates p53. They also observed by Western
blotting an increase in low molecular weight Ub species that comigrate with purified, free Lys48linked chains and concluded that these are unanchored Ub species induced by USP5
suppression. Expression of Ub∆GG recapitulated the effects of USP5 knockdown in ARN8 cells,
leading to increased p53 activity. USP5 siRNA, or Ub∆GG expression also caused increased
ubiquitination of p53. Since this ubiquitination, which could be a degradation signal, counterintuitively coincides with slowed p53 turnover, the authors argued that the effects of USP5
suppression on p53 activity are mediated by unanchored Ub chains that outcompete ubiquitinated
p53 at the proteasome and extend its half-life [47]; this study did not directly examine whether the
observed p53 ubiquitination is consistent with a degradation signal, or whether its binding to the
proteasome is impaired in the presence of mutant Ub.
Ultimately, various early studies on unanchored poly-Ub pointed toward a toxic effect,
often linked to inhibition of the proteasome and buildup of proteins that were destined to be
degraded. It is important to note that these studies were performed using in vitro systems or a
single-cell organism, yeast; there remains a potential for free Ub chains to behave differently in
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cells in vivo and in multicellular organisms. Although Ub itself is highly conserved and enzymes
that dictate its use, editing and recycling are also conserved at several levels, there is also a
significant expansion in the number and types of Ub-related proteins and enzymes with
evolutionary progression, leaving open the possibility that free Ub chains may have different roles
and be regulated differently among species.
1.3. Unanchored chains and innate immunity
Beyond their potential for toxicity, untethered Ub chains have been implicated as
participants in specific cellular pathways, discussed below. Their inclusion in these pathways is
evidence that they are not exclusively toxic, but that they also have important physiological roles
in regulating innate immune pathways that guard against invading pathogens and control
inflammation.
1.3.1. TAK1 and IKK Activation
Just as USP5 studies uncovered the potential for untethered poly-Ub to inhibit the
proteasome in some systems, much of our knowledge of the normal functions of free Ub chains
came to us originally from investigations into Ubc13/Uev1a, an E2 complex that generates
unanchored poly-Ub. Ubc13/Uev1a is important for innate immunity, as it is required for
intracellular NF-κB signaling that originates with interleukin-1 receptors (IL-1Rs) and Toll-like
receptors (TLRs) [48, 49]. IL-1 cytokines in humans, including IL-1β, are small, proinflammatory
proteins that bind IL-1 receptors (IL-1Rs) on the cell’s surface (figure 1.2). IL-1β binding to IL-1R
causes the receptor to form a complex that includes IL-1R-associated kinase 1 (IRAK-1) and the
E3 ligase TNFR-associated factor 6 (TRAF6). IRAK-1 and TRAF6 dissociate from IL-1R and
TRAF6 joins transforming growth factor β-activated kinase 1 (TAK1), TAK1-binding protein 1
(TAB1) and TAB2 in a new complex in the cytoplasm. Activated TAK1 phosphorylates another
cytoplasmic complex, the IκB kinase (IKK) complex, consisting of two catalytic subunits (IKKα and
IKKβ) and a regulatory subunit (IKKγ/NF-κB essential modulator (NEMO)). The IKK complex then

10

Figure 1.2. Unanchored poly-ubiquitin in IL-1R signaling. Multiple types of unanchored chains play a role
in innate immunity and the NF-κB signaling pathway. In one NF-κB pathway, cytokines including IL-1β bind
the IL-1 receptor on the cell surface, setting off a cascade that results in the activation and nuclear
translocation of NF-κB transcription factors. Green: unanchored Lys63-linked ubiquitin chains bind TAB2 to
bring together two TAK1 complexes, enabling their mutual phosphorylation and activation, which is critical for
NF-κB signaling. Further down this signaling cascade, unanchored Met1- and Met1/Lys63-linked ubiquitin
chains bind and conformationally alter NEMO and activate the IKK complex, which ultimately leads to NF-κBbased transcription. Red: an antagonistic relationship exists between unanchored ubiquitin chains and NF-κB
signaling. The interaction among long (six or more moieties) unanchored Lys63-linked chains, the DUB A20,
and NEMO prevents IKK complex formation and activation.

phosphorylates IκBα, resulting in its proteasomal degradation and the nuclear translocation of the
freed NF-κB proteins (figure 1.2) [50, 51].
In 2009, Xia et al. directly implicated unanchored, Lys63-linked Ub chains in the activation
of TAK1 – and, by extension, in the activation of a canonical NF-κB pathway [52]. At the time, it
was known that Ubc13/Uev1a is required for TAK1 to phosphorylate the IKK complex [48, 49],
but the mechanism was unclear. The authors reconstituted TAK1 activation using purified
components and found that unanchored, Lys63-linked poly-Ub generated by Ubc13/Uev1a and
TRAF6 triggered the phosphorylation and activation of TAK1 in vitro [52]. Moving to cultured cells,
the authors used IL-1β to stimulate HEK-293 cells that stably express IL-1R (termed stable IL-1R
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cells) and immunoprecipitated the TAK1 complex using TAB2 antibody. The kinase complex coimmunoprecipitated with endogenous, USP5-sensitive (suggesting unanchored) poly-Ub, which
they then purified for in vitro experiments. The presence of these poly-Ub species activated TAK1
in vitro by binding TAB2 at its NZF Ub-binding domain, inducing TAK1 phosphorylation.
Furthermore, USP5-sensitive poly-Ub species generated by Ubc13/Uev1a and Ubc5, which can
make various Ub chain types beyond Lys63-linked species, activated the IKK complex via
NEMO’s Ub-binding domain. The authors proposed a model by which unanchored, Lys63-linked
chains bind TAB2 and draw two TAK1 complexes together for them to mutually phosphorylate
and activate one another, while other types of untethered chains bind and activate NEMO in the
IKK complex (figure 1.2).
What type of poly-Ub activates NEMO has been a complicated question to address.
NEMO contains a Ub-binding domain, the Ub binding in ABIN and NEMO (UBAN) domain, that
is required for NF-κB activation in mouse embryonic fibroblasts (MEFs) [53]. UBAN can interact
with both anchored and unanchored Ub chains, and although it preferentially binds linear poly-Ub
with as few as two Ub moieties, longer chains with different linkage types also bind NEMO in vitro
and in cultured cells [53-56]. In stable, IL-1R HEK-293T cells, IL-1β treatment stimulates the
production of Lys63-linked poly-Ub decorated with Met1-linked poly-Ub, i.e., branched Ub chains
[57]. NEMO can bind these hybrid chains, based on immunoprecipitation experiments, but it was
unclear whether any of the associated poly-Ub species were unanchored. Other in vitro studies
showed that covalent, Met1-linked di-ubiquitination of NEMO activates the IKK complex more
potently than unanchored, Met1-linked Ub2, but longer poly-Ub chains were not tested.
Spectroscopy studies suggested that NEMO’s interactions with other proteins are mediated by
long, linear poly-Ub chains: binding of Met1-linked Ub10 induces a conformational change in
NEMO that promotes its association with IKKβ and IκBα and in vitro [58]. It seems that Ubdependent NEMO activity can be mediated by both substrate-conjugated and untethered poly-
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Ub, and the magnitude of the effect may depend on chain length, linkage composition, and the
type of interaction or bond.
Untethered Ub chains have also been linked to the negative regulation of NF-κB through
their interaction with A20, a dual function enzyme with an N-terminal OTU DUB domain and seven
ZnF domains, with E3 activity at its C-terminus [24]. It suppresses NF-κB activity in the tumor
necrosis factor receptor (TNFR) and TLR pathways by editing poly-Ub attached to various
mediators and by disrupting the assembly of E2/E3 Ub enzyme complexes [24, 59]. Skaug et al.
discovered an additional, noncatalytic mechanism for A20 suppression of NF-κB activity that
depends on unanchored Ub chains [60]. Through in vitro experiments including GST pulldowns,
Ub-binding assays, and cell-free IKK activation systems, the authors showed that A20 can form
a complex with NEMO and long (six or more), untethered, Lys63-linked Ub chains, which then
prevents IKK activation. Formation of this complex in vitro is aided by long, unanchored chains.
Lys63-, Lys48-, and Met1-linked Ub4 had no effect, and long chains with linkage types other than
Lys63 were not tested. Overexpression and RNAi studies using HeLa S100 cell extracts
confirmed the formation of an A20-NEMO complex, dependent on TRAF6, Ubc13, and A20’s
ZnF7 Ub-binding domain. The authors concluded that IL-1β binding to IL1R promotes the
assembly of unanchored, Lys63-linked Ub chains by TRAF6 and Ubc13/Uev1a, which then recruit
the TAK1 and IKK complexes via Ub-binding domains in TAB2 and NEMO, respectively. If A20 is
present, it outcompetes TAB2 for poly-Ub binding, and poly-Ub becomes the scaffold in a complex
with A20 and NEMO. Formation of this complex inhibits IKK phosphorylation by TAK1, thereby
blocking NF-κB signaling (figure 1.2).
The studies summarized above provide evidence that unanchored poly-Ub species
contribute to innate immune signaling by modulating at least two steps within NF- κB pathways:
1) the activation of the IKK complex (via TAK1) to phosphorylate IκB to free NF-κB transcription
factors, and 2) the termination of TNFR- and TLR-regulated NF-κB signaling by A20 (figure 1.2).
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Collectively, they underscore important physiological roles for free poly-Ub in normal physiological
functions of eukaryotic cells.
1.3.2. RIG-I Activation
Innate immunity also protects organisms against viruses. In the cytosol of a virus-infected
cell, RIG-I-like receptors (RLRs) detect viral RNA and initiate a signaling cascade that culminates
in the production of antiviral molecules including type-1 interferons (IFNs) (figure 1.3).
Transcription factors involved in this antiviral response include NF-κBs, interferon regulatory
factor 3 (IRF3) and IRF7. In contrast to NF-κB proteins, which are activated by the degradation of
their inhibitor IκBα, IRF3 and IRF7 are activated by direct phosphorylation by the noncanonical
IKKs, IKKε and TANK-binding kinase 1 (TBK1), which causes the transcription factors to dimerize
and translocate to the nucleus [61, 62]. RIG-I is an RLR expressed at low levels in the cytoplasm
of most human cells. When RIG-I detects double-stranded viral RNA, an ATP-dependent
dimerization and conformation change is triggered, exposing two tandem, N-terminal caspase
activation and recruitment domains (CARDs). These CARDs interact with a CARD on the Nterminus of the signaling adaptor protein mitochondrial activator of virus signaling (MAVS), which
in turn activates IKKε and TBK1 to phosphorylate IRF3 and IRF7 (figure 1.3) [61, 62].
To study ubiquitin-dependent mechanisms involved in RIG-I signaling, Zeng et al.
developed a cell-free model of viral infection that combines purified RIG-I protein, mitochondrial
and cytosolic extracts, RNA, and ubiquitination enzymes, using IRF3 dimerization as a reporter
for RIG-I and MAVS activity [63]. Viral or engineered RNA was used to activate RIG-I in cytosolic
extracts, which stimulates MAVS in mitochondrial extracts to promote the dimerization of IRF3.
The authors determined that Lys63-linked, unanchored Ub chains are potent, direct activators of
RIG-I in vitro, binding its tandem CARD domains after RIG-1 detects viral RNA (figure 1.3). The
authors also verified the existence of this Ub chain type in a human cell line by devising a method
to immunoprecipitate endogenous, free poly-Ub from HEK-293T cells using recombinant RIG-I
N-terminus (GST-RIG-I(N)). Some poly-Ub species that bind GST-RIG-I(N) formed β-
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Figure 1.3. Unanchored poly-ubiquitin in RLR signaling. Unanchored ubiquitin chains play a role in the
cellular response to viral RNA. RIG-I-like receptors detect cytosolic viral RNA and initiate a signaling cascade
that triggers the production of antiviral molecules. Unanchored Lys63-linked ubiquitin chains interact with RIG1’s CARD domain to promote its oligomerization and activation. Downstream, the MAVS protein forms large,
prion-like fibrils in the presence of viral RNA and free Lys63-linked poly-ubiquitin noncovalently bound to RIGI. Lys48-linked unanchored poly-ubiquitin with two to sixteen ubiquitin moieties induce IKKε-dependent
phosphorylation of both itself and STAT1, resulting in the dimerization and nuclear translocation of the
transcription factor, IRF3.

mercaptoethanol-sensitive thioester bonds with E1 Ub-activating enzyme, indicating a free Cterminus, and were sensitive to both USP5 and the Lys63-specific DUB CYLD, leading the
authors to identify them as unanchored, Lys63-linked chains. The endogenous poly-Ub isolated
by this method potently activated IRF3 dimerization in the cell-free system, and their expression
was induced by viral infection in HEK-293T cells. TRIM25 is at least partially responsible for
producing these Ub chains, as siRNA targeting this E3 ligase diminished Lys63-linked, free polyUb levels in HEK-293T cells; conversely, CYLD siRNA led to higher levels, indicating a negative
regulatory role for the DUB.
In later studies, Jiang et al. expanded on these findings by using the reconstituted RIG-I
activation assay to demonstrate that noncovalent binding of free, Lys63-linked Ub chains to RIG-
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I’s CARD domains promotes RIG-I’s oligomerization (figure 1.3) [64]. Sedimentation velocity
analytical ultracentrifugation indicated that RIG-I specifically forms tetramers in complex with four
unanchored poly-Ub molecules; the 4:4 ratio remained constant with all Ub chain lengths tested,
from Ub3 to Ub6. RIG-I formed high molecular weight complexes in response to viral infection in
HEK-293T cells and MEFs, but not in Ubc13 knockout MEFs, or in RIG-I knockout MEFs
expressing RIG-I that cannot bind Ub, leading the authors to conclude that RIG-1 oligomerization
depends on binding to Lys63-linked poly-Ub generated by Ubc13. When RIG-I was isolated from
both types of knockout MEFs to use in in vitro IRF3 dimerization assays, only the higher molecular
weight RIG-I aggregates were active, suggesting that Lys63-linked poly-Ub-dependent
oligomerization of RIG-I is necessary for its activity. Another RLR with a CARD domain, melanoma
differentiation-associated protein 5, behaves similarly to RIG-I in vitro, with Lys63-linked Ub6
inducing its oligomerization and enhancing its activation of IRF3 in dimerization assays.
Hou et al. also used the cell-free RIG-I activation system to elucidate the details of MAVS
activation. Performing biochemical assays using isolated, crude mitochondria from virus-infected
or uninfected HEK-293T cells, they determined that activated MAVS forms large, prion-like fibrils
that induce IRF3 dimerization. MAVS aggregation was induced by RIG-I in the presence of RNA
and Lys63-linked, free Ub4. Based on these in vitro studies and the previous work from Zeng et
al., the authors constructed a model for MAVS activation in the viral response that is dependent
on binding of unanchored, Lys63-linked poly-Ub to the CARD domains of RIG-I to trigger MAVS
aggregation on the mitochondrial membrane (figure 1.3) [65]. Crystal structure studies examining
covalent and noncovalent binding between RIG-I and poly-Ub revealed that Lys63-linked free Ub2
binds RIG-I CARD tetramers, stabilizing them as a scaffold to recruit and activate MAVS to form
fibrils in vitro [66]. Covalent poly-ubiquitination of RIG-I by TRIM25 also induced MAVS
aggregation in vitro, indicating a potential for multiple Ub-dependent mechanisms to activate this
important antiviral pathway. As mentioned above, TRIM25 is a Lys63-specific E3 that also
produces at least some of the free poly-Ub chains that activate RIG-I in cultured human cells [63].
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In vitro, the RING domain of TRIM25 can partner with distinct E2s like Ubc13/Uev1a or Ubc5 to
produce unanchored or substrate-conjugated Ub chains, respectively [67].
Another TRIM E3, TRIM6, is also involved in viral immunity through RIG-I signaling [28].
As mentioned above, IFN IRF3’s phosphorylation and activation is mediated by IKKε. This action
depends on signal transducer and activator of transcription 1 (STAT1), which is phosphorylated
by IKKε (figure 1.3). Co-immunoprecipitation experiments using HEK-293T cells and primary
human monocyte-derived dendritic cells showed an interaction between TRIM6 and IKKε, and
knockdown of TRIM6 depleted IFN-mediated antiviral activity in human lung epithelial A549 cells.
In vitro, IKKε interacted with free, Lys48-linked poly-Ub synthesized by TRIM6 and the E2 UBE2K,
and USP5-sensitive poly-Ub interacted noncovalently with IKKε in HEK-293T cells, based on coimmunoprecipitation studies. By confocal microscopy, TRIM6 and IKKε co-localize with Ub-rich,
cytoplasmic puncta in HeLa cells, and the formation of these puncta was disrupted by the
introduction of USP5, which the authors interpreted to indicate the presence of free poly-Ub in the
observed foci. In vitro STAT1 phosphorylation assays revealed that untethered, Lys48-linked
chains with two to sixteen Ub moieties induce IKKε phosphorylation of both itself and STAT1,
inducing IKKε oligomerization and IRF3 activation. Taken together, these studies highlight the
importance of two types of unanchored poly-Ub in innate immune pathways (figure 1.3).
The participation of free poly-Ub in various immune responses is evidence that these
chains – especially open-conformation Met1- and Lys63-linked chains – have direct, physiological
effects that are not limited to the proteasomal toxicity previously seen in yeast and in vitro systems
(figures 1.2 and 1.3). As the pool of research on unanchored Ub chains has grown, there is
increasing evidence that chain length and the type of linkage within the chain dictates its specific
role in immune signaling (e.g., Lys63-linked chains interact with RIG-I, while Lys48-linked chains
activate IKKε [28, 63, 64]). The roles of other linkage types remain to be studied in immune
signaling and in other physiological processes; thus, it is possible that distinct species of free polyUb have yet-to-be discovered cellular functions.
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1.4. Other physiological purposes of unanchored Ub chains
Other potential regulatory roles for free poly-Ub species have emerged, beyond their
involvement in immune pathways. Braten et al. expressed a Ub∆GG mutant in yeast and
performed a gene deletion screen to determine which E2(s) and E3(s) are responsible for
constructing Ub∆GG-terminal chains. By exposing these yeast strains to stressors, they showed
that free Ub chains are upregulated during certain types of stress, including heat shock, DNA
damage, and oxidative stress, and that the yeast E3, UFD4 generates unanchored chains under
basal conditions, while the E3, HUL5 is responsible for most of the ones generated in response
to a DNA alkylation agent [68]. This study did not determine a physiological role for the free chains
generated, but their stress-induced upregulation and the identification of two E3s responsible for
them is notable and warrants further examination in this model organism and beyond.
Heat shock also induces the reversible formation of cytoplasmic stress granules, which
are small, dense aggregations of proteins and mRNA. In cultured HeLa cells, USP5 is recruited
to heat shock-induced stress granules, and its knockdown prevents their disassembly, leading
Xie et al. to investigate the potential involvement of unanchored poly-Ub [69]. Heat shocking cells
expressing Ub∆GG led to the formation of stress granules at the same rate as it did in cells
expressing wild-type Ub, but more than twice as many Ub∆GG cells (76%) were unable to clear
the newly formed granules [69]. The authors concluded that untethered poly-Ub interferes with
the process of disassembling stress granules; the specifics of this action remain to be determined.
Thus far, not many physiological functions have been ascribed to unanchored poly-Ub;
but, it is important to note that they indeed have innate roles and do not appear to simply be
byproducts of chains assembly sand disassembly. Clearly, additional investigations are needed
in intact organisms and in specific cell types and tissues to explore and understand their
physiological implications.
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1.5. Reduced or absent toxicity from unanchored poly-Ub in Drosophila melanogaster
The inclusion of free poly-Ub in several cellular pathways casts their previously described
toxicity in a new, more complex light. In an effort to further understand the potential toxicity of
unanchored chains, our laboratory conducted a series of studies to determine their impact in vivo
and understand how they might be regulated in an intact, multi-cellular organism. Our collective
results point to a non-toxic role for unanchored poly-Ub chains and mild transcriptomic response
to their presence, indicating lower toxicity from free Ub chains than has been previously thought.
Our investigations began by focusing on unanchored chain disassembly and whether
DUBs are necessary for their control in vivo [70]. This study set the stage for the investigations
discussed in this section by introducing two types of unanchored poly-Ub transgenes that were
expressed in Drosophila melanogaster. Both types of chains consist of six Ub in tandem and lack
internal “GG” motifs that are necessary for isopeptide bond formation and disassembly by DUBs
[1, 15, 22, 70]. Whereas one type of chain also lacks a terminal “GG,” and thus cannot be
conjugated onto other proteins (referred to as Ub6-Stop), the other chain type contains a “GG”
motif at its end to allow for protein conjugation (referred to as Ub6-GG; figure 1.4). Their
expression was enabled by the binary, Gal4-UAS system, which allows for tissue-specific as well
as timed expression through specific promoters and compounds delivered in fly media [71-74].
Biochemical analyses of the Drosophila lines generated with these transgenic free Ub
chains showed robust expression. Intriguingly, the chains were amply modified by endogenous
Ub, effectively creating branched Ub chains with various linkage combinations [70]. When
expressed in all cells, Ub6 did not impact Drosophila development or adult fly longevity under both
normal and heat-stressed conditions. Tissue-specific expression in muscles, glia, and neurons
showed once again that there were no developmental differences between experimental chain
expressing flies and controls, but expression in glia and neurons resulted in a mild decrease in
adult fly longevity, whereas muscle-specific expression did not result in a significant change in

19

Figure 1.4. Summary of findings from transgenic, unanchored poly-ubiquitin in Drosophila. Overview
of the composition, processing and physiological effects of unanchored ubiquitin chains used in Drosophila
melanogaster. Red arrows: worsening of phenotypes and outcomes as free poly-ubiquitin is mutated to
become resistant to its own ubiquitination. Green arrows: improvement of phenotypes and outcomes as
ubiquitination-resistant, free poly-ubiquitin is further modified to inactivate its Ile44 hydrophobic patch.

overall lifespan compared to controls [70]. Overall, longevity results indicated that unanchored
chains are not necessarily universally toxic.
Because of studies indicating an inhibitory role for unanchored poly-Ub at the proteasome
in vitro and in yeast, proteasomal activity was assessed in flies expressing, or not, Ub6-Stop in all
cells. Ub6-Stop expression did not affect protein levels of proteasomal components, nor did it
hinder the turnover of the proteasomal substrates GFP-CL1 or cyclin A [70]. Ub6-Stop is itself
degraded by the proteasome: RNAi against both 20S and 19S proteasome components led to
high levels of these unanchored chains. Knockdown of certain proteasome-associated proteins
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that help target ubiquitinated substrates to this degradative machinery resulted in markedly
increased levels of Ub6-Stop (VCP, p47, and Ufd1-like) [70]. Additional genetic and biochemical
experiments suggested a model whereby the VCP-associated protein, p47 is important for the
association of unanchored, Ub6-Stop with VCP and the proteasome, and highlighted the
proteasome as a key regulator of the stability of these Ub species in the fly.
Generally, ubiquitination is considered to occur at via serial addition of mono-Ub onto an
extending chain or substrate. Intriguingly, the Ub6 constructs showed that the conjugation-capable
Ub6-GG could be attached as a single unit onto other proteins in flies and in cultured mammalian
cells [70]. These results indicated that Ub recycling need not only occur at the level of a monomer;
in fact, a whole chain could be removed from one substrate and attached onto another en bloc.
While the notion of en bloc transfer of an intact chain, without its disassembly into mono-Ub, has
been purported before and has been observed in vitro [75-78], insofar as we know, it had not
been shown before in a cell or intact, multi-cellular organism. These findings led to the possibility
of free poly-Ub regulation beyond their disassembly into mono-Ub: they can be degraded by the
proteasome, or become conjugated onto other proteins whole-sale, painting a wider tableau of
possibilities for unanchored chain regulation in the cell.
Because of the surprising finding that untethered, linear poly-Ub species are not toxic [70],
we wondered whether Drosophila is mounting a response towards these chains. We examined
changes at the transcriptional level through RNA-seq, using flies expressing everywhere Ub6Stop, Ub6-GG, or no transgene with the same genetic background. The presence of each type of
Ub6 chain led to significant changes in the expression of approximately 90 fly genes, but with no
clear coordinated cellular response to indicate the induction of any particular pathways [79]. Only
30% of the altered Drosophila transcripts observed have assigned gene names, indicating that
most of the affected genes have not garnered enough attention to be ascribed function or genetic
background in the fly. Additionally, 27% of the genes identified had no predicted function, opening
up the potential for the future identification of proteins that interact with untethered poly-Ub. It
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appears that the expression of unanchored poly-Ub in Drosophila translates to minimal
transcriptomic or organismal response, judging by the low number of altered transcripts and a
lack of specificity for Ub-related pathways in those transcripts that were altered [79]; we
interpreted these results as further evidence that free poly-Ub species are not inherently toxic.
This lack of observable toxicity from linear hexa-Ub chains in Drosophila does not dovetail
with earlier studies that strongly indicated that unanchored chains are toxic in yeast [8, 30, 43,
44], leading us to wonder what makes the difference between an unanchored Ub chain that
causes proteasomal toxicity and one that is essentially innocuous in flies. As previously
mentioned, the Ub6-Stop is ubiquitinated in flies, introducing endogenous Ub that could potentially
change the way these chains are handled and explain why they are innocuous [70]. To assess
the influence of endogenous ubiquitination on the toxicity of unanchored chains, we mutated all
lysine residues in Ub6-Stop to alanine, creating Ub6-Stop-K0, a ubiquitination-resistant, linear
hexa-Ub chain that cannot be cleaved by DUBs or conjugated onto a substrate (figure 1.4). By
mirroring the longevity assays we used to characterize Ub6-Stop in various fly tissues, we
observed that Ub6-Stop-K0 is significantly more toxic than its ubiquitination-prone counterpart: it
is developmentally lethal when expressed in all cells, and it significantly reduces fly lifespan when
expressed in neurons, glia, or muscles [80]. Compared to the ubiquitination-prone Ub6, turnover
of Ub6-Stop-K0 is slowed but not halted, indicating that ubiquitination aids in the turnover of linear
Ub6 but is not essential to its eventual clearance [80].
We then sought to elucidate a mechanism for the enhanced toxicity of ubiquitinationresistant Ub6. Since unanchored poly-Ub species are known to participate in NF- κB pathways,
and some of them may be linear poly-Ub, we wondered whether Ub6-Stop-K0 can influence NFκB signaling in Drosophila [50, 51, 81-83]. We co-expressed in glial cells Ub6-Stop-K0 and RNAi
targeting several proteins involved in NF- κB signaling. We found that knockdown of NF-κB
components extends the lifespan of Ub6-Stop-K0 flies, although not to the extent of controls that
are genetically similar but without a Ub6 transgene [80]. RT-qPCR revealed that Ub6-Stop-K0
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expression causes an increase in mRNA levels of several of these NF-κB components [80]. Based
on these results, we concluded that ubiquitination-resistant, linear Ub chains induce aberrant NFκB signaling, accounting for at least some of its toxicity in flies.
Because of the importance of Ub’s ile44-centered hydrophobic patch in its binding to Ubbinding proteins [1, 5, 39-41], including some NF-κB regulatory proteins, we examined ile44’s role
in NF-κB-mediated toxicity from Ub6-Stop-K0. We reasoned that Ub6-Stop-K0 may not be capable
of interacting with NF-κB without its hydrophobic patches; thus, we mutated ile44 to alanine in
each Ub moiety to create the binding-deficient mutant Ub6-Stop-K0-ile44a (figure 1.4). These
mutations reversed most of the toxicity as well as aberrant NF- κB signaling in flies and also in
cultured, HEK-293T mammalian cells [80]. These results indicated a role for free, linear,
ubiquitination-resistant chains in NF-κB signaling that depends on an intact ile44 hydrophobic
patch; without ile44, ubiquitination-resistant Ub6 likely is unable to interact with Ub-binding NF-κB
components, prohibiting much of its toxicity in vivo.
Taken together, these studies add yet more complexity to the general understanding of
unanchored poly-Ub. Clearly, free Ub chains are not always toxic. In flies, linear hexa-Ub chains
are well tolerated, as long as they can be ubiquitinated or conjugated onto other proteins. Due to
the current unavailability of genetic techniques to stably express in in the fly chains of different
topologies and linkages, we were restricted to using linear, head-to-tail chains. However, it bears
highlighting that these linear chains quickly and abundantly become decorated with endogenous
ubiquitin, and are thus transformed into a pool of free Ub species that comprises linear as well as
branched chains consisting of M1, K27, K48, K63 [70] and, based on more recent proteomic
assays, also K29 and K33 linkages (Blount and Todi, unpublished observations). Consequently,
the findings summarized in this section pertain to various types of free poly-Ub in vivo and, with
the above caveats in mind, may be extrapolated to apply more widely to other types of chains.
Additionally, the fact that all of these Ub6 mutants are based on the same backbone – Met1-linked
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hexa-Ub – but behave so differently in Drosophila is evidence of the complicated nature of
unanchored poly-Ub in vivo.
1.6. Conclusions
The studies described in this review provide a complex picture of unanchored poly-Ub
handling and function. It is now apparent that the previous understanding of these chains – that
they only exist briefly before being disassembled by DUBs to prevent toxicity and allow mono-Ub
recycling – is only part of the picture. These members of the Ub family have clear physiological
roles and seem to be controlled in ways that have not garnered much attention so far. It appears
that untethered Ub chains are regulated through various mechanisms. Not all of the possibilities
we present next need to exist and operate at the same time in each cell. They may be cell typeand cell condition-dependent. Also, evolutionary differences may place more weight on some
such pathways compared to others.
We propose the following routes of unanchored poly-Ub control and recycling (figure 1.5).
The first, and in all likelihood major route of regulation and recycling remains the disassembly of
free chains into mono-Ub so that they can be reused to modify other proteins. A second route
may be that of unanchored poly-Ub degradation, either as they are or through additional
decoration by endogenous Ub. A third mechanism of free poly-Ub use and control may be their
conjugation onto another substrate, essentially removing them from the unanchored population.
Additionally, free chains may associate with Ub-binding proteins in a type of “reserve” pool until
they can be re-utilized, which may function in conjunction with the other proposed routes of
unanchored chain management. In an example of the latter route--and under special conditions
where they may not be able to be dispensed off or controlled in other ways--free Ub chains can
interact with NF-kB signaling components, causing abnormal signaling and toxicity. Free poly-Ub
is also involved in normal immune signaling, at least through the IL-1R and RLR signaling
pathways, and also appears to be involved with stress granule clearance after cellular stress.
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Figure 1.5. Proposed model of unanchored ubiquitin chain use and control. Outline of current and
proposed routes of unanchored poly-ubiquitin utility and regulation. The current model presents one primary
mechanism of handling free ubiquitin chains: their disassembly into mono-ubiquitin for future reuse. Earlier in
vitro and yeast studies indicated a toxic role for unanchored poly-ubiquitin through proteasomal inhibition.
Based on evidence from mammalian cells and Drosophila, we propose additional regulatory roles and
mechanisms. Free ubiquitin chains can be degraded by the proteasome (without inhibiting it), either as they
are, or with additional ubiquitination by endogenous ubiquitin. Since free ubiquitin chains in flies and in
mammalian cells can also be conjugated onto other proteins, another mechanism for their control may be
achieved through en bloc conjugation onto other substrates. Unanchored Ub may also associate with
ubiquitin-binding proteins that hold chains in a “reserve” pool for later use in any of the other suggested routes
of management (dotted arrows). Untethered poly-Ub species also participate in normal immune signaling and
response to cellular stress, such as heat shock and stress granules. Lack of control of free ubiquitin chains
could lead to adverse outcomes, such as when unanchored poly-ubiquitin that cannot themselves become
ubiquitinated activate NF-kB signaling. The possibilities we summarize here are most probably fluidly
connected to enable free ubiquitin-chain designation among different roles and regulatory routes. We did not
depict these intersections in an effort of simplifying the diagram. Additional regulatory mechanisms and
functions likely exist and necessitate further research into unanchored poly-ubiquitin.

What we present is not an exhaustive tableau of potential outcomes; further studies may lead to
the discovery of additional functions and cellular responses.
It may seem that more recent studies revealing unanchored Ub’s physiological roles and
lack of toxicity contradict earlier studies that characterized free poly-Ub as harmful, but the
seeming contradiction only highlights the importance of Ub chain type and context. Some of the
previous in vitro and yeast studies that suggest proteasomal inhibition by untethered poly-Ub
focused on Lys48-linked chains [8, 43, 47], while the Ub6 chains expressed in Drosophila are
head-to-tail [70, 79]. In principle, it makes sense that unanchored chains that resemble poly-Ub
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attached to proteasome-targeted proteins – which are often Lys48-linked – could outcompete
proteasomal substrates in a manner not observed with linear chains that are not traditionally
associated with proteasomal degradation [1, 8, 43]. This out-competition most likely depends on
chain abundance compared to endogenous substrates. (We should note here that in the fly, linear
chains that could become ubiquitinated, including with Lys48 linkages, did not impact proteasome
activity and both ubiquitination-resistant and -restricted free Ub6 were turned over in the fly, with
the latter being a little delayed in the earlier stages of its degradation. [70]) Proximity to the
proteasome is likely key: in vitro proteasome assays allow close association between Ub and the
proteasome, with few proteins present to interfere, while Ub6 expression in transgenic flies does
not guarantee such proximity. It is also clear that free poly-Ub toxicity is dependent on posttranslational modification of the chain and its interactions with other proteins. Linear Ub6 species
did not become particularly toxic until they could no longer be used or modified, at which point
they were highly toxic through NF-kB in a manner dependent on their ability to interact with other
proteins’ Ub-binding domains. Future studies need to take into account post-translational
modifications and interactions that affect free poly-Ub function and processing.
It also stands to reason that there could be evolutionary differences between single-cell
organisms like yeast, in which free poly-Ub is toxic, and higher order organisms that may have
evolved compensatory mechanisms or pathways that utilize these chains. One function for
untethered Ub chains that may be conserved between yeast and mammals involves stress
granules: in cultured HeLa cells, free poly-Ub interferes with the clearance of stress granules [69].
Yeast also form stress granules [84], and they produce free poly-Ub species in response to
stressors like heat shock and DNA alkylation [68], but any interplay between stress granules and
unanchored Ub chains has not been established in yeast. In contrast to the conservation of stress
granules, this review describes several studies linking unanchored Ub chains to signaling
pathways that are not present in yeast [85]. Unanchored Ub chains can both positively and
negatively regulate NF-κB pathways and viral response in multi-cellular organisms [28, 52, 57,
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58, 60, 63-66]. Continued studies will be essential to the discovery of additional physiological
functions for free poly-Ub that may not be present in single-cell organisms.
Ultimately, the fact that unanchored Ub chains are not exclusively toxic presents exciting
research opportunities. Different species of free poly-Ub have unique effects; it will be important
to distinguish the type of chain responsible for specific actions within the cell, and under what
circumstances these actions take place. Markers that recognize unanchored poly-Ub with specific
linkage types could be developed to aid in the identification of chain types that are upregulated
during certain stress responses, or in the mapping of the cellular distribution of different
untethered Ub species. Since poly-Ub chains can be transferred en bloc to substrates in vivo, it
will be interesting to investigate whether there are situations in which cells may prefer to use preformed chains for ubiquitination – perhaps when ATP is quickly consumed by other processes,
such as during exercise. Proteomics, genetic and biochemical studies will be needed to identify
E2s and E3s that can transfer Ub chains en bloc, and they can provide additional clues about
pathways that involve free chains by identifying signaling proteins that bind or interact with them.
Even within the pathways that are already known to involve unanchored poly-Ub, there are details
that remain to be clarified; for instance, it is unclear why clearance of stress granules is impaired
in cells that express free Ub chains. Do the chains interfere with the recruitment of proteins that
normally disassemble stress granules? Do they serve a function, or are they just meant to be
disassembled by USP5? In sum, this collection of studies highlights that unanchored poly-Ub
species are multi-faceted entities that necessitate further study to comprehensively understand
the consequences of their presence in the cell.
The next three chapters comprise the evidence that I collected regarding the expression,
regulation, response and roles of free poly-Ub in Drosophila. Included verbatim are the following
published manuscripts:
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Chapter 2: Blount, J. R., Libohova, K., Marsh, G. B., Sutton, J. R., & Todi, S. V. (2018).
Expression and Regulation of Deubiquitinase-Resistant, Unanchored Ubiquitin Chains in
Drosophila. Scientific reports, 8(1), 8513.
Chapter 3: Blount, J. R., Meyer, D. N., Akemann, C., Johnson, S. L., Gurdziel, K., Baker, T. R.,
& Todi, S. V. (2019). Unanchored ubiquitin chains do not lead to marked alterations in
gene expression in Drosophila melanogaster. Biology open, 8(5), bio043372.
Chapter 4: Blount, J. R., Libohova, K., Silva, G. M., & Todi, S. V. (2020). Isoleucine 44
Hydrophobic Patch Controls Toxicity of Unanchored, Linear Ubiquitin Chains through NFκB Signaling. Cells, 9(6), E1519.
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CHAPTER 2: EXPRESSION AND REGULATION OF DEUBIQUITINASE-RESISTANT,
UNANCHORED UBIQUITIN CHAINS IN DROSOPHILA
2.1. Introduction
Posttranslational modification of proteins by ubiquitin (Ub) controls most cellular
processes [1, 2, 20]. This modification adjusts how a protein interacts with cellular constituents,
because Ub presents additional interaction interfaces [1, 21, 86]. Ubiquitination regulates protein
localization, activity, function and half-life [1, 87]. Addition and removal of Ub from specific proteins
is vital and is implicated in human diseases [1, 2, 20]. Ubiquitination involves the covalent
attachment of Ub to—most commonly—lysine residues of substrate proteins through the
coordinated action of a Ub activating enzyme (E1), a Ub conjugating enzyme (E2) and a Ub ligase
(E3). Since Ub itself contains seven lysines, different Ub chains can be formed by the attachment
of one Ub to another at different lysine residues; head-to-tail/linear chains, chains with mixedlinkages and branched chains are also generated [1, 6, 12]. Arguably the best known chain is
K48-linked poly-Ub, which targets proteins for proteasomal degradation [8]. Other types of chains
also exist in cells [1, 2, 57, 88-90].
Similar to other types of posttranslational modification, ubiquitination is reversible. Ub
removal is accomplished by deubiquitinases (DUBs) and serves multiple roles: 1) editing chains
to reduce errors; 2) bringing a molecular process to an end by, for example, disassembling a
protein complex that merged as a result of a member’s ubiquitination; 3) recycling mono-Ub; and
4) disassembling unanchored/free poly-Ub [2, 21, 87, 91]. Unanchored poly-Ub results from en
bloc cleavage of chains from substrates. Free chains function in autophagy-dependent
processes, immune system-related steps and during DNA stress; unanchored poly-Ub chains are
also synthesized anew [2, 21, 26, 33, 57, 68, 87, 88, 92-94].
Unanchored poly-Ub is thought to be quickly disassembled by DUBs [1, 21, 22, 87].
Accumulation of unanchored chains is proposed to be toxic by perturbing Ub-dependent
processes. For instance, they may titrate out binding of ubiquitinated proteins to the proteasome
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[20, 33, 43, 92, 93, 95-97]. To the best of our knowledge, there are no published reports that
directly examine unanchored poly-Ub species in an intact organism to address questions such
as: what happens to unanchored chains if DUBs cannot dismantle them? Are unanchored polyUb species inherently toxic in vivo?
We generated poly-Ub transgenes that are not cleavable by DUBs and function as
unanchored species. Their expression in Drosophila melanogaster is not lethal during
development and adult flies tolerate the poly-Ub species well. These unanchored, non-cleavable
poly-Ub are themselves decorated with Ub and regulated by the proteasome. We also found that
these chains can be utilized en bloc without the need to be dismantled into mono-Ub. We propose
that unanchored poly-Ub can be regulated independently of DUB-based disassembly and suggest
a need to re-evaluate the extent of toxicity from free chains. Additionally, the new tools that we
developed should help future work to pursue regulation of unanchored poly-Ub in non-canonical
ways.
2.2. Materials and Methods
2.2.1. Antibodies
Anti-ataxin-3 (1:15000; MJD, rabbit polyclonal, [98]); anti-HA (1:1000; rabbit monoclonal;
Cell Signaling Technology, #3724); anti-Ub (1:500; rabbit polyclonal; DAKO, #Z0458); antiTubulin (1:10000, mouse monoclonal, Sigma-Aldrich, #T5168); anti-Rpn10 (1:2000; rabbit
polyclonal; AbCam, #ab18512); anti-20Sα (1:100; mouse monoclonal, Santa Cruz Biotech, #sc65755); anti-Rpn9 (1:100; mouse monoclonal, Santa Cruz Biotech, #sc-65754); anti-Rpt6
(1:1000; rabbit polyclonal; Cell Signaling Technology, #13392); anti-VCP (1:1000; rabbit
polyclonal; LSBio, #LS-C313248); anti-K63 (1:1000; rabbit monoclonal; Cell Signaling
Technology, #5621); anti-K48 (1:1000; rabbit monoclonal; Cell Signaling Technology, #8081);
anti-K27 (1:2000; rabbit polyclonal, Advanced Biomart, #FPA-21344M); anti-CycA (1:200; mouse
monoclonal, Developmental Studies Hybridoma Bank at the University of Iowa, #A12); anti-actin
(1:200; mouse monoclonal, Developmental Studies Hybridoma Bank at the University of Iowa,
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#1E12); anti-Lamin (1:200; mouse monoclonal; Developmental Studies Hybridoma Bank at the
University of Iowa, ADL84.12); anti-GFP (1:1000; mouse monoclonal, Millipore, #MAB3580); goat
anti-mouse, peroxidase conjugated secondary (1:5000; Jackson Immunoresearch); goat antirabbit, peroxidase conjugated secondary (1:5000; Jackson Immunoresearch). Antibodies against
K27, K48 and K63 linkages were the only antibodies we were able to obtain.
2.2.2. Construct generation
Ub6 transgenes (figure 2.1A) were synthesized by GenScript and cloned into
pWalium10.moe. Purified plasmid was injected into yw; attP40 by Duke University Model
Systems. The transformed chromosome was migrated onto w1118 parental line. The Ub
transgenes were subcloned into pcDNA3.1-HA vector for mammalian expression and into pGEX6P1 for recombinant production in bacteria.
2.2.3. Drosophila-related procedures and stocks
In all panels and figures, flies were heterozygous for driver and transgenes. Flies were
maintained in diurnal incubators at 25 °C and ~60% humidity, in conventional cornmeal media.
Where noted, RU486 was used in the same media, as previously described [99]. Where noted,
adults were maintained at 30 °C and ~60% humidity. Tubulin-Gal4-GS was a generous gift of Dr.
R. J. Wessells, Wayne State University; sqh-Gal4 was originally gifted by Dr. Daniel Kiehart, Duke
University; Mef2-Gal4 (#27390), elav-Gal4 (#458) and GMR-Gal4 (#8121) were from
Bloomington Drosophila Stock Center; repo-Gal4 was gifted by Dr. Daniel Eberl, University of
Iowa. The ataxin-3 lines have been described before [100-102]. The following RNAi lines were
from the Bloomington Drosophila Stock Center: VCP (#32869, #35608), Rad23 (#44031,
#44465), Rpt5 (#53886), Rpn1 (#34348), Ufd1-like (#41823), prosalpha2 (#36898), prosalpha3
(#55217), prosbeta5 (#34810), Rpn9 (#34034). The following RNAi lines were from the
Vienna Drosophila RNAi Center: Rad23 (#30498), Rpn11 (#19272), Sem1 (#31787, #31789,
#49152, #49153), Ufd1-like (#24700, #10473), p47 (#17529, #10748). For fly longevity, male and
female adults were collected after eclosion and aged in conventional cornmeal fly media at 25 °C,
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unless otherwise noted. The total number of flies per vial was ~20. Flies were transferred to new
vials every 2–3 days, until all were dead.
2.2.4. Western blotting
Five whole adults flies, or ten dissected fly heads per group were homogenized in hot lysis
buffer (50 mM Tris pH 6.8, 2% SDS, 10% glycerol, 100 mM dithiothreitol), sonicated, boiled for
10 min, and centrifuged at top speed at room temperature for 10 min. Western blots were
developed and quantified using a CCD-equipped VersaDoc 5000MP system and Quantity One
software (Bio-Rad), as described previously [103-105]. For transfected cells, media was removed,
cells were rinsed with ice-cold PBS and lysed in hot lysis buffer, boiled for 10 minutes and spun
for 10 minutes at max speed at RT.
2.2.5. Immunoprecipitation and subcellular fractionation
For stringent precipitation of HA-Ub6 from flies, 30 flies per group were homogenized in
RIPA lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% deoxycholic acid, 1% NP40, pH
7.4) supplemented with complete protease inhibitor cocktail (PI; Sigma-Aldrich), sonicated,
centrifuged at 15000 × g for 20 minutes at 4 °C. Supernatant was denatured for 30 min with 1%
final SDS at RT, renatured for 30 min with final 4.5% TritonX-100 at RT, and then incubated with
anti-HA antibody-bound beads (Sigma-Aldrich) for 4 hours tumbling at 4 °C. Beads were rinsed
5 × with RIPA, twice at 4 °C for 5 minutes, and bead-bound complexes were eluted with SDS
loading buffer and boiling for 5 minutes. For co-IPs under gentler conditions from the same flies,
NETN lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, and 0.5% IPEGAL ca-630) was used
instead, and the supernatant was incubated with beads without a denature/renature step, rinsed
4 × with NETN and bead-bound complexes were eluted with SDS loading buffer and heat.
Precipitations for HIS6-tagged Ub6 were conducted differently. Flies were homogenized in Buffer
1 (50 mM Tris pH 8, 6 M guanidine HCl, 10 mM imidazole) supplemented with PI, sonicated,
centrifuged as above and the supernatant was incubated with Ni-NTA beads (Qiagen) for 2 hrs
at 4 °C. Afterwards, beads were rinsed 6 × each with Buffer 1, Buffer 2 (50 mM Tris pH 8, 150 mM

32
NaCl, 8 M urea, 20 mM imidazole), and Buffer 3 (50 mM Tris pH 8, 500 mM NaCl, 20 mM
imidazole). Complexes were eluted with final 250 mM imidazole in Buffer 3. For stringent, HAbased purification from mammalian cells, pelleted cells (in ice-cold PBS) were lysed in RIPA
buffer + PI, sonicated, centrifuged (15000 × g, 20 minutes, 4 °C) then denatured for 30 min at RT
with 1% final SDS, renatured at RT with final 4.5 × TritonX-100 and incubated with anti-HA beadbound antibody for 4 hours at 4 °C. Beads were then rinsed 10 × with RIPA + PI and protein was
eluted with SDS loading buffer and heat. In all precipitation experiments, controls included beadbound antibodies (for HIS6 pulldowns, Ni-NTA resin) with lysate lacking the protein targeted by
the antibody/resin. For subcellular fractionation, 5 flies per group were used with the ReadyPrep
Protein Extraction Kit (Cytoplasmic/Nuclear; Bio-Rad). Flies were lysed in cytoplasmic extraction
buffer and nuclei were resuspended in protein solubilization buffer. Samples were analyzed by
western blotting.
2.2.6. Recombinant protein preparation and in vitro deubiquitination
Recombinant Ub6 was produced in bacteria using previously published protocols, and
eluted from glutathione sepharose beads using PreScission Protease (GE Healthcare) [38, 103,
104, 106-111]. For in vitro deubiquitination assays with recombinant Ub6 and USP5, we utilized
methods previously described [38, 103, 104, 107, 111, 112]. In brief, Ub6 and USP5 were
produced in bacteria, and eluted from glutathione sepharose beads by PreScission Protease (GE
Healthcare). 1 µM (final) Ub6 or 1 µM (final) commercial Ub chain (Boston Biochem) and 50 nM
(final) USP5 were combined together in kinase reaction buffer (0.5 M Tris pH 7.5, 0.5 M KCl, 0.2%
DTT) and incubated at 37 °C for the indicated amounts of time. Fractions were collected at the
indicated time points and reactions were stopped by adding SDS loading buffer and boiling for
1 minute. For deubiquitination of ubiquitinated Ub6 species from Drosophila lysates, 40 whole flies
expressing HA-Ub6-STOP in all tissues (sqh-Gal4 was the driver) were homogenized in RIPA
lysis buffer + PI, sonicated, centrifuged (15 min, 15000 × g at 4 °C) and supernatant was incubated
with anti-HA bead-bound antibody (Sigma-Aldrich) for 1.5 hr. Beads were rinsed 10X with

33
RIPA + PI and 3X with kinase buffer, split equally and one side was supplemented with additional
PI, whereas the other was supplemented with 100 nM (final) USP2 catalytic domain (Boston
Biochem). Reactions were incubated at 37 °C for the times indicated in figures and reactions were
stopped by the addition of 2X SDS sample buffer and by boiling for 1 minute.
2.2.7. Mammalian cells and procedures
HEK-293 and HeLa cells were from ATCC and were grown in DMEM with 10% FBS and
5% Penicillin-Streptomycin under conventional conditions. Cells were transfected using
Lipofectamine LTX (Invitrogen) as directed by the manufacturer. Twenty-four hours after
transfection, cells were harvested in boiling SDS lysis buffer.
2.3. Results
2.3.1. Expression of unanchored poly-Ub in Drosophila
We devised a strategy to express in Drosophila unanchored poly-Ub that cannot be
dismantled by DUBs. While this approach introduces exogenous Ub, we reasoned that our plan
would directly examine unanchored chains that cannot be removed through deubiquitination. We
designed two chains that consist of six Ub in tandem and lack internal “GG” motifs that are
necessary for isopeptide bond formation and their dismantling by DUBs (figure 2.1A). The first
(Ub6-Stop) cannot be cleaved by DUBs and lacks a terminal “GG”, meaning that it cannot itself
be conjugated onto other proteins. The second version is conjugatable; it does not have internal
“GG” motifs, but contains a “GG” at the end (Ub6-GG). We tested two DUBs for their ability to
cleave these chains. As shown in figure 2.1B, the chains we generated are not cleaved in vitro by
USP5. USP5 rapidly cleaves all types of chains in vitro, including linear chains [38] and can also
cleave chains with a free C-terminal “GG” or with an occupied “GG” (i.e. anchored chain) [1, 22,
38, 106, 113]. Figure 2.1F shows that another DUB, USP2, is also unable to cleave Ub6-Stop into
single Ub. We began our studies with the non-cleavable, non-conjugatable Ub6-Stop. We should
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Figure 2.1. Non-cleavable poly-Ub in Drosophila. (A) Summary of poly-Ub constructs. (B) Recombinant, untagged Ub6 (1 µM) was
incubated with USP5 (50 nM). See Methods for details. (C) Western blots of Ub6-Stop expressed in all tissues. Driver was sqh-Gal4.
HMW: higher molecular weight. Asterisk: non-specific band. Flies were one day old. (D) Western blots from whole flies expressing the
indicated transgenes, driven everywhere by sqh-Gal4. HIS6-pulldown of Ub6-Stop was conducted under denaturing conditions. Solid
line separates blots from the same membrane probed with the indicated antibodies. Dotted lines separate lanes reorganized from the
same membrane. (E) Histograms summarizing Ub6-Stop that is unmodified (non-conjugated band) vs. modified (conjugated bands and
upper smear) in blots in panels (C,F,G) and other, similar experiments. N = 10 independent repeats. Means −/+SD. Driver: sqh-Gal4.
(F) Deubiquitination reaction of Ub6-Stop isolated from flies and incubated in the absence or presence of the catalytic domain of
recombinant USP2 (USP2CD). See Methods for details. (G) Western blots from denature/renature IPs to examine ubiquitination of HAtagged Ub6-Stop by the indicated linkages. Solid lines indicate that membrane was loaded multiple times with the same samples, same
amounts, cut and probed simultaneously, as shown, to eliminate cross-contamination issues from stripping and re-probing the same
membrane. Asterisks: non-specific bands that we observe consistently with the respective antibodies. Dotted lines separate lanes
cropped from the same membrane. (H) Western blots of whole, adult flies expressing Ub6-Stop in all tissues (driver was sqh-Gal4), and
loaded to probe all Ub species. HMW: higher molecular weight. Box on the right summarizes quantification of signal from the adjacent
blots and other, independent experiments, normalized to respective loading controls, with Ctrl. lanes set to 100%. P value is from twotailed Student’s t-test. Signal quantified encompassed the band at the arrow all the way at the top of the gel. I) Western blots of stringent
purification of HA-Ub6-Stop driven by tubulin-Gal4-GS, which is dependent on RU486 to induce expression of Ub6-Stop in all tissues;
see main text for details. Arrows: unmodified Ub6-Stop. Curved lines: higher molecular weight species consistent with ubiquitinated Ub6Stop. For panels (B–D,F–I), results are representative of experiments conducted independently at least thrice, with similar results. In all
panels with Drosophila data, flies were heterozygous for driver and Ub6.

note that utilizing a linear chain is currently the only way to ensure efficient and robust production
of non-cleavable poly-Ub in an intact organism. Importantly, as we describe below, these linear

35
chains are quickly modified with different linkages to form various topologies.
We generated Drosophila lines that utilize the Gal4-UAS system [71, 72] to express Ub6Stop. We began by expressing Ub6-Stop throughout the fly, using the driver sqh-Gal4, which
expresses in all tissues, during development and in adults [114-119]. As shown in figure 2.1C,
Ub6-Stop migrates as a number of species on western blots. The lowermost band is the expected,
unmodified version of the protein, whereas the higher species are most likely posttranslationally
modified. Based on results from stringent immunopurifications (IPs) with a denature/renature step,
higher species consist of ubiquitinated versions of Ub6-Stop. We first co-expressed a mono-Ub
transgene that is HA-tagged alongside Ub6-Stop that is HIS6 tagged, then precipitated HIS6-Ub6Stop and examined its labeling by the mono-Ub. As shown in figure 2.1D, Ub6-Stop heavy
molecular weight species, but not the unmodified form, are labelled by the antibody that detects
the mono-Ub we introduced. This finding indicates that the Ub6-Stop linear chain is itself
posttranslationally modified by Ub. Based on the quantification of Ub6-Stop conjugated and nonconjugated bands and smears, ~75% of the total Ub6-Stop is modified (figure 2.1E).
To additionally confirm that higher molecular weight Ub6-Stop species are ubiquitinated,
we subjected Ub6-Stop from flies to the catalytic domain of USP2 (USP2CD). Within 10 minutes,
the higher molecular weight species collapse to the expected, unmodified Ub6-Stop in the
presence of USP2CD (figure 2.1F). A band immediately above Ub6-Stop remains stable. Based on
our stringent IPs (figure 2.1D,G), this is most likely mono-ubiquitinated Ub6-Stop. USP2CD might
be unable to remove this modification. Also, we cannot formally discount the possibility of another
type of posttranslational modification of this Ub6-Stop band. This species notwithstanding, our
results demonstrate that Ub6-Stop is itself ubiquitinated in the fly.
To get a glimpse at the type of Ub linkages attached onto Ub6-Stop, we conducted
additional, stringent IPs and probed Ub6-Stop with antibodies against K27, K48 and K63 linkages.
We found that Ub6-Stop is modified with K27, K48 and K63 linkages (figure 2.1G). Ub6-Stop itself
is essentially a linear chain; the fact that there are K27, K48 and K63 Ub-Ub conjugates on it
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means that the higher molecular weight species of Ub6-Stop constitute branched chains with
various Ub-Ub linkages. These types of poly-Ub species exist in cells. Our analysis does not
distinguish whether a specific branch of Ub moieties added onto Ub6-Stop comprises the same
type or different types of linkages. Based on these biochemical data, we conclude that higher
molecular weight species of Ub6-Stop contain branched chains and various Ub-Ub linkages.
When compared to the rest of Ub in the fly by western blotting, Ub6-Stop species are
abundant in Drosophila. We observe the unmodified band of Ub6-Stop, as well as an overall
darkening of the Ub smear above it (Figure 2.1H), which most likely consists of Ub6-Stop
conjugated with endogenous Ub. Quantification of these data shows a statistically significant
increase in Ub signal in the presence of Ub6-Stop, when expressed in all tissues (figure 2.1H,
quantification box). Thus, Ub6-Stop species appear to be prominently expressed.
To assess how quickly Ub6-Stop is ubiquitinated, we used the inducible, RU486dependent ubiquitous driver, tubulin-Gal4-GS to drive the Ub6 construct. We raised flies in media
without RU486. On day 1 as adults, flies were switched to RU486-food for 0–7 days. Ub6-Stop is
rapidly produced (figure 2.1I). Within 24 hours of being placed into RU486-containing media, we
observe prominent Ub6-Stop species, which reach an equilibrium over 3–4 days. This is most
likely due to initial Ub6-Stop production followed by degradation as the process stabilizes.
Next, we assessed the distribution of Ub6-Stop into major cellular sub-compartments. We
found that these species are cytoplasmic (figure 2.2A). We also found that their expression does
not impair proteasome-dependent degradation (figure 2.2B,C). We examined endogenous cyclin
A, a proteasome substrate, and CL1-GFP, a reporter of proteasome activity in mammalian and
fly systems; the CL1 degron targets GFP for ubiquitination and subsequent proteasomedependent degradation [38, 120-122]. Panels 2B and 2 C show that the levels of neither
proteasome substrate increase in the presence of Ub6-Stop. In fact, we observed diminished
levels of CL1-GFP with Ub6-Stop, indicating increased—not decreased—proteasome activity. The
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Figure 2.2. Ub6-Stop does not inhibit protein degradation or affect proteasome levels in Drosophila.
(A) Western blots from cytoplasmic/nuclear fractionation of whole flies expressing Ub6-Stop in all
tissues (Methods). Results are representative of experiments conducted independently at least three times,
with similar results. Asterisks: non-specific signal. Driver was sqh-Gal4. Two different exposures are shown
for Ub signal. (B,C) Western blots of the levels of the indicated proteins in the absence or presence of Ub6Stop. Boxes underneath blots show quantification summaries of the levels of the respective proteins. Means
−/+SD. Statistics: two-tailed Student’s t-tests. For (B) CL1-GFP was co-expressed alongside Ub6-Stop in
fly eyes, driven by GMR-Gal4. Flies were one day old. For (C) we probed one day old whole adults expressing
Ub6-Stop in all tissues through sqh-Gal4. The different lanes in blots represent independent experimental
repeats. (D) Levels of endogenous proteasome subunits when Ub6-Stop is expressed everywhere via sqhGal4. Flies were one day old. Boxes underneath blots show quantification summaries of the levels of the
respective proteasome proteins. Means −/+SD. Statistics: two-tailed Student’s t-tests. The different lanes in
all blots represent independent experimental repeats. Tubulin signal in top blot remains after stripping to probe
with the antibodies indicated in that panel. In all panels, flies were heterozygous for driver and transgenes.

levels of cyclin A did not change in the presence of Ub6-Stop. We also blotted for VCP, whose
expression is increased when proteasome function is reduced in the fly [123] and did not find
significant differences in the presence of Ub6-Stop (figure 2.2C). Lastly, endogenous proteasome
subunits were not significantly impacted by the presence of Ub6-Stop (figure 2.2D). Results in
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figure 2.2B–D indicate that Ub6-Stop does not inhibit the activity of the proteasome in vivo and
that its presence does not perturb levels of endogenous proteasome components.
2.3.2. Expression of unanchored poly-Ub is not devastating in Drosophila
We examined lethality from unanchored chains in Drosophila by driving the expression of
Ub6-Stop through sqh-Gal4. This is a highly robust driver that others and we have used with strong
outcomes, such as early developmental lethality from knockdown of various genes and high
toxicity from expression of various, mutant proteins [36, 38, 100-102, 114-118, 124,
125]. Drosophilae undergo several developmental stages, none of which appears impacted by
Ub6-Stop (figure 2.3A). When we tracked adult fly longevity in the absence or presence of Ub6Stop, we again did not notice marked deviation between the two groups (figure 2.3B). This lack
of a statistically significant difference in longevity in adult flies expressing Ub6-Stop was also
noticeable when adults were stressed with heat. As shown in figure 2.3C, flies expressing Ub6Stop and placed at 30 °C live similarly to their non-Ub6-Stop counterparts.
We subsequently expressed Ub6-Stop in select fly tissues—neurons, glia and muscle
cells—using drivers common to the fly community. We selected this approach because tissuespecific drivers can express UAS transgenes more strongly in that particular tissue than
ubiquitous drivers, as exemplified in figure 2.3D. Figure 2.3D shows expression of Ub6-Stop in
different tissues; the muscle driver expresses this construct very highly. Developmental
observations did not show marked differences in lethality from Ub6-Stop expressed in the tissues
tested (figure 2.3E). When we examined adult fly longevity, 50% were dead a few days earlier
than controls in the presence of Ub6-Stop (figure 2.3F). Comparison of the day when all flies were
dead showed that with muscle expression, adults expressing Ub6-Stop persisted longer than
controls. Statistical analyses of these results revealed a significant difference in the overall
longevity of flies expressing Ub6-Stop in glial or neuronal cells compared to control flies: presence
of Ub6-Stop in these tissues led to overall shorter lifespan. Still, this is a mild deviation. Muscle-
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Figure 2.3. Expression of Ub6-Stop everywhere or in specific tissues is not lethal to Drosophila. (A)
Summary of the effects of expression of Ub6-Stop throughout fly development. Driver was sqh-Gal4. Control:
sqh-Gal4 on the genetic background used to generate the Ub6 flies. We monitored daily lethality at larval,
pupal and pharate adult stages among groups and did not notice differences in their development. Little to no
developmental lethality occurred in all crosses. We monitored at least 10 independent crosses, all at 25 °C.
(B,C) Percent longevity of adult flies not expressing or expressing Ub6-Stop at the indicated temperatures. P
values were calculated using log-rank (Mantel-Cox) tests. (D) Western blots showing the expression levels of
Ub6-Stop in the indicated tissues. We used one day old, whole adult flies for all lysates. Results are
representative of experiments conducted independently four or more times, with similar results. Asterisk: nonspecific band. (E) Summary of lethality during development when Ub6-Stop was expressed in specific tissues,
as in (A). We monitored lethality at larval, pupal and pharate adult stages. We did not notice differences in
their development and little to no developmental lethality occurred in all crosses. We monitored at least 10
independent crosses, all at 25 °C. (F) Percent longevity of adult flies not expressing or expressing Ub6-Stop
in the indicated fly tissues. Controls consisted of the respective drivers on the genetic background utilized to
generate Ub6 flies, but without the transgene. P values were calculated using log-rank (Mantel-Cox) tests. In
all panels, flies were heterozygous for driver and Ub6.

specific

expression did not lead to a statistically different lifespan compared to controls.

Collectively, these data lead us to the conclusion that Ub6-Stop is not devastating overall.
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Longevity studies with the ubiquitous driver (figure 2.3A–C) and tissue-specific drivers
(figure 2.3D–F) were conducted at different times, maintained in different rooms and reared and
aged in fly media prepared with different batches of primary ingredients. These factors most likely
account for the overall shorter longevity of flies in figure 2.3F compared to 3B. However, control
flies for each experiment (figure 2.3A,B,C,E,F) were collected, aged and observed side by side
with the Ub6-Stop flies.
2.3.3. Protein levels of Ub6-Stop depend on the proteasome
Since Ub6-Stop cannot be disassembled by DUBs, we wondered whether it can be
regulated by the proteasome. First, we assessed its persistence in vivo. We again utilized the
RU486-dependent, ubiquitous driver, tubulin-Gal4-GS. Flies that contained one copy each of the
driver and Ub6-Stop transgenes were reared in food without RU486 until day 1 as adults, then
placed on media with RU486 for 7 days to induce transgene production. On day 7, they were
switched to media without RU486 to halt Ub6-Stop expression and collected at different points.
As shown in figure 2.4A, Ub6-Stop protein is mostly degraded within seven days, although we still
observe it at 14 days. Thus, this protein is turned over in the intact fly. Next, we examined whether
the proteasome regulates its levels.
We used RNA-interference (RNAi) to specifically knock down genes that encode
proteasome components. Where available, we employed more than one RNAi line for each gene.
We conducted RNAi-based studies in fly eyes, because knockdown of most of the genes we
targeted is lethal when performed everywhere. We targeted α and β subunits of the 20S
proteolytic core and the following components of the 19S proteasome: Rpn1 (helps with Ub
binding and processing at the proteasome) [126], Rpn9 (anchors other components to the 19S)
[127], Rpn11 (removes Ub chains) [20, 96], Rpt5 (facilitates interaction of 19S with 20S) [128] and
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Figure 2.4. Ub6-Stop turnover in Drosophila. (A) Left: Western blots of whole fly lysates expressing Ub6Stop via tubulin-Gal4-GS. Flies were reared in media without RU486. On day 1 as adults, they were switched
to media with the inducer and allowed to produce Ub6-Stop for seven days. On day 7, flies were switched to
media without RU486 to shut off Ub6-Stop production and whole flies were frozen on the indicated days. Right:
quantification of the entire Ub6-Stop smear from the images on the left and other, independent experiments.
Means −/+SD. N = 6 independent repeats. Two different exposures are shown for Ub signal. (B–D) Western
blots from dissected fly heads expressing Ub6-Stop and the indicated RNAi lines. Numbers denote different
RNAi lines. In all panels, flies were heterozygous for GMR-Gal4, Ub6-Stop and RNAi transgenes. Results are
representative of experiments conducted independently three or more times with each RNAi line, with similar
results. For Rad23 lines we are including results from two independent experiments, since the results are not
as clear or consistent as with the other lines from experiment to experiment. Samples, gels and probes were
conducted on different days. Samples in one membrane were collected and prepared on the same day. (E)
Table summarizing quantification of images from blots in panels (B–D) and other, independent experiments.
The entire Ub6-Stop signal was quantified. N is at least three for each RNAi line and controls. Signal from
RNAi lines was normalized to its respective control. Means −/+SD. P values are from two-tailed Student’s ttests comparing each RNAi to its own control (no RNAi). Asterisks: p < 0.05.

Rpn13 (Ub receptor) [129]. Targeting each of these subunits through RNAi led to higher levels of
Ub6-Stop protein compared to controls; controls consisted of the background genetic line of RNAi
constructs in the absence of any knockdown (figure 2.4B–E). Similarly, knockdown of Sem1 led
to prominently higher levels of Ub6-Stop (figure 2.4D,E). Sem1 is necessary for 19S assembly
[130] and is a stoichiometric component of the 19S, where it functions as a Ub receptor [130-132].
Collectively, these results strongly implicate the proteasome in Ub6-Stop degradation.
Ubiquitinated proteins can come into direct contact with the proteasome, or can be
assisted by Ub-binding proteins, referred to as proteasome shuttles. To examine the involvement
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of proteasome shuttles in Ub6-Stop turnover, we investigated the segregase, VCP, which
functions in part to help deliver ubiquitinated proteins to the proteasome for degradation, as well
as its cofactors, p47 and Ufd1-like [133-138]. We also targeted the proteasome shuttle protein
Rad23 [139-142]. Knockdown of VCP (figure 2.4C,E), p47 and Ufd1-like (figure 2.4D,E) each led
to consistently higher protein levels of Ub6-Stop. Knockdown of Rad23 did not have as prominent
of an effect on Ub6-Stop protein levels compared to p47, Ufd1-like and VCP (figure 2.4D,E).
Subsequently, we examined the interaction of Ub6-Stop with VCP and the proteasome.
We expressed Ub6-Stop in fly eyes, precipitated it under mild conditions and examined its
interaction with endogenous Rpn9 (anchors Rpn10 to the 19S), Rpn10 (Ub receptor), 20Sα
(proteolytic portion) and VCP [127, 143, 144]. Ub6-Stop co-precipitated VCP, Rpn10 and Rpn9.
Unlike with the 19S components, we were unable to specifically co-precipitate 20Sα with Ub6Stop (figure 2.5A,B). This could be due to dissociation of the 19S and 20S components during
the IP. The rest of the results from panels 5A and B, however, indicate that Ub6-Stop comes into
physical contact with the proteasome and VCP.
Lastly, we examined the effect of p47 in the interaction of Ub6-Stop with VCP and,
downstream from this AAA ATPase, the proteasome [145]. We targeted this VCP cofactor based
on data that it binds branched chains [12] and because its knockdown has a clear impact on Ub6Stop levels (figure 2.4). As shown in figure 2.5C, knocking down p47 leads to decreased levels of
VCP and Rpn10 that co-precipitate with Ub6-Stop. Knockdown of p47 did not reduce the amount
of Rpn10 that co-precipitates with Ub6-Stop as much as the levels of VCP that co-precipitates
with Ub6-Stop. This may be due to VCP-independent routes through which Ub6-Stop reaches the
proteasome. Collectively, data in figure 2.5 suggest that Ub6-Stop comes into contact with the
proteasome at least in part through p47 and VCP.
2.3.4. Ub6-GG can be conjugated en bloc in mammalian cells and in Drosophila
Our work thus far focused on Ub6-Stop, which cannot be conjugated onto other proteins.
We studied these chains to examine the regulation of unanchored species when they cannot be
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Figure 2.5. Ub6-Stop interacts with the proteasome, VCP and p47 in Drosophila. (A–C) Western blots of
co-IPs from whole fly heads expressing Ub6-Stop in fly eyes. Flies were heterozygous for GMR-Gal4 and HAtagged Ub6-Stop. Asterisks: non-specific bands in lanes not expressing HA-Ub6-Stop. Results are
representative of experiments conducted independently at least three times, with similar results. In each panel,
“Ctrl” signifies anti-HA-bead-bound antibody that was incubated with fly lysates that do not express any HAtagged Ub6-Stop. For quantified blots in panel (C), we loaded gels to achieve comparable levels of Ub6-Stop
in the IP lanes. The entire HA-Ub6 smear was quantified. Shown in histograms are means −/+ SD. P values
are from two-tailed Student’s t-tests.

cleaved into mono-Ub. Still, the prospect exists that unanchored chains, which normally contain
a terminal “GG”, might become conjugated onto other proteins, effectively eliminating them from
the unanchored pool. The possibility of en bloc conjugation of an entire Ub chain has been
considered for some time in the Ub community [75-78, 146]. We reasoned that our non-cleavable
Ub species could be used to assess en bloc transfer within the frame of unanchored poly-Ub
regulation.
We transiently expressed Ub6-Stop and Ub6-GG in mammalian cells. As shown in
figure 2.6A, expression of Ub6-GG leads to a smear above the unmodified band. Unlike in flies,
we do not observe a smear above Ub6-Stop when it is transiently transfected in cells, even though
it is degraded via the proteasome. Using stringent, denature/renature IPs of Ub6-GG from
mammalian cells, we found an endogenous protein chemically modified by this chain, ataxin-3
(figure 2.6B), whose ubiquitination we have documented before [103, 107, 111]. Ataxin-3 is a
DUB whose catalytic activity does not eliminate its own ubiquitination [108]. Mutations in the
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Figure 2.6. Ub6-GG is conjugated to proteins in mammalian cells and in flies. (A) HEK-293 cells were
transiently transfected as indicated and harvested for whole lysate western blotting 24 hours later. No Ub6:
empty vector control transfection. 1 × and 2 × denote relative transfection amounts. (B) HEK-293 cells were
transfected with the empty host vector of Ub6-GG or with HA-tagged Ub6-GG for 24 hours. Cells were pelleted,
lysed in RIPA buffer with protease inhibitors (PI) and subjected to a denature/renature protocol (Methods)
before IP. Asterisks: non-specific signal. Red arrows: unmodified, full length ataxin-3 protein. Ataxin-3 runs as
a doublet in input blots. This reflects the two alleles of the gene that have different CAG repeats. Dotted lines
separate lanes from the same membrane, cropped and reorganized for ease of viewing. (C) Longevity from
adult flies expressing, or not, Ub6-GG in all tissues via sqh-Gal4. P value was calculated using log-rank
(Mantel-Cox) test. (D) Western blots from denature/renature HIS6-based precipitation of Ub6-GG expressed
in all neurons alongside ataxin-3. Ctrl: no HIS6-Ub6-GG expressed alongside ataxin-3. Membrane was loaded
with the same samples twice, cut in half and probed simultaneously with the indicated antibodies. We used a
pan-Ub antibody in this case to show the specificity of the pulldown. Asterisk: non-specific band in the absence
of HIS6-Ub6-GG expression in the fly. Red arrow: unmodified ataxin-3 protein. Blue arrow: ataxin-3 protein
fragment most likely resulting from proteolytic cleavage77; this species of ataxin-3 is absent in IP lanes. Two
different exposures are shown for anti-ataxin-3 signal. Dotted line separates lanes from the same membrane,
cropped and reorganized for ease of viewing. For all panels, results are representative of experiments
conducted independently at least three times, with similar results.

polyglutamine region of this DUB cause the neurodegenerative disease, Spinocerebellar Ataxia
Type 3 [147]. Unmodified ataxin-3 migrates at ~42 kDa. Ub6-GG migrates immediately below
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50 kDa. We would expect ubiquitinated forms of ataxin-3 by Ub6-GG to appear ≥90 kDa. In
figure 6B, the ataxin-3-positive smear from Ub6-GG denature/renature IPs begins below 100 kDa
and extends all the way to the top, consistent with Ub6-GG-ataxin-3.
We then turned to flies. Expression of the non-cleavable, conjugatable Ub6-GG in all
tissues does not cause marked lethality (figure 2.6C). To examine whether Ub6-GG can be
utilized en bloc in flies, we again investigated ataxin-3, which is ubiquitinated in Drosophila [111,
148]. Here, we used ataxin-3 with an expanded polyglutamine tract (from wild-type with ~20
repeats to pathogenic -range 77 glutamine residues), because this version of the protein is well
ubiquitinated in the fly (our unpublished observations). We expressed ataxin-3 in the absence or
presence of Ub6-GG pan-neuronally and utilized whole, intact flies to isolate HIS6-Ub6-GG under
stringent, denaturing conditions. As shown in figure 2.6D, in the presence of Ub6-GG we observe
ataxin-3 species in the high molecular weight portion of the pulldown lane, but not in the negative
control lane, which has ataxin-3 but lacks Ub6-GG. We do not notice unmodified ataxin-3 species,
intact or proteolytically cleaved, in either of the IP lanes (figure 2.6D). Polyglutamine-expanded,
unmodified ataxin-3 migrates at ~60 kDa. Accounting for Ub6-GG (~50 kDa), we would expect the
ubiquitinated species of ataxin-3 above the 100 kDa band, which is what we see (figure 2.6D).
There isn’t a marked change in the higher molecular weight species of ataxin-3 in input lanes
when Ub6- GG is expressed alongside this protein, but we clearly observe ataxin-3 signal in the
Ub6-GG pulldown lane. Our interpretation of these results is that a portion of ataxin-3, in the high
molecular weight part of the gel, is modified with Ub6-GG. Thus, some of ataxin-3 in the fly can
be modified with the non-cleavable, conjugatable Ub6 species, without the need for this type of
chain to be first cleaved into mono-Ub. We conclude that unanchored poly-Ub can be utilized en
bloc for conjugation onto other proteins in an intact organism, without first being disassembled
into mono-Ub.
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2.4. Discussion
We set out to examine what happens to unanchored chains when they cannot be
disassembled by DUBs. We generated new Drosophila models of poly-Ub, which we believe will
find future use in the fly and ubiquitin communities. The unanchored chains that we constructed
exist in different lengths and topologies in vivo, from unmodified Ub6 to markedly higher molecular
weight species, and contain various linkages. Nearly 75% of Ub6 appears as modified
bands/smears conjugated with endogenous Ub. These free chains were degraded by the
proteasome and could also be attached onto other proteins, without the need to be first
deconstructed into mono-Ub. Based on these findings, we propose a model of unanchored chain
management that comprises four potential routes (figure 2.7): the first is canonical, where
unanchored poly-Ub is dismantled and then reutilized [1, 21, 22, 92, 96]. Besides it, we posit that
there may be additional options for unanchored chains: they can be degraded by the proteasome,
they can be eliminated by being used en bloc to be conjugated onto other proteins in the cell, or
they can be bound by Ub-binding proteins and maintained in a separate or “reserve” pool until
they re-enter utilization, if or when needed. The last possibility is not necessarily mutually
exclusive with the other potential avenues and may serve as a feeding route for the other options.
How is the decision made to degrade or reutilize an unanchored chain rather than dismantle it?
Under some conditions, it might be more advantageous to use a ready-made chain than to make
a new one to attach to a specific substrate, perhaps during low energy states or when increased
rates of

protein turnover are required—in other words, chain shuffling among different

proteasome substrates could enhance their targeting and degradation.
The unanchored chains that we designed and expressed in flies do not represent all of
the various types of Ub linkages and species that can be found in the cell. In fact, linear chains
are a minor constituent of the total Ub pool [149] and the functions of these types of chains are
not entirely known [150], hindering to some extent the utility of the lines that we generated toward
understanding more broadly Ub-dependent pathways. Still, the linear Ub6 that we constructed

47

Figure 2.7. Model of unanchored poly-Ub regulation in vivo. Unanchored poly-Ub can be dismantled into
mono-Ub and reutilized in future Ub reactions by the coordinated action of E1/E2/E3. This is the canonical
model of Ub recycling. Our results in Drosophila suggest the possibility of other, non-mutually exclusive
mechanisms of unanchored Ub chain control: their degradation as whole units by the proteasome; their
reutilization en bloc, enabling the conjugation of the entire chain onto a substrate without the prior need for
dismantling into mono-Ub; or their maintenance in a separate, “reserve” pool through interaction with Ubbinding proteins. The “reserve” pool could feed into the other routes.

exist as modified and unmodified species of various lengths and topologies in Drosophila. We
contend that these species represent different types of free poly-Ub in vivo and, at the very least,
can be used to provide clues into regulatory mechanisms that dictate what happens to branched
chains containing multiple Ub-Ub linkages. It was recently reported that branched chains
consisting of K48 and K11 linkages are generated by E2/E3 complexes and play critical roles in
targeting misfolded proteins for proteasomal degradation [12].
The VCP cofactors Ufd1-like and p47 as well as VCP itself are critical for the levels of
unanchored poly-Ub. The proteasome-associated protein, Rad23 also appeared important in this
process. We did notice variation in the extent of effect with different RNAi lines targeting a specific
gene; this is most likely due to differences in the efficacy of each line in reducing the mRNA levels
of the targeted fly gene. Based on our results, VCP and its co-factors are key players for the
protein levels of unanchored poly-Ub in the fly. This is not surprising for chains comprising various
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linkages (K48, K63 and K27, at least), since p47 and VCP are adept at recognizing branched
chains in mammalian cells [12].
Unanchored chains have been argued to compete with ubiquitinated proteasome
substrates for access to the 26S proteasome [43, 44, 47, 96]. However, unanchored poly-Ub
species that we induced in the fly do not negatively impact degradation of proteasome substrates,
even though these chains interact with the proteasome. We examined two substrates,
endogenous cyclin A and the reporter CL1-GFP. The protein levels of neither substrate were
increased. In fact, we observed lower protein levels of CL1-GFP, indicative of enhanced
degradation of this fusion protein. We also did not observe changes in the levels of VCP, which
is upregulated when the fly proteasome is inhibited [123]. Our results suggest that unanchored
chains need not play an exclusively inhibitory role for the proteasome. Binding of free poly-Ub to
various Ub-binding proteins could sequester the chains away from the proteasome, keeping the
degradative machinery unperturbed. But, what might account for lower levels of CL1-GFP? For a
subset of proteins degraded by the proteasome, unanchored poly-Ub might enhance substrate
delivery to this machinery as a result of recruitment of Ub-binding proteins that normally delay
their degradation, but which are now occupied with free poly-Ub. In the case of CL1-GFP, it might
be that a protein that would normally bind to CL1-GFP and restrain its degradation is now
occupied with Ub6, leading to more prompt degradation of CL1-GFP. Other possibilities exist.
Future work is required to untangle these and other details.
The discrepancy between our work and prior reports that unanchored chains impede
proteasome activity [43, 44, 47, 96] could be due to various reasons and highlights a need for
additional studies of unanchored poly-Ub regulation. Some earlier work was conducted in cultured
mammalian cells using transient expression. Perhaps, unanchored poly-Ub transiently inhibits the
proteasome and becomes toxic in isolated cells, whereas in vivo free chains are easily managed.
Other work focused on the function of specific DUBs, such as USP5, whereas we assessed
unanchored poly-Ub more directly. Proteasome inhibition when certain DUBs are absent might
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result from perturbation of specific substrates rather than general effects from unanchored polyUb. For example, similar to others [37], we observed impeded proteasome function when USP5
was knocked down in the fruit fly [38]. However, USP5 mutation or knockdown might lead to
inhibited proteasome activity as a result of accumulation of its substrates, independently of
unanchored chains. In fact, not all proteasome substrates are impacted by USP5 knockdown
[47] and there is evidence that USP5 has specific substrates [113, 151, 152]. The tools that we
generated here will be beneficial for future work to continue assessing the consequences of
unanchored poly-Ub in intact organisms.
Lack of consistent and marked lethality from unanchored chains during development or in
adults, including under heat stress, suggests that they are not necessarily toxic. Nonetheless,
conditions or tissues where unanchored poly-Ub can be problematic may exist. For example, we
did observe mild reduction in the lifespan of flies expressing Ub6-Stop in glial cells or neurons
specifically. A study of ubiquitin homeostasis at the Drosophila neuromuscular junction (NMJ)
during larval development [97] utilized mono-Ub transgenes that can be modified with
endogenous Ub, but which cannot themselves be added onto other substrates because they lack
a terminal “GG”. Post-synaptic presence of these transgenes caused morphological anomalies
under some circumstances, but not others. If K48 linkages could be attached onto the transgene,
there were mild, but statistically significant, anomalies. If K48 linkages could not be made onto
the mono-Ub transgene (other chains could be constructed) there was no toxicity [97]. Thus, some
types of unanchored linkages appeared mildly problematic in this assay, while others did not.
Whether NMJ anomalies disappeared with continued development, or if these constructs were
lethal throughout the fly was not clear. Together with our results, this earlier study
[97] substantiates the conclusion that unanchored chains need not be toxic. Although we used
robust drivers without devastating lethality effects, we will not discount the possibility of anomalies
caused by free chains at very high levels, under certain stressors, or in specific types of assays.
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The point we want to highlight is that unanchored chains can be handled well in vivo and that the
extent of their toxicity should be reevaluated.
In summary, unanchored chains can be managed in vivo in ways that do not require their
disassembly by DUBs: they can be degraded and they may even be conjugated en bloc to other
proteins. Our work presents new possibilities into Ub recycling and reutilization.
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CHAPTER 3: UNANCHORED UBIQUITIN CHAINS DO NOT LEAD TO MARKED
ALTERATIONS IN GENE EXPRESSION IN DROSOPHILA MELANOGASTER
3.1. Introduction
Cellular and organismal physiology and homeostasis are regulated at multiple, interdependent levels that extend from DNA-based regulation of gene expression to the epigenetic
control of genes themselves and of their products. Among the more flexible systems of epigenetic
control is the post-translational modification of cellular proteins by various adducts, including
ubiquitination, phosphorylation, methylation and acetylation. Ubiquitination represent a highly
malleable system of post-translational regulation of proteins and the complexes in which they
participate[1, 2]. Ubiquitin (Ub), itself a small protein of approximately 8.5 kDa, is highly conserved
among all eukaryotic species and regulates proteins in various ways, from tagging them for
proteasomal degradation to directing their participation in cellular signaling pathways[1, 87, 153].
Ubiquitin conjugation onto another protein, what is termed “ubiquitination”, requires the
concerted effort of three types of enzymes: an E1 activating enzyme, an E2 conjugating enzyme
and an E3 ligase (Figure 1A). This ATP-dependent process results in an iso-peptide bond
between the C-terminal “GG” motif of a Ub molecule and the substrate protein, typically at a lysine
residue. Ub itself can also become ubiquitinated, resulting in a poly-Ub chain defined by the
specific modified lysine residue or, in the case of M1/linear chains, the methionine residue[1, 6,
12]. The type of chain created has a distinct effect on the fate of its substrate protein; for instance,
K48 chains are known for their involvement in targeting proteins for proteasomal degradation[8].
Ubiquitination is reversible; deubiquitinases (DUBs) remove Ub from a protein or edit the length
of a chain[2].
Unanchored Ub chains--poly-Ub that is not tethered onto a substrate protein--also exist in
the cell and can arise when a DUB removes an intact chain from a protein, or can be generated
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Figure 3.1. Unanchored poly-Ub. (A) Unanchored poly-Ub can arise after E1/E2/E3 cycles build a Ub chain
onto a substrate, after which a DUB removes the chain as a single species. It is believed that these untethered
chains are then dismantled by additional DUBs to yield mono-Ub that can be recycled in new ubiquitination
events. (B) Schematic of the two types of Ub6 chains we designed for expression in Drosophila. Both Ub6Stop and Ub6-GG are head-to-tail hexa-Ub that cannot be dismantled by DUBs. Ub6-GG, but not Ub6-Stop,
can be conjugated onto other proteins. (C) Ubiquitous Ub6 expression does not affect the development or the
lifespan of the fly (Blount et al., 2018). One-day-old adults were collected and processed for RNA-Seq and
qRT-PCR analyses.

anew through E1/E2/E3 cycles. Although unanchored poly-Ub is not well understood, it has been
implicated as a participant in several cellular processes, including NF-κB signaling and
autophagy[2, 21, 26, 33, 57, 68, 88, 92-94, 154]. The currently prevailing view is that unanchored
Ub chains are quickly disassembled by DUBs and recycled as mono-Ub (Figure 1A)[1, 21, 22,
87]. Studies in yeast and in cultured mammalian cells have suggested that the buildup of free
poly-Ub might become toxic by perturbing Ub-dependent proteasomal degradation[37, 43, 44, 47,
95, 96].
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Intriguingly, when we examined the toxicity of untethered chains in an in vivo context, we
observed that the extended presence of untethered Ub chains is not necessarily deleterious to an
intact organism, Drosophila melanogaster[70]. For these studies in Drosophila, we designed
head-to-tail hexa-Ub chains that lack all “GG” motifs (Ub6; Figure 1B), making them both resistant
to cleavage by DUBs and unable to be conjugated onto other proteins; these resemble linear,
unanchored Ub chains that are endogenously present [1, 21, 22, 87]. When expressed in all
tissues, unanchored poly-Ub does not negatively impact the lifespan of the fly (Figure 1C)[70]. It
has been suggested that free poly-Ub could interfere with the proteasome. However, we observed
no deficiencies in proteasome subunit expression or function; in fact, untethered poly-Ub were
degraded by the proteasome[70]. We also observed that a pre-existing Ub chain can be used en
bloc to ubiquitinate a protein in vivo[70].
Throughout our studies[70], we became confident that unanchored poly-Ub is not
inherently or especially toxic, but it was still unclear whether the presence of either form induces
a concerted cellular response against them. While both Ub6 constructs resemble linear,
unanchored poly-Ub, their inability to be cleaved is unnatural. Does the introduction of these
exogenous chains bring about an organismal response, or are they as readily tolerated as they
seem to be? Is there an upregulation of dismantling DUBs, like USP5, which is widely reported to
disassemble free poly-Ub[1, 22, 38, 106, 113]? Is there a change in the expression of E2/E3 pairs
that might be able to take advantage of premade chains? Using RNA-Seq to compare Ub6-GG
and Ub6-Stop to non-Ub6-expressing controls we observed that ubiquitous expression of each
Ub6 construct induces significant changes in the expression of approximately 90 genes, with no
clear indication of a specific cellular response mounted. Surprisingly, only two Ub-related genes
were affected at the transcript level, and our analyses did not reveal a coordinated effect on
pathways that are known to involve unanchored poly-Ub. According to these analyses,
unanchored poly-Ub does not elicit a marked organismal response in Drosophila, suggesting that
these species are not inherently problematic.
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3.2. Materials and methods
3.2.1. Fly lines
Generation of transgenic Drosophila lines was described previously [70]. Ubiquitous gene
expression was driven by sqh-Gal4 [71, 72, 114-116, 118, 119], with all flies heterozygous for the
transgene and the driver. In the case of controls, all flies were heterozygous for sqh-Gal4 on the
genetic background of Ub6 flies. Crosses were maintained in diurnal incubators at 25°C and ∼60%
humidity, on conventional cornmeal media. One-day-old adult offspring were collected for RNA
isolation.
3.2.2. RNA isolation
Total RNA was extracted from ten whole flies per group using TRIzol reagent (Invitrogen),
following the manufacturer's protocol. RNA was then treated with TURBO DNase (Ambion) to
eliminate contamination by DNA.
3.2.3. RNA-Seq
RNA expression analysis was conducted at the Wayne State University Applied Genomics
Technology Center. Four biological replicates were used for each genotype. An aliquot of the
RNA was assessed by microfluidics using the ScreenTape for the Agilent 2200 TapeStation. The
electrophoretogram, RNA integrity number (RIN), and the ratio of the 28S:18S RNA bands were
collectively examined to determine overall quality of the RNA (Table S3.10). RNA-Seq, primed
from the poly(A) tail, was used to determine expression profiles. Lexogen's QuantSeq 3′mRNASeq Library Prep Kit (FWD for Illumina) was utilized for building RNA-Seq libraries from 250 ng of
total RNA in 5 µl of nuclease-free ultrapure water. Libraries were quantified on the Qubit and
Agilent 2200 TapeStation using the DNA High Sensitivity Screen tape. The barcoded libraries
were multiplexed at equimolar concentrations and sequenced with 50 bp reads in rapid mode on
an Illumina HiSeq 2500. Data were de-multiplexed using Illumina's CASAVA 1.8.2 software. After
quality was assessed [155] reads were aligned to the Drosophila genome (Build dm3) with
STAR_2.4 [156] and tabulated for each gene region [157]. All raw data was uploaded into NCBI
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GEO database (awaiting GEO ID number). Differential gene expression analysis was used to
compare transcriptome changes between conditions using edgeR v.3.22.3 [158]. All conditions
were individually compared (i.e. Ub6-GG versus control, Ub6-Stop versus control, and Ub6-Stop
versus Ub6-GG) and transcripts were defined as significantly differentially expressed at absolute
Log2 fold change >1, FDR <0.05. Dataset S1 contains all differentially expressed transcripts for
each comparison.
3.2.4. DAVID/Pathway analysis
Differentially expressed (absolute Log2 fold change >1, FDR<0.05) RNA-Seq transcripts
at each level of comparison (Ub6-GG versus control, Ub6-Stop versus control, Ub6-Stop versus
Ub6-GG) were used to identify affected pathways. Transcripts were separated into lists of
upregulated and downregulated genes for each condition. Each list was uploaded into the
Functional Annotation tool provided by DAVID (https://david.ncifcrf.gov, v. 6.8) as a gene list and
submitted using the official gene symbol as identifier and D. melanogaster as background
(or Homo sapiens where indicated). Charts were created from several terms of interest, including
enriched Biological Process (BP_DIRECT), Molecular Function (MF_DIRECT), and Cellular
Component (CC_DIRECT) gene ontology as well as KEGG Pathway (KEGG_PATHWAY) terms.
Terms were included as enriched if P-value<0.05.
3.2.5. Quantitative real time PCR7
qRT-PCR was performed on select genes to validate RNA-Seq results. High-Capacity
cDNA Reverse Transcription Kit (ABI) was used to obtain a cDNA library, following the
manufacturer's protocol. Pre-amplification of the genes of interest was performed using TaqMan
PreAmp Master Mix (Thermo Fisher Scientific). A Gilson 268 PIPETMAX liquid handling platform
was used to plate Fast SYBR Green (ABI) qRT-PCR reactions in triplicate in 384-well plates.
Messenger RNA levels were quantified with QuantStudio 5, using 2−ΔΔCt (cycle threshold)
methods and normalizing all transcripts to the reference gene, Rp49. All primer sequences are
listed in Table S3.9.
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3.3. Results
3.3.1. Unanchored Ub chain design and expression in Drosophila for RNA-Seq analyses
As a strategy to study unanchored poly-Ub in Drosophila, we designed two types of Ub
chain transgenes, each consisting of six Ub in tandem, without internal di-glycine, ‘GG’ motifs that
are required for dismantling into mono-Ub by DUBs (figure 3.1B; [70]). The first chain type, Ub6Stop, also lacks the C-terminal ‘GG’ motif required for conjugation onto substrate proteins. The
second type, Ub6-GG, contains a C-terminal ‘GG’ motif, allowing the full chain to form iso-peptide
bonds onto other proteins in mammalian cells and in vivo in the fly, as we demonstrated before
[70]. Although the use of these chains introduces exogenous poly-Ub, this strategy permits us to
directly examine the effects of intact, free poly-Ub on the Drosophila transcriptome. Presently,
there is a lack of tools to more directly investigate unanchored poly-Ub in the fly; for example,
targeting of DUBs implicated in free Ub chain disassembly would also impact other protein
substrates that these DUBs have.
We utilized the binary Gal4-UAS expression system to drive our Ub6 transgenes in the fly.
In this system, transgenes with upstream activating sequence (UAS) sites are activated under the
control of the transcription factor Gal4, itself expressed in the pattern of a specific gene [71, 72].
For our work in this study, we selected the Gal4 driver sqh-Gal4 [114-116, 118, 119] to express
either form of Ub6 in all fly tissues, throughout development and in adults. This driver employs the
promoter and expression pattern of the gene spaghetti squash (sqh), which encodes the
regulatory light chain of non-muscle type 2 myosin. sqh-Gal4 is a strong driver that leads to high
levels of UAS-based transgene expression (such as our Ub6), during all developmental stages
and throughout adulthood. We and others have used this driver in the past with robust outcomes,
including lethality during various developmental stages and in adults as a result of the knockdown
of various genes, and high toxicity from the expression of mutated or toxic proteins [36, 38, 100102, 115-118, 125].
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Our previously published work showed that the ubiquitous expression of Ub6 (via sqhGal4) had no significant effect on the development or lifespan of adult flies under normal
conditions or during heat stress (30°C), indicating that robust levels of Ub6 are not especially
detrimental (figure 3.1C; Table S3.1; [70]). Still, the possibility remains that cells could mount a
response against them. One may surmise that in response to the presence of Ub6, DUBs or
proteasomal proteins might be upregulated to attempt to clear the chains from the cell.
Conceivably, Ub6 might also influence normal cellular processes, for instance by its recruitment
into pathways that involve unanchored, linear poly-Ub, such as NF-κB signaling [57, 90, 94, 153].
Thus, we set out to examine if there are changes at the transcriptome level in response to Ub6.
We reasoned that we could detect changes in the fly transcriptome as a result of the
expression and presence of untethered poly-Ub through RNA-Seq analysis. We selected to
examine adult flies that were one day old as a middle point between developmental stages and
adulthood, neither of which was impacted by the expression of Ub6 (Table S3.1; [70]. We
extracted total RNA from one-day-old whole flies using TRIzol. The isolated RNA was then quality
tested by electrophoretogram, RNA Integrity Number and the ratio of the 28S:18S RNA bands,
and RNA-Seq was performed by the Applied Genomics Technology Center at Wayne State
University (please see the Materials and Methods). The differentially expressed transcripts were
analyzed using the Database for Annotation, Visualization and Integrated Discovery (DAVID)
[159].
While Ingenuity Pathway Analysis (IPA) is often the tool of choice to analyze RNA-Seq
results, human orthologues exist for only about two-thirds of the transcripts affected by either form
of Ub6 (Dataset S1) and the IPA databases available to us do not emphasize Drosophila genes.
Because the success of IPA is heavily dependent on having access to the most applicable
database [160], we opted to perform our analyses using DAVID. DAVID avoids stretching our
observations to fit within the context of organisms other than Drosophila, or excluding Drosophilaspecific genes involved in pathways of interest. Other fly laboratories have shown that DAVID
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analysis recognizes and compares genes from the fly genome, while also providing the tools to
group functionally related genes and terms into a manageable number of biological modules
(Table S3.2; [159, 161-164]. figure 3.1C outlines our experimental workflow. We note at this point
that all of the genes discussed here are identified by their Drosophila symbol/name. The names
of their potential human orthologues, where applicable, are also provided in the text and tables.
3.3.2. DAVID analyses
We found a limited number of altered transcripts in flies expressing non-conjugatable and
conjugatable untethered Ub6 chains: 94 transcripts were altered in Ub6-Stop and 86 were altered
in Ub6-GG flies compared to controls, including 26 transcripts affected in both lines
(figure 3.2; Dataset S1). Controls were flies with the same genetic background used to generate
Ub6 flies, crossed to the sqh-Gal4 driver, ensuring that flies were as comparable as possible at
the genetic level. The majority of altered transcripts was upregulated (65 from each condition),
with

22

transcripts

overlapping

between

groups

(figure .2).

Only

30%

of

all

identified Drosophila transcripts have assigned gene names, indicating that most of the affected
genes have not drawn sufficient genetic or functional attention in the fly, and 27% of the genes
have no predicted function.
To place these altered transcripts into physiological context, we submitted the differentially
expressed transcripts to DAVID [159]. This allowed us to determine enriched gene ontology terms
and pathways, assessing biological processes, molecular functions and KEGG (Kyoto
Encyclopedia of Genes and Genomes) pathways (Tables 3.1–3.3). Five biological process terms
(proteolysis, peptide catabolic process, mannose metabolic process, protein deglycosylation and
melanin biosynthetic process from tyrosine) were enriched in upregulated Ub6-GG transcripts,
whereas for Ub6-Stop, three terms (proteolysis, peptide catabolic process and transmembrane
transport) were enriched in upregulated and six terms (carbohydrate metabolic process, folic acidcontaining compound biosynthesis process, tetrahydrofolate interconversion, de novo IMP
biosynthetic process, one-carbon metabolic process and oxidation-reduction process) were
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Figure 3.2. Overlap of differentially expressed genes in transgenic Ub6 flies. Venn diagrams
(http://bioinformatics.psb.ugent.be/webtools/Venn/) depict overlap in the number of differentially expressed
(absolute Log2 fold change >1, FDR<0.05) genes as determined by RNA-Seq at each level of comparison
(Ub6-GG versus control, Ub6-Stop versus control, Ub6-Stop versus Ub6-GG). (A) All genes, (B) upregulated
genes only, (C) downregulated genes only. (D) Overlapping, differentially-expressed transcripts that are
consistent in direction in both Ub6-GG versus control and Ub6-Stop versus control comparisons. FC, fold
change. All genes are identified by their Drosophila symbol/name, with ‘CG’ denoting that the gene has not
yet been named in Drosophila. Transcripts were researched using Flybase.org and any information on
function and human orthologues is displayed in the table.

enriched in downregulated transcripts. The biological process terms ‘proteolysis’ and ‘peptide
catabolic process’ were enriched in upregulated transcripts from both groups, the former
associated with ∼22% of all upregulated Ub6-GG transcripts and ∼18% of upregulated Ub6-Stop
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Table 3.1. Biological processes

transcripts (Table 3.1; Table S3.3 lists all genes for each term). Five molecular function terms, the
most prominent of which were ‘serine-type endopeptidase activity’ and ‘peptide binding’ were
enriched in upregulated transcripts from both groups. The molecular function category overall
reported nine enriched terms in upregulated Ub6-GG transcripts, as well as five upregulated and
six downregulated transcripts for Ub6-Stop (Table 3.2; Table S3.4 lists all genes associated with
each term).
As in other transcriptomic studies [165, 166], we assessed differentially expressed genes
for both enriched Gene Ontology terms and KEGG pathways, in order to provide both a genespecific and broader pathway context. For KEGG analysis, two pathways (lysosome and other
glycan degradation) were enriched in upregulated Ub6-GG transcripts, with three (one carbon
pool by folate, metabolic pathways and galactose metabolism) enriched in downregulated Ub6Stop transcripts. Although few KEGG pathways were enriched, the term ‘metabolic pathways’
was

associated

with

34%

of

downregulated

transcripts

in

Ub6-Stop

flies

61
Table 3.2. Molecular functions

(Table 3.3; Table S3.5 lists all genes associated with each term). The relatively modest number
of enriched gene ontology terms and pathways is not unexpected, considering the limited number
of differentially expressed transcripts that reached statistical significance.
Next, we examined the possibility that unanchored Ub chains that cannot be conjugated
elicit a response different from chains that can be conjugated. Thus, we directly compared flies
expressing Ub6-Stop to those expressing Ub6-GG. Only 21 transcripts were altered in Ub6-Stop
compared to Ub6-GG, 17 of which were downregulated (figure 3.2 and Dataset S1; no transcripts
were altered across all comparisons). We again relied on DAVID to analyze differentially
expressed transcripts for gene ontology terms and pathways (Tables 3.1–3.3; Tables S3.3–
S3.5 list all genes associated with each term). Two biological processes (carbohydrate metabolic
process and oxidation-reduction process) and three molecular functions (maltose alpha-
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Table 3.3. KEGG pathways

glucosidase activity, alpha-1,4-glucosidase activity and catalytic activity) were enriched in
downregulated Ub6-Stop transcripts in comparison to both Ub6-GG and controls (Tables 3.13.2; Tables S3.3,S3.4). For KEGG analysis, four pathways were enriched in downregulated Ub6Stop transcripts, with two of the four (galactose metabolism and metabolic pathways) enriched in
comparison with both other conditions (Table 3.3; Table S3.5). While these transcriptomic and
pathway analysis outcomes suggest a response specific to flies expressing non-conjugatable free
Ub chains, the small number of differentially expressed transcripts limits this interpretation.
Lastly, we used DAVID to analyze only the set of human genes that have fly orthologues,
in case additional or different pathways arise that might not have been captured by analyzing the
fly genes exclusively. As shown in Tables S3.6–S3.8, there was general agreement with the flybased DAVID analyses. The biological processes, molecular functions and pathways that were
represented by the largest numbers of fly genes were well conserved between the two sets of
analyses, including proteolysis and carbohydrate metabolic process, zinc-ion binding and serinetype endopeptidase activity, and lysosome and metabolic pathways. Still, biological processes
and molecular functions arose that were not observed from fly-based gene analysis. These
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differences were most often represented by small numbers of genes, generally two to four. Among
biological processes, these include upregulation of regulation of cell shape, response to pH and
termination of signal transduction (comparing Ub6-GG versus control), upregulation of biotin
metabolism (comparing Ub6-Stop versus control), and downregulation of amino acid transport and
protein tetramerization (comparing Ub6-Stop versus control). Among molecular functions that
emerged from the human gene-based analyses, apolipoprotein binding and mannose binding
were upregulated (comparing Ub6-GG versus control), zinc-ion binding was upregulated
(comparing Ub6-Stop versus control), and electron carrier activity and oxidoreductase activity
were downregulated (comparing Ub6-Stop versus Ub6-GG). Based on KEGG pathway analyses,
the following differences were observed in the human-based analyses when compared to the flybased analyses: upregulation of metabolic pathways (comparing Ub6-GG versus control),
downregulation of the biosynthesis of antibiotics and glycerolipid metabolism (comparing Ub6Stop versus control), and downregulation of the biosynthesis of antibiotics (comparing Ub6-Stop
versus Ub6-GG). Collectively, while there are some variations between the two sets of analyses,
the overall outcomes are not markedly different. Importantly, considering the small numbers of
genes representing the divergences between the two sets of analyses, it is warranted that
differences in outcomes be interpreted with caution.
Overall, expression of unanchored Ub chains in Drosophila has a seemingly minimal
impact on transcriptomic response, as the number of altered transcripts (<100 for each group) is
markedly low in comparison to the majority of reports by other, whole-fly RNA-Seq studies [167170]. Although one study reported a comparable 57 genes affected by formaldehyde exposure
[167], most were within the range of hundreds to several thousand genes, in studies ranging from
cold acclimation to infection [167-170].
3.3.3. Validation by qRT-PCR
To validate RNA-Seq observations, we selected twelve genes from several pathways for
confirmation by qRT-PCR. cDNA libraries were obtained from the same RNA used for RNA-Seq,
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Figure 3.3. qRT-PCR validation of differential expression trends for select RNA-Seq hits. Asterisk
indicates inconsistency between RNA-Seq and qRT-PCR results. All P-values were determined using a onetailed Student's t-test comparing gene expression fold change.

as well as from RNA extracted from new genetic crosses, for at least three biological replicates
per genotype. All primer sequences are listed in Table S3.9. In most cases, results from RNASeq were confirmed by statistically significant changes, in the same direction, by qRT-PCR
(figure 3.3). Our overall confirmation success is well within the range of confirmation reported
widely in the literature [171-174]. qRT-PCR-validated transcripts include several genes with
marked

expression

changes

increase); Drsl3 and LysE (∼tenfold

observed

by

RNA-Seq: CG32751 (∼78-fold

increase); Mal-A7 and CG2650 (∼tenfold

decrease)

(Dataset S1 lists all log2 fold changes determined by RNA-Seq).
The direction of change for the transcripts that were confirmed to reach statistical
significance by qRT-PCR was the same between RNA-Seq and qRT-PCR results, with one
exception: Takl1 in response to Ub6-Stop (figure 3.3; please see the Discussion for additional
information on Takl1 protein). By RNA-Seq, Takl1 on the Ub6-Stop background nearly missed the
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FDR cutoff (FDR=0.047; GEO data available online). We interpret this divergence in outcomes
for Takl1 as an indicator of lack of overall change in its expression in the presence of Ub6-Stop. It
is not uncommon for the direction of change in RNA-Seq results to differ from the direction of
change observed from qRT-PCR data [171-174]. These discrepancies can arise for a variety of
reasons, including the housekeeping gene used [173] as well as the length of the identified genes
[175]. The rest of the genes we tested by qRT-PCR, whose differential expression reached
statistical significance, matched the direction of fold change observed with RNA-Seq. The
expression pattern of the genes assessed by qRT-PCR in the fly is summarized in Table S3.9,
although we note that this table only lists the tissues in which the genes are more highly
expressed; they may also be present in other tissues.
3.4. Discussion
Here, we evaluated whether there is an organismal response at the gene expression level
in the presence of unanchored poly-Ub in Drosophila. Unanchored Ub chains are thought to be
transient, toxic residents of the cellular milieu [37, 43, 44, 47, 95, 96]. However, our previously
published work showed that this might not need to be the case in vivo: we observed little to no
toxicity from the presence of unanchored poly-Ub in intact flies at all ages and stages examined
[70]. Thus, we wondered whether lack of clear toxicity is due to a mounted defense or response,
which we elected to start examining by RNA-Seq.
To model unanchored poly-Ub in the fly, we utilized transgenes that express six Ub
moieties in tandem, lacking internal motifs that enable their disassembly into mono-Ub; one
transgene encodes Ub6 that cannot be attached onto other proteins, whereas the other enables
this option (figure 3.1B). Transgenes were expressed in all fly tissues and at all stages of
development and in adults, and RNA-Seq analyses were conducted using one-day-old flies. While
planning this study, we had several hypotheses on the types of genes that could be affected by
untethered Ub chains that we generated and expressed in Drosophila. Primarily, we thought that
genes involved in Ub-dependent processes and pathways, as well as proteasome-related genes,
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might be altered. These hypotheses were based on the current notion that unanchored poly-Ub
is rapidly disassembled [1, 15, 21, 22, 87] and on our previous work showing that Ub6 is degraded
by the proteasome [70]. For Ub6-GG, we further hypothesized a potential upregulation of Ub
conjugation systems that could transfer these chains onto other proteins as single units. These
hypotheses went unsupported by our RNA-Seq data; our analyses did not reveal a detectable
difference in the transcription of those genes, with the exception of one E3 ligase, qin (figure 3.4),
whose change at the transcript level was not confirmed through qRT-PCR. qin is a Tudor domain
protein involved in the production of piRNAs that repress transposons in germline cells. It contains
a RING domain and two B-Box domains, indicating E3 ligase activity, but its E3 function has not
been characterized [176-178]. The lack of congruency between RNA-Seq and qRT-PCR results
for qin argues against a marked effect from unanchored, conjugatable poly-Ub on the transcript
levels of this E3 Ub ligase.
Insofar as Ub-related genes are concerned, we noted a reduction in the levels of Ubip5E in

the

presence

of

Ub6-Stop

(Figs 3,,4;4; Dataset

S1). Ubi-p5E is

one

of

five Drosophila genes that encode mono-Ub either as a linear chain of multiple Ub moieties or in
fusion to ribosomal components [179-184]. Ub genes expressed as linear chains, such as Ubip5E, are believed to be processed by DUBs down to mono-Ub [185, 186]. Reduced levels of this
specific Ub-encoding gene, but not of the other four, suggest that the presence of unanchored
poly-Ub that is not conjugatable to other proteins could be perceived as Ubi-p5E product. What
senses this unanchored chain and the processes through which Ubi-p5E is regulated are unclear.
One might surmise that lower levels of Ubi-p5E translate into reduced mono-Ub protein in the fly
and impaired Ub-dependent processes; in turn, this would be expected to lead to upregulation of
other Ub-encoding genes or of DUBs that process it, none of which was detected by our analyses.
Whether there is a physiological significance attached to the reduced levels of Ubi-p5E in the
presence of Ub6-Stop presently is unclear; perhaps Ubi-p5E regulation can be utilized in the future
to understand unanchored poly-Ub sensing at the protein level and its downstream events.
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Figure 3.4. Overview of the types of genes and pathways that we hypothesized might have been
upregulated to dismantle, clear, or re-utilize Ub6, compared to the observed outcome by RNA-Seq.

We did not detect coordinated changes in pathways that involve unanchored poly-Ub,
such as NF-κB. One gene altered in both the Ub6-Stop and Ub6-GG conditions, Takl1 (Tak1-like
1), is closely related to Tak1, a MAP3K required for the immune activation of NF-κB and JNK
pathways [57, 187]; little is known about fly Takl1 itself. We caution here that the direction in the
difference of transcript levels for Takl1 differed between RNA-Seq and qRT-PCR results, arguing
against a clear effect from unanchored poly-Ub on this gene's expression. Ub6-Stop also led to
differential expression of two transcripts linked to immunity: the upregulation of LysE (Lysozyme
E) and the downregulation of DptA (Diptericin A). LysE protein is expressed in the midgut, where
it is believed to aid in the digestion of food-borne bacteria [188]. DptA is an antimicrobial protein
whose expression is induced by the immune deficiency pathway via NF-κB-related proteins [81,
189]. While these genes are likely participants in immunity or some NF-κB processes, their limited
number is not indicative of a major alteration in those processes, and our DAVID analyses did not
point to an effect on immunity or NF-κB signaling as a whole.
The small number of enriched gene ontology terms and pathways that we observed is
reasonable considering the limited input of differentially expressed genes, suggesting that the
alteration of these genes does not overtly perturb critical physiological processes. One interesting
exception is the enrichment of proteolysis and peptide catabolic process in both Ub6 species.
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While there is a consensus among the two types of untethered Ub chains in the upregulation of
proteolysis-related genes, the number of impacted genes is not large. The GO category
‘proteolysis’ comprised about 15 genes, including two genes in the Trypsin family
(zetaTry and Jon65Aii). Several proteolysis-related genes share homology with human PRSS
genes

(serine

proteases; CG18493, CG31266, CG8299, CG9763, CG11911, CG11912, CG6048, zetaTry)
and Aminopeptidase N (CG31198, CG31343, CG42335). Those genes might be involved with the
disassembly of unanchored chains (figure 3.4), but it is unlikely that they act alone, as we
observed previously that the proteasome is critically important for the degradation of unanchored
chains in the fly [70]. The increase in proteolysis-related genes suggests an attempt by the
organism to remove these species via specific peptidases, which might indeed play a role in the
removal of endogenous, unanchored poly-Ub; this possibility requires future attention. Our
previous work showed that the proteasome is important for degradation of free poly-Ub [70].
Perhaps the proteasome and these peptidases work in concert to dismantle free poly-Ub
(figure 3.4).
A caveat to note is that our studies examined changes at the gene expression level.
Perhaps control of untethered Ub6 species is coordinated by changes at the protein level.
Changes in fly proteomics as a result of untethered poly-Ub await investigation. Suffice it to say
here that, based on western blotting, none of the proteasome subunits we examined before
showed a difference at the protein level [70]. It is also important to note that the majority of the
differentially expressed transcripts identified here are unannotated, leaving open the possibility
that some of them have undiscovered roles in the handling of unanchored poly-Ub.
Because we utilized ubiquitous expression and whole flies for RNA-Seq analyses, it is
possible that tissue- or system-specific responses are masked by conflicting changes in other
tissues [190]. We elected to examine changes in the whole fly, as done in prior work that identified
numerous genes altered due to specific types of conditions or insults [167-170]. As we continue
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to investigate unanchored poly-Ub in vivo, should we observe a need to examine transcriptome
changes in a tissue-specific manner we will be well positioned to do so. However, our current
work with unanchored poly-Ub species overall indicates that these members of the Ub family are
not inherently toxic and do not present cells with particularly egregious insults that necessitate
large, coordinated responses.
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CHAPTER 4: ISOLEUCINE 44 HYDROPHOBIC PATCH CONTROLS TOXICITY OF
UNANCHORED, LINEAR UBIQUITIN CHAINS THROUGH NF-ΚB SIGNALING
4.1. Introduction
Post-translational modification adds a critical layer of complexity to the genome, allowing
for regulation of many cellular functions. Methylation of histones in nucleosomes controls the
expression of specific genes [191], phosphorylation of enzymes determines their activity [192],
and glycosylation affects a protein’s conformation and ability to form complexes [193]. Ubiquitin
(Ub) is a small protein adduct that is arguably known best for its role in protein quality control due
to its participation in proteasome-dependent degradation [8]. Beyond that, Ub is an essential
player in nearly all cellular processes, making it vital to eukaryotic cell health. A protein’s
ubiquitination status can lead to various outcomes, from alteration of its protein-protein
interactions, to changes in its localization, function, enzymatic activity and half-life [1, 87, 103,
107, 111].
Ubiquitination is a sequential, ATP-dependent process that requires a Ub activating
enzyme (E1), a Ub conjugating enzyme (E2), and a Ub ligase (E3) to covalently attach a Ub
molecule to a substrate protein, typically at one of the substrate’s lysine residues [1]. With seven
lysine residues of its own, Ub itself becomes ubiquitinated, resulting in the formation of poly-Ub
chains with unique topologies dependent on the specific lysine residue linkers. Head-to-tail chains
also exist, linked at the N-terminal methionine, as well as chains that contain a mixture of linkage
types [6, 12]. Ub chains that are not attached to a protein – known as unanchored, untethered, or
free poly-Ub – can be synthesized by specialized E2s and E3s, and also arise from the removal
of a preexisting chain from a ubiquitinated protein by deubiquitinating enzymes (DUBs) [2].
Ubiquitination is editable and reversible, ensuring that ubiquitinated substrates are
targeted to the proper cellular complex while maintaining an available pool of Ub for reutilization.
DUBs are a family of enzymes responsible for cleaving the linkages of Ub with its substrate or the
linkages between Ub monomers in a poly-Ub chain. Depending on the DUB, it may influence the
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outcome for a ubiquitinated protein by editing the length or topological makeup of the Ub chain,
or by removing the chain entirely [2, 20, 22]. In the case of unanchored poly-Ub, specific DUBs
break down multiple, linked Ub molecules into mono-Ub; such is the case with Ubiquitin Specific
Protease 5, which has been evidenced to disassemble unanchored chains [33]. Processing of
unanchored poly-Ub is important, as these chains participate in several processes, such as NFkB signaling, and because disassembly of unanchored poly-Ub can replenish the pool of monoUb for reuse [22, 35, 57, 68, 88, 186].
Unanchored poly-Ub has not been as well studied as other Ub species. There are several
concepts regarding free poly-Ub based on studies in yeast and cultured mammalian cells: that it
exists only at very low concentrations, that it is quickly disassembled by DUBs to be reused as
mono-Ub, and that its accumulation is toxic [2, 21, 22, 37, 87]. It has been proposed that
unanchored poly-Ub interferes with the normal function of the proteasome, either by directly
interacting with and occluding it – i.e., free poly-Ub could begin its own degradation process, but
overwhelms the proteasomal machinery – or by outcompeting ubiquitinated proteasomal
substrates [43, 44, 47].
Our previous work introduced transgenic, DUB-resistant, untethered Ub chains into a
physiological system, Drosophila melanogaster, to address questions surrounding the potential
toxicity and handling of free poly-Ub in an intact, multicellular organism [70, 79]. We synthesized
DNA to express six Ub molecules in tandem, without any internal “GG” motifs (denoted as Ub6),
which prevents them from being cleaved into mono-Ub by DUBs. Ub6 chains exhibited little-to-no
toxicity, did not interfere with proteasomal function, and were readily subjected to proteasomal
degradation [70]. These chains could also be transferred to a substrate protein en bloc in flies
and in mammalian cells, without the need for prior disassembly into mono-Ub [70]. The DUBresistant, free Ub6 chains become ubiquitinated themselves through various linkages,
transforming them into mixed-linkage, free chains [70]. Additional work indicated that continuous
presence of these Ub chains in vivo does not cause marked changes at the transcriptome level
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in the fly [79]. Collectively, we interpreted these results to indicate that free poly-Ub is not
necessarily detrimental in vivo and that Ub recycling may take place not only at the level of the
monomer, but also through the reutilization of intact, untethered Ub chains.
Nonetheless, considering earlier studies that suggested toxicity from free chains [43, 44,
96], we sought to understand under what circumstances unanchored poly-Ub might become
problematic to the cell. One key feature of the transgenic Ub chains expressed in flies is their
conjugation with endogenous Ub [70]. This phenomenon made us wonder whether ubiquitination
of these chains is important for the lack of toxicity we observe. Therefore, we generated new,
isogenic fly lines that express Ub6 that are identical to the previously described species, with the
exception that they lack all internal lysine residues, rendering them ubiquitination-resistant. The
new chains essentially resemble free, linear poly-Ub. By manipulating the potential of Ub6 to be
ubiquitinated, rather than the cell’s ability to ubiquitinate proteins, we avoid impacting
ubiquitination processes more generally and can attribute changes in toxicity to the presence of
Ub6.
We found stark differences in the toxicity of and response to ubiquitination-resistant Ub6
chains in vivo. Depending on the type of tissue where lysine-less Ub6 was expressed, it led to
either developmental lethality or markedly shortened adult lifespan. Ubiquitination-resistant Ub6
has an extended turnover cycle when compared to Ub6 with all its lysine residues intact.
Additionally, ubiquitination-resistant Ub6 leads to the upregulation of several components of NFκB pathways in the fly, indicating a mechanism for toxicity from these free chains in Drosophila.
Importantly, toxicity from ubiquitination-resistant Ub6 is reversed by mutating isoleucine (ile)
residues at position 44 of each constituent Ub into alanine. Ile44 is a key part of a hydrophobic
patch on Ub that controls many interactions [1, 5, 39-41]. We conclude that while unanchored
poly-Ub is not inherently problematic in vivo, there can be circumstances in which these species
may become detrimental, such as when cells’ abilities to manipulate and handle them are severely
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hampered. The studies that we describe here also introduce to the field new genetic tools for
continued investigation of untethered poly-Ub.
4.2. Materials and Methods
4.2.1. Antibodies
Anti-HA (1:500 or 1:1,000; rabbit monoclonal; Cell Signaling Technology, #3724); anti-Ub
(1:1,000; rabbit polyclonal; Cell Signaling Technology, #3933); anti-Tubulin (1:1,000, mouse
monoclonal, Sigma-Aldrich, #T5168); anti-Relish (1:500 from concentrate; mouse monoclonal;
Developmental Studies Hybridoma Bank, #21F3); anti-Lamin (1:1,000; mouse monoclonal;
Developmental Studies Hybridoma Bank, #ADL84.12); anti-phosphorylated-p65 (Ser36) (1:1,000;
rabbit monoclonal; Cell Signaling Technology, #3033); anti-p65 (1:1,000; rabbit monoclonal; Cell
Signaling Technology, #8242); goat anti-mouse, peroxidase conjugated secondary (1:10,000;
Jackson Immunoresearch); goat anti-rabbit, peroxidase conjugated secondary (1:10,000;
Jackson Immunoresearch).
4.2.2. Fly generation
GenScript

(genscript.com)

synthesized

Ub6 transgenes

and

cloned

them

into

pWalium10.moe by using restriction sites EcoRI and XbaI, as also described before [70]. The
amino acid sequences of the new lines generated for this study are shown in figures 4.1 and 4.5.
The purified plasmid was injected into yw; attP40 by Duke University Model Systems, using the
PhiC31 targeted integration to achieve site-specific, unidirectional integration into the second
chromosome [194, 195]. The transformed chromosome was migrated onto the w1118 parental line
and balanced lines were confirmed through genomic DNA-based PCR assays for transgene
insertion and orientation, as described before [102, 125]. All fly lines were sequence-verified.
4.2.3. Drosophila stocks and procedures
All flies were maintained in diurnal incubators at 25 °C and ~60% humidity, in conventional
cornmeal media. Where noted, RU486 was added to the conventional media, as previously
described [99]. tubulin-Gal4-GS was a generous gift of Dr. R. J. Wessells, Wayne State University;
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sqh-Gal4 was a gift of Dr. Daniel Kiehart, Duke University; repo-Gal4 was gifted by Dr. Daniel
Eberl,

University

of

Iowa.

Mef2-Gal4

(#27390)

and

elav-Gal4

(#458)

were

from

Bloomington Drosophila Stock Center. The following RNAi lines were also from the
Bloomington Drosophila Stock Center: Relish (#3361), Dif (#30513), cactus (#31713), dorsal
(#27650), IKKBeta (#35186), kenny (#35572, 57759). dorsal overexpression line was from
FlyORF (#000638). For longevity assays, male and female flies were collected as they eclosed
from their pupal cases and aged on conventional cornmeal fly media at 25 °C, with ~20 flies per
vial. Flies were transferred to fresh vials every 2–3 days until all were dead. Throughout this study,
flies were heterozygous for driver and transgenes.
4.2.4. Western Blotting
Five whole adults flies or pharate adults, or ten dissected heads per group were lysed as
described previously [70]. Blots were developed and quantified using a CCD-equipped VersaDoc
system and Quantity One software (Bio-Rad), Syngene PXi4 and GeneSys software (Syngene),
or ChemiDoc and ImageLab (Bio-Rad).
4.2.5. Immunoprecipitation and in vitro deubiquitination
For precipitation of HA-Ub6 from flies, 40 flies per group were homogenized in RIPA lysis
buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% deoxycholic acid, 1% NP40, pH 7.4)
supplemented with protease inhibitor cocktail (PI; Sigma-Aldrich), sonicated, centrifuged at
15,000 x g for 20 minutes at 4 °C, and then incubated with anti-HA antibody-bound beads for four
hours, tumbling at 4 °C. Beads were rinsed 10 X (including 2 x 5 minutes tumbling at 4˚C), then
split into two microfuge tubes and incubated at 37 °C with either NEM (0.5 mM) or the catalytic
domain of USP2 (0.1 uM; Boston Biochem). After incubation for the selected times, reactions
were stopped by the addition of 6X SDS sample buffer and by boiling for 1 minute.
4.2.6. Soluble/insoluble fractionation
Five flies per group were mechanically homogenized in 200 μL of NETN lysis buffer
(50 mM Tris pH 7.5, 150 mM NaCl, and 0.5% IPEGAL ca-630) supplemented with PI, sonicated
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briefly, and were then centrifuged at 20,000 x g for 30 min at 4 °C. The resulting supernatant was
removed, transferred into a new microfuge tube, and subsequently quantified by using the BCA
assay (ThermoFisher). The remaining pellet was fully resuspended in 200 μL of PBS + 1% SDS
by vortexing and boiling. Ten μg of the supernatant fraction and 7 μL of the pellet fraction were
supplemented with loading buffer, boiled briefly and were then electrophoresed on SDS-PAGE
gels for analyses by Western blots.
4.2.7. Quantitative real-time PCR
From 10 dissected pharate heads per group, total RNA was extracted using TRIzol
reagent (Invitrogen) and treated with TURBO DNase (Ambion) to eliminate contaminating DNA.
High-Capacity cDNA Reverse Transcription Kit (ABI) was used to obtain a cDNA library, and
preamplification of the genes of interest was performed using SsoAdvanced Preamplification
Supermix (Bio-Rad). Fast SYBR Green Master Mix (Thermo Fisher Scientific) was used in
conjunction with a StepOne real-time PCR system. mRNA levels were quantified using
2−ΔΔCt (cycle threshold) methods and normalizing all transcripts to the reference gene, rp49. The
following primer sequences were used:
rp49 (F: AGATCGTGAAGAAGCGCACCAAG; R: CACCAGGAACTTCTTGAATCCGG)
Relish (F: ATGAACTTGAACCAGGTGCGG; R: TGCCGACTTGCGGTTATTGA)
Dif (F: CAGAGTTCCAACCCACGGAC; R: AGGAGTTCTGGATTCGGGTAGT)
dorsal (F: AGAGCCCGCCAAGGTTTTT; R: TGCCATCCTGGTGGTCATTC)
cactus (F: ATCCAACGACAAAGCGGTCA; R: GATTTTCCCTCCCTGGCGTTA)
kenny (F: TACCTCGCGCTAAAGAGCAC; R: CAGCTCTTGGTTTTCCACGC)
4.2.8. Subcellular fractionation
ReadyPrep Cytoplasmic/Nuclear Protein Extraction Kit (Bio-Rad) was used to separate
nuclear and cytoplasmic proteins from 10 pharate adult dissected heads (figure 4.5E), or
individual wells in a 24-well culture plate for experiments with HEK-293T cells. The manufacturer’s
protocol was used, with two variations: 1) nuclear fractions were rinsed once with cytoplasmic
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protein exclusion buffer (CPEB) for 10 minutes, tumbling at 4°C before subsequent incubations
in CPEB on ice; 2) cytoplasmic fractions were centrifuged 3 times, with the supernatant
transferred to a fresh tube between spins.
4.2.9. Mammalian cell maintenance and transfection
HEK-293T cells were maintained under conventional conditions in DMEM with 10% FBS
and 5% Penicillin-Streptomycin. Cells were transfected using Lipofectamine LTX (Invitrogen),
using the manufacturer’s protocol. Twenty-four hours after transfection, cells were collected and
rinsed in cold PBS, then used for whole cell lysis (using the same buffer and protocol as for blots
with flies), or for subcellular fractionation. DNA constructs used for transfections were the same
as those synthesized for fly generation, but subcloned into the mammalian vector pcDNA3.1.
4.3. Results
4.3.1. New Drosophila lines expressing ubiquitination-resistant, unanchored chains
As introduced above, we previously examined whether expression of unanchored poly-Ub
is toxic in Drosophila. Using the Gal4-UAS system [71, 72], we expressed Ub6 chains that cannot
be dismantled by DUBs (e.g. Ub6-Stop in figure 4.1A). These poly-Ub resemble linear, untethered
chains that exists in nature [1, 21, 22]. The chains were constructed to either remain unanchored,
due to the lack of the terminal “GG” motif that would enable their isopeptide-bond fusion to another
protein (Ub6-Stop; figure 4.1A), or could be tethered wholesale onto another protein as a result of
a single “GG” motif at the very end [70]. We found that these Ub6 species are innocuous [70, 79].
Nonetheless, as some studies concluded that untethered poly-Ub is toxic [43, 44, 96], we sought
to explore when free chains might become detrimental to the cell. We focused on a potential role
from the ubiquitination of untethered poly-Ub by endogenous Ub, since this is a major feature of
transgenically-expressed chains [70].
We designed head-to-tail Ub6 that, similar to the prior constructs [70], does not contain
“GG” motifs internally or at the very end, and is also devoid of lysine residues (lys to arg mutation),
making it resistant to ubiquitination (Ub6-Stop-K0; figure 4.1A). Removing the potential for
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Figure 4.1. New transgenic Drosophila lines expressing non-cleavable, unanchored ubiquitin chains.
(A) Amino acid sequence, abbreviation and purpose of new HA-tagged ubiquitin chain transgenes. Neither
chain can be conjugated onto another protein as it lacks a terminal “GG” motif that is required for isopeptide
bond formation. Absence of “GG” motifs internally also ensures that they are not dismantled by DUBs [26]. All
lysine (K) residues within Ub6-Stop-K0 were mutated into the similar, but non-ubiquitinatable amino acid,
arginine (R) to prevent ubiquitination. (B) Western blots from flies expressing the noted transgenes in all
neurons (elav-Gal4, adult lysates), muscle cells (Mef-Gal4, adult lysates), or all glial cells (repo-Gal4, pharate
adult lysates). Delta symbol (Δ): signal underneath the main band of lysine-less Ub6 that we observe
sometimes and could be a proteolytic fragment of the chain. (C) Western blots from stringently immunopurified, HA-tagged ubiquitin chains treated, or not, with the catalytic domain of USP2 for the indicated
amounts of time. Mef2-Gal4 flies were one day old. Flies with tub-Gal4-GS driver were induced to express
Ub6 for 7 days before being collected for protein extraction. (D) Western blots from soluble/pellet fractionation
of flies expressing the noted ubiquitin chains in all muscle cells. Flies were one day old. The smear present in
the Ub6-Stop-K0 samples comprises SDS-resistant species as a result of the buffer used in this protocol. As
shown in figure 1C, second lane from the left and USP2CD-treated lanes, similar smears from a different buffer
and lysis protocol (Materials and Methods) are not collapsed by the addition of the DUB. Asterisks in panels:
non-specific band detected by the anti-HA antibody.

ubiquitination of Ub6 allows us to examine the behavior of an untethered Ub chain that cannot be
decorated by ubiquitination within the cell, in contrast to the mixed-linkage chains that arose and
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were highly abundant in our previous studies [70].
We generated new transgenic flies that incorporate Ub6-Stop-K0 at the same
chromosomal site that contains Ub6-Stop, attP40 on the second chromosome of Drosophila. The
PhiC31 system of transgene integration ensures single copy, same orientation insertion of the
intended construct into the same chromosomal site [70, 101, 194-197]. Following established
protocols from our published work [102, 125], we utilized PCR-based assays and sequencing to
ensure integration of the transgene into attP40 at the right locus and in the same orientation, and
to ensure that the sequence inserted was the one intended (data not shown). With these isogenic
lines on hand, we began our investigations. To characterize the biochemical properties of Ub6Stop-K0 in comparison to Ub6-Stop, we first performed Western blotting using lysates collected
from flies expressing either version of Ub6. We observed Ub6-Stop-K0 at the expected molecular
weight of ~50 kDa, without the distinct and clearly defined ubiquitination laddering that we see
above Ub6-Stop (figure 4.1B and other supportive information in figures 4.3 and 4.5). At this point,
it is interesting to note that the precise type of ubiquitination laddering above the main band of
Ub6-Stop differs among different tissues. In muscle cells, there appears to be a higher
preponderance of >Ub1 addition (Ub3-5, middle portion of the blots in figure 4.1B; see also figure
4.5E) compared to neuronal and glial cells, whose signal is stronger closer to the main, unmodified
band. The reasons for these differences and their potential physiological consequences are
unknown. Still, the key point from these comparisons is that Ub6-Stop-K0 migrates similarly in
different fly tissues.
We showed previously that the laddering above the main band of Ub6-Stop comprises
ubiquitinated species [70]. One of the methods we utilized was to incubate immunoprecipitated
(IP-ed) Ub6-Stop with the catalytic domain of USP2 (USP2CD), a DUB that would remove Ub added
onto Ub6 in any type of linkage, including met1/linear fusions [198], while leaving Ub6 itself intact
due to absence of “GG” motifs. As shown in figure 4.1C, while USP2CD readily removes
conjugated Ub from Ub6-Stop, as evidenced by the collapse of the higher molecular weight (HMW)
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bands into the main Ub6 band, it has no detectable effect on Ub6-Stop-K0. The faint HMW smear
observed in the long exposure image in figure 4.1C is likely aggregated Ub6-Stop-K0, as
suggested by centrifugation protocols (figure 4.1D). Through centrifugation of fly lysates, we
observe the presence of some Ub6-Stop, and especially of Ub6-Stop-K0, in the pellet fraction,
suggesting that both chains may aggregate (figure 4.1D). Together, these data indicate that Ub6Stop-K0 is expressed in the fly and that it is resistant to ubiquitination.
4.3.2. Lysine-less, unanchored poly-Ub is highly toxic in Drosophila
We found before that expression of Ub6-Stop in all tissues or only in muscle cells did not
impact longevity, while restricted expression in glial cells or neurons reduced adult fly longevity
slightly, by a few days (normal flies can live around 90 days; [70]). Here, we used various Gal4UAS drivers to test the impact of Ub6-Stop and Ub6-Stop-K0 in fly longevity. sqh-Gal4 is a
commonly used driver that leads to expression of the transgene of interest in all tissues during
development and as adults [70, 101, 115, 124, 196]. Flies heterozygous for sqh-Gal4 and Ub6Stop-K0 die as embryos or young larvae (figure 4.2A). elav-Gal4 (pan-neuronal expression) and
repo-Gal4 (pan-glial expression) both lead to developmental death and drastically shortened adult
lifespans when expressing Ub6-Stop-K0 (figures 4.2A-C). In the case of glial expression, no Ub6Stop-K0-expressing adults emerged from most crosses that we set up; developing flies died as
pharate adults. We were able to collect some live adults in later crosses for experiments described
in figure 4.4 and their lives were significantly shorter than control adults. It is the longevity of these
adults that is shown in figure 4.2C. Expression of Ub6-Stop-K0 in muscle cells (Mef2-Gal4) results
in a less dramatically, but still statistically significantly abbreviated lifespan (figures 4.2A, D). In
essence, with every Gal4 driver used, Ub6-Stop-K0 leads to markedly reduced lifespan compared
to both Ub6-Stop flies and control flies that are genetically similar but do not express either Ub6
(figure 4.2). Clearly, different drivers lead to variable toxicity from ubiquitination-resistant, linear
poly-Ub. Among the tissues examined, muscle cells are least impacted. This is unlikely to be
directly due to differences in relative amounts expressed by the different drivers, since we showed
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Figure 4.2. Lysine-less, non-cleavable ubiquitin chains are toxic in flies. (A) Summary of findings when
the noted transgenes are expressed as indicated. “None” denotes flies that contained the indicated transgene
without a Gal4 driver. Results are from crosses that were conducted simultaneously. A schematic of the fly
life cycle, with the approximate number of days (“D”) spent in each stage, is provided. (B-D) Longevity assays
of adult flies expressing Ub6 chains under the noted Gal4 drivers. “Ctrls” do not contain Ub6 transgenes but
have the Gal4 driver on the genetic background used to generate the ubiquitin chain-containing flies. ‘p’ values
are from log-rank tests.

before that muscle cells express Ub6 transgenes highly robustly [70]. More likely, different tissues
handle and tolerate these species in different ways, leading to the observed variation in toxicity.
These findings highlight the need to investigate Ub-dependent pathways in a tissue-specific
manner to understand the full scope of their roles and importance in vivo. Collectively, these data
point to marked toxicity from ubiquitination-resistant, untethered Ub6 species in Drosophila, unlike
the ubiquitination-prone counterpart.
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4.3.3. Lysine-less, unanchored poly-Ub is more stable in the fly
Since endogenous ubiquitination may influence the toxicity of Ub6, we questioned whether
fly cells clear Ub6-Stop-K0 as readily as Ub6-Stop, which can be ubiquitinated. Lys48- and lys11linked ubiquitination are proteasomal degradation signals [1, 8, 199, 200] that are present on Ub6Stop ([70] and unpublished observations from J. R. Blount and S. V. Todi). It is not unreasonable
to hypothesize that their absence could hinder the degradation of Ub6-Stop-K0. To determine
whether Ub6-Stop-K0 is turned over more slowly than Ub6-Stop, we employed the RU486dependent, ubiquitous driver, tub-Gal4-GS to perform an experiment akin to a pulse-chase [70].
Flies heterozygous for tub-Gal4-GS and either form of Ub6 were reared on regular fly food until
they emerged from their pupal cases, at which point they were switched to RU486 food for 2 days
to induce Ub6 transgene expression (the "pulse"). Adults were then switched to regular media to
halt additional Ub6 production and were flash-frozen periodically to assess Ub6 disappearance by
Western blotting (the "chase"). We selected an inducible, ubiquitous Gal4 driver and focused on
adult flies to gain a general perspective on the turnover of these Ub species, aware of the fact
that degradation rates may differ in a tissue- and developmental stage-dependent manner.
Nonetheless, this approach provides us with critical insight into the handling of ubiquitinationprone and ubiquitination-resistant, linear poly-Ub at the level of the whole organism.
Figure 3 summarizes our findings. We observe that lack of ubiquitination stabilizes Ub6Stop-K0 compared to Ub6-Stop. Fifty percent of Ub6-Stop-K0 is degraded around 72h in
comparison to less than 24h for Ub6-Stop. By 7 days, both proteins reach comparable levels.
These data suggest that internal lysine residues and their ubiquitination are critical, but not entirely
essential for chain turnover in flies.
4.3.4. Toxicity of lysine-less, unanchored poly-Ub depends on NF-κB signaling
Recent studies focusing on innate immunity pathways have revealed roles for free polyUb in NF-κB signaling cascades [50-52, 57, 60, 63]. “NF-κB” refers to a family of inducible
transcription factors which, in response to the activation of immune receptors by invading
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Figure 4.3. Decelerated turnover of lysine-less, non-cleavable ubiquitin chains in flies. Western blots
from flies expressing the noted Ub6 transgenes under the RU486-dependent driver, tub-Gal4-GS for 2 days,
then chased in the absence of the inducer for up to 14 days. Whole fly lysates. Graphs in the bottom are
quantifications from images on the top and other independent repeats. The entire signal for each lane was
quantified. Shown are means ± SD. ‘p’ values are from Student’s t-tests comparing Ub6-Stop-K0 to Ub6-Stop
of the same timepoint

microbes, induce the expression of antimicrobial peptides. In Drosophila, innate immunity is
primarily regulated by two pathways that activate NF-κB: Imd and Toll (figure 4.4A). During the
Drosophila immune response mediated by NF-κB pathways, a series of downstream regulators
are involved (e.g. cactus, dorsal, kenny, and Relish; figure 4.4A). Lysine-less Ub6 resembles
unanchored, linear chains that have been proposed to regulate components of NF-κB in the
mammalian system [53, 58, 201]; therefore, we posited that Ub6-Stop-K0 might mimic
endogenous poly-Ub involved in the Imd pathway and cause abnormal signaling, which could
explain toxicity that we observe with the expression of Ub6-Stop-K0 chains (figure 4.2).
To address the possibility of aberrant NF-κB signaling in the toxicity of lysine-less Ub6, we
used the repo-Gal4 driver to express in glia Ub6-Stop-K0 alongside RNAi transgenes targeting
components of the Drosophila Imd and Toll pathways, and monitored effects on longevity. We
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Figure 4.4. NF-kB pathway dysregulation when lysine-less, untethered hexa-ubiquitin is expressed in
fly glia. (A) Summary of the IMD (left) and Toll (right) pathways in flies and potential roles for unanchored
ubiquitin chains in them. (B, C) Longevity of adult flies expressing Ub6-Stop-K0 alone or in combination with
RNAi-dependent knockdown of the noted NF-kB-related genes in fly glia. ‘p’ values are from log-rank tests.
Longevity curves in panel B for “No Ub6-K0” and “Ub6-K0 Alone” are the same as in figure 2C. Adult flies from
experiments with RNAi lines were collected and aged simultaneously and supplement results from earlier
setups where no adults emerged from repo-Gal4 X Ub6-Stop-K0 crosses conducted for figure 2C (all
developing flies from those earlier crosses died as pharate adults). (D) Box-and-whisker plot of mRNA levels
of the noted NF-kB-related genes by qRT-PCR from dissected heads of pharate adults expressing Ub6-StopK0 in glial cells, presented as fold change over controls. Statistics are from Student’s t-tests comparing levels
of each gene from Ub6-Stop-K0 flies to “Ctrls” that contained the repo-Gal4 driver on the genetic background
of Ub6-Stop-K0. Asterisks: p<0.05. (E) Survival outcomes for flies that express exogenous dorsal in glial cells,
in the absence of any Ub6.

chose repo-Gal4 because Ub6-Stop-K0 expression in glial cells causes toxicity in developing and
adult flies (figures 4.2A, C); thus, any relief of this toxicity is observable along developmental and
adult stages.
Independent knockdown of Relish and Dif significantly alleviates toxicity from Ub6-StopK0, although neither restores adult fly lifespan to that of the controls that do not express Ub6-Stop-
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K0 (figure 4.4B). A separate longevity study revealed that knockdown of dorsal, cactus and IKKβ
also significantly reduces toxicity (figure 4.4C). In this second study, Ub6-Stop-K0 leads to
widespread pharate adult lethality with no surviving adults (figure 4.2A summarizes fly stages of
development). We have observed that transient factors, such as variation in ingredient lot
numbers, can influence the development and survival of these flies; therefore, all comparisons in
development and longevity are made only among flies reared simultaneously. Still, even though
we notice some variation in the extent of toxicity, Ub6-Stop-K0 is consistently toxic and knockdown
of NF-kB components consistently leads to increased survival (figures 4.4B, C). The one
exception is kenny. Knockdown of kenny does not improve toxicity from Ub6-Stop-K0. No flies
with pan-glial expression of both kenny RNAi and Ub6-Stop-K0 survive to adulthood, despite the
eclosure of a small number of flies expressing Ub6-Stop-K0 alone (figure 4.4B). This observation
indicates that toxicity-rescuing effects we see with NF-κB knockdown are specific to key genes.
In summary, targeting of several NF-κB players reduces the toxicity of lysine-less, free Ub6,
implicating Ub6-Stop-K0 in immune signaling via both Imd and Toll pathways.
To further explore this implication, we performed qRT-PCR using dissected heads from
pharate adults expressing Ub6-Stop-K0 and repo-Gal4 to drive expression in glial cells only,
compared to those with the same genetic background but without the Ub6 transgene. We used
pharate adult heads because most Ub6-Stop-K0 adult flies do not eclose and because repo is
robustly expressed in the head (flyatlas.com). In the presence of Ub6-Stop-K0, we observe
statistically significantly increased levels of Relish, Cactus, Dif, and dorsal mRNA. In agreement
with our previous results, kenny mRNA levels trend upward, however without reaching
significance (figure 4.4D). dorsal mRNA, in particular, is markedly upregulated. Importantly,
overexpression of dorsal in glial cells recapitulates lethality in flies that do not express any Ub6,
indicating that dorsal upregulation alone is sufficient for toxicity (figure 4.4E). These results
illustrate a disturbance in normal NF-κB signaling in the presence of Ub6-Stop-K0 and present a
mechanism for unanchored chain toxicity that relies on aberrant NF-κB upregulation.
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4.3.5. Aberrant NF-κB signaling is mediated by the ile44-centered hydrophobic patch of
lysine-less, linear poly-Ub
Proper folding of Ub molecules results in a hydrophobic patch centered around amino
acids isoleucine (ile) 44, leucine 8, histidine 68, and valine 70 (figure 4.5A; [1]). This surface is
the recognition site for many Ub-binding domains (UBDs) and is thus essential to the interaction
of Ub with other proteins and for many of its actions (figure 4.5B; [4, 39-41]). NEMO, the NF-κB
regulator, binds linear and lys63-linked chains [53, 56] and 3D analysis of this interaction shows
a critical position for Ub’s ile44 (figure 4.5C). Likewise, TAB2 and TAB3, which activate TAK1 in
mammalian NF-κB signaling, recognize the ile44 patch through their C-terminal Np14 zinc finger
domains [202]. Reasoning that ile44 within Ub6-Stop-K0 is likely important for its incorporation
into, or recognition by, NF-κB signaling, we generated an additional Ub6 chain identical to Ub6Stop-K0, with the exception that every ile44 residue is mutated to alanine (Ub6-Stop-K0-ile44a;
figure 4.5D), a mutation that is commonly used to disrupt the hydrophobic patch [39-41]. These

Figure 4.5. New transgenic, lysine-less ubiquitin chains with mutated isoleucine 44. (A) Surface
representation of ubiquitin (PDB 1ubq) highlighting the structural location of the amino acids forming the
hydrophobic patch involved in ubiquitin recognition (I44 in yellow, and L8, H68, and V70 in white). (B, C)
Ribbon representation of ubiquitin (blue) displaying isoleucine 44 in the binding surface of different ubiquitininteracting motifs in pink. (B, UIM; PDB 1yx5; C, the UBD domain of NEMO; PDB 2zvo). Inset highlights
ubiquitin’s hydrophobic patch and the key position of isoleucine 44 (yellow). Images were generated using
PyMol (Schrodinger, Inc). (D) Summary of the new ile44a transgenic line that we generated, its abbreviation
and purpose. (E) Western blots from flies expressing the noted transgenes in all muscle cells (Mef2-Gal4,
adult lysates) or all glial cells (repo-Gal4, pharate adult lysates).
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new chains allow us to examine the influence of the ile44 hydrophobic patch on the toxicity of Ub6
chains. Expression of Ub6-Stop-K0-ile44a in Drosophila muscle cells and in glial cells leads to
protein levels that are comparable to those of Ub6-Stop-K0. Similar to Ub6-Stop-K0, Ub6-Stop-K0ile44a does not show the distinct HMW bands consistent with ubiquitination in Western blots. This
is contrary to Ub6-Stop, which presents with clear and distinct laddering of ubiquitination above
its main band (figure 4.5E).
To assess toxicity from Ub6-Stop-K0-ile44a, we used the tissue-specific drivers described
earlier to express the new transgene and then performed longevity assays. In each case, Ub6Stop-K0-ile44a flies survive longer than their Ub6-Stop-K0 counterparts (figures 4.6A, B). In fact,
Ub6-Stop-K0-ile44a expression in muscle cells and in neurons does not have a statistically
significant effect on adult fly lifespan compared to controls that express no Ub6. Driving expression
in all fly cells or only in glia results in a modest reduction in longevity (figure 4.6B). It is particularly
remarkable that disrupting the hydrophobic interaction interface of Ub eliminates developmental
lethality from ubiquitous expression of Ub6-Stop-K0 and only mildly reduces adult fly longevity
compared to controls without Ub6 (figure 4.6A, B).
Next, we examined whether reduced toxicity from Ub6-Stop-K0-ile44a coincides with
normalized levels of genes involved in NF-κB signaling, compared to Ub6-Stop-K0. We
recapitulated studies conducted for figure 4.4D by using new crosses and adding flies that
express Ub6-Stop-K0-ile44a in all glia. As summarized in qRT-PCR results in figure 4.6C, the
mRNA levels of dorsal and Relish are not statistically different in the presence of Ub6-Stop-K0ile44a compared to flies not expressing any Ub6 transgenes, but continue to be upregulated in
the presence of Ub6-Stop-K0.
We validated these findings by examining the protein levels of Relish (antibodies tested
for other NF-κB components in flies were non-specific or inconsistent). We observed that in the
presence of Ub6-Stop-K0, Relish protein levels are noticeably higher, compared to flies not
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Figure 4.6. Isoleucine 44 mediates toxicity from free, linear, lysine-less ubiquitin chains. (A) Summary
of findings when the noted transgenes are expressed as described. “None” denotes no Gal4 driver was
present. Results are from crosses that were conducted simultaneously. (B) Longevity assays of adult flies
expressing Ub6 chains under the noted Gal4 drivers. “Ctrls” do not contain Ub6 transgenes, but have the Gal4
driver on the genetic background used to generate the Ub6 chain-containing flies. ‘p’ values are from log-rank
tests. (C) mRNA levels of the noted NF-kB-related genes by qRT-PCR in dissected heads of pharate adults
expressing Ub6-Stop-K0 or Ub6-Stop-K0-i44a in glial cells, presented as fold change over controls without the
Ub6 transgene. ‘p’ values are from Student’s t-tests comparing Ub6-expressing flies to controls. (D) Western
blots from dissected pharate adult heads expressing the noted transgenes in all glial cells (left). Relish protein
levels were normalized to direct blue and quantified (right). ‘p’ value is from Student’s t-tests comparing Ub6expressing flies to controls that contain the driver on the same genetic background as ubiquitin chain-encoding
flies. (E) Western blots from two independent cytoplasmic/nuclear fractionations of dissected pharate heads
expressing, or not, Ub6 transgenes in glial cells. Due to the temporary closure of our institution as a result of
the COVID-19 pandemic, we were unable to obtain additional, independent samples for this panel. We also
encountered some difficulties with signal-to-noise ratio from anti-Relish antibody for this panel, but were
unable to procure more reagents as a result of university closure. In (C) and (D), “N.S.” denotes no statistical
significance comparing a specific Ub6 group to its respective control.

expressing any Ub6 transgene, or expressing the ubiquitinatable Ub6-Stop. In the presence of
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Ub6-Stop-K0-ile44a, Relish levels return towards normality (figure 4.6D). Because NF-κB
transcription factors translocate to the nucleus when activated, we performed subcellular
fractionation to visualize nuclear Relish protein levels in heads dissected from pharate adults
expressing Ub6 in glial cells. We observed that more Relish is present in the nuclei of Ub6-StopK0 pharate adults, compared to controls that are genetically similar, but lack Ub6 (figure 4.6E).
Nuclear Relish levels in the presence of either Ub6-Stop or Ub6-Stop-K0-ile44a appear lower than
those in the presence of Ub6-Stop-K0, indicating the importance of the chains’ susceptibility to
ubiquitination and ile44. Collectively, these results lead us to conclude that ubiquitinationresistant, free, linear Ub chains can be highly toxic in flies at least in part due to NF-κB signaling
that is dependent on the ile44-centered hydrophobic patch on Ub.
Due to a lack of quality antibodies for NF-κB components in flies, we performed subcellular
fractionation experiments using cultured, HEK-293T human cells to validate our findings in figure
4.6E. In humans, p65 is an NF-κB transcription factor whose phosphorylation at ser536 controls
its nuclear translocation and activity [203]. To examine p65 translocation, we transiently
transfected HEK-293T cells with the Ub6 constructs and 24 hours later performed subcellular
fractionation and Western blotting. Expression of the various Ub6 constructs in HEK-293T cells
leads to ubiquitinated species for Ub6-Stop, but not so for lysine-less variants (figure 4.7A). As
shown in figure 4.7B, Ub6-Stop-K0 expression leads to markedly more endogenous
phosphorylated-p65 in the nucleus compared to cells transfected with empty vector; the ile44a
mutation reverses this effect. There was no statistically significant difference in the total p65 levels
in the cytoplasm or nucleus (figure 4.7B). Based on the increased nuclear translocation of
activated p65, it is likely that Ub6-Stop-K0 induces the transcription of downstream NF-κB
response genes; additional studies are needed to determine the precise outcomes. These results
reinforce a role for ubiquitination-resistant, unanchored, linear poly-Ub in NF-κB signaling, notably
in a human cell line.

89

Figure 4.7. Isoleucine 44 mediates nuclear translocation of phosphorylated p65 in mammalian cells.
A) Western blots from whole cell lysates of HEK-293T cells transfected with empty vector or Ub6 plasmids. B)
Western blots and quantifications from cytoplasmic/nuclear fractionation of HEK-293T cells transfected as in
(A). For both (A) and (B), results are representative of three independent experiments. In panel (B) p65 protein
levels were quantified, divided by the respective loading control (tubulin or lamin) for each fraction and
normalized to controls lacking Ub6. Shown in histograms are means -/+ standard deviation. ‘p’ value is from
Student’s t-tests comparing cells expressing Ub6 to non Ub6-expressing controls. “N.S.” denotes no statistical
significance comparing a specific Ub6 group to its respective control. p65-P: phosphorylated-p65. The COVID19 situation also hampered our ability to conduct additional cell-based studies.

4.4. Discussion
We have developed a model to study the control and function of untethered poly-Ub in an
intact, multicellular organism, Drosophila melanogaster. By manipulating the properties of linear,
unanchored poly-Ub, we propose that free chains are not intrinsically toxic, but that the ability of
cells to control them, e.g. through endogenous ubiquitination, is crucial to their remaining
innocuous. Ub6-Stop-K0, which is unreceptive to ubiquitination, causes aberrant NF-κB signaling
and fly death that is largely dependent on amino acid ile44 on Ub. Our results, therefore, also
demonstrate a critical role for ile44 on Ub in NF-κB-dependent pathways.
The Ub6 chains that we designed are head-to-tail by necessity; current technology limits
the ability to stably, genetically encode other linkage types in vivo. Endogenous, unanchored poly-
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Ub chains are diverse in their linkage types and lengths, and their composition controls their
functions and interaction partners [1, 2, 6, 57, 60]. We previously characterized Ub6 species that
are endogenously ubiquitinated, transforming them into branched chains with various lysine
linkages [70]. Unlike them, Ub6-Stop-K0 and Ub6-Stop-K0-ile44a that we described here are
homogenous, linear poly-Ub. We also established in prior work [70] and through the results of this
study that each of the Ub6 species has distinct properties, from turnover rates to physiological
outcomes. For these reasons, the transgenically-encoded Ub6 fly lines that we developed serve
as valuable tools to study the function and regulation of unanchored poly-Ub in vivo.
It remains to be resolved which proteins recognize and interact with Ub6-Stop-K0. For
example, upstream elements that lead to upregulated NF-κB component levels in the presence
of lysine-less, linear poly-Ub need to be identified. Still, we infer that these elements likely depend
on interacting with the ile44 hydrophobic patch, since mutating this amino acid residue markedly
reverses Ub6-Stop-K0 toxicity in intact flies. Our results highlight NF-κB components as key
players in toxicity from ubiquitination-resistant, linear chains. According to mammalian studies,
canonical activation of NF-κB requires the linear Ub chain assembly complex (LUBAC), which
attaches head-to-tail, met1-linked chains to NEMO, an NF-κB regulator, and participates in the
synthesis of branched, unanchored poly-Ub chains composed of both met1- and lys63-linkages
[57]. Free Ub chains are required for the activation of the MAP kinase kinase kinase, TAK1 and
the subsequent phosphorylation and degradation of the inhibitory kinase, IKKβ [52]. Several other
proteins within the pathway, including NEMO and the LUBAC proteins, contain UBDs that may
interact with untethered chains and may be regulated by them [50]. Thus, it is likely that the
presence of lysine-less, linear, unanchored poly-Ub places NF-κB in overdrive by interacting with
NEMO and LUBAC. In the absence of a functional binding interface on Ub (the ile44a mutation),
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Figure 4.8. Summary of potential outcomes of ubiquitin recycling. “Traditional Ub cycle”: Ub is attached
to a substrate protein either as monomer (not shown) or as polymer. The poly-Ub can be removed as a single
unit by DUBs, dismantled into mono-Ub, and then reused. “Additional outcomes”: Based on our studies in
Drosophila from earlier investigations and from this work, unanchored poly-Ub can be reused as a single unit
and become attached onto another protein ([26]), or can be degraded ([26] and current work). If handled as
described thus far, unanchored chains are not detrimental (No Toxicity). However, if the ability of cells to
ubiquitinate free poly-Ub as described here is hampered, unanchored Ub chain toxicity results from cellular
pathway perturbation, as with NF-kB processes evidenced here (Toxicity). Based on our data, this toxicity is
reverted by an isoleucine 44 to alanine mutation that disrupts a critical interaction site on ubiquitin.

NF-κB is not improperly triggered. Our results lead to the conclusion that toxicity induced by linear
chains is due to overstimulation of the NF-κB pathway. In the case of the ile44a mutant, these
linear chains are not recognizable by the cellular components so their expression per se does not
induce toxicity.
As introduced earlier, flies have two NF-κB pathways, Imd and Toll. The Imd pathway is
initiated when gram-negative bacteria are detected by peptidoglycan recognition protein-LC at
the plasma membrane [204-206]. This event triggers the activation of Tab2/Tak1 that
phosphorylates and activates the IKK complex (kenny and IKKβ) [207-209] which then, via Relish
(the NF-κB transcription factor) activates antimicrobial genes including Diptericin and Cecropin
([81, 210, 211] and figure 4.4A). The involvement of unanchored poly-Ub in the Imd pathway is
expected at multiple steps, based on mammalian NF-κB signaling orthologues. Ubcd4, an E2
conjugase whose mammalian orthologue, E2-25K/Ube2K generates poly-Ub chains without a
substrate protein [78], is required for Imd activation [212]. The concomitant knockdown of the E3
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ligase Bendless and the E2 conjugase Uev1a abrogates Imd signaling in cultured insect cells [83],
and Bendless/Uev1a together synthesize unanchored lys63-linked Ub chains in vitro [213]. To
the best of our knowledge, there are no published reports showing a direct involvement of
unanchored poly-Ub in the Imd pathway in Drosophila, but the importance of Ubcd4 and
Bendless/Uev1a implicates these chains. Our results that linear poly-Ub activates Relish
strengthen this connection and further indicate that free, linear Ub chains are involved in the Imd
pathway in flies.
Unlike for the Imd pathway, where evidence from mammalian orthologues and functional
assays of fly proteins indicates a role for free Ub chains, it is unclear whether unanchored polyUb is involved in the Toll pathway. Toll signaling begins when gram-positive bacteria or fungi are
detected by extracellular peptidoglycan recognition proteins and glucan-binding proteins,
triggering a cascade that results in the processing of the Toll ligand Spaetzle to facilitate its binding
to the Toll receptor [214-216]. After activation, the Toll receptor binds the adaptor MyD88 and
recruits Tube and Pelle to phosphorylate cactus [217], ultimately activating dorsal and Dif [218]
and driving the transcription of antimicrobial peptides like Drosomycin and Defensin ([82] and
figure 4.4A). Insofar as we know, our data that free, linear poly-Ub increases levels of cactus and
dorsal are the first to link linear chains to the Toll pathway, thus merging gram-negative and grampositive/fungi, NF-κB-centered processes under the regulation of linear Ub chains. Which proteins
serve as “receptors” that recognize lysine-less, linear poly-Ub and lead to activation of the Toll
pathway? Studies with unbiased approaches and targeted genetics will be necessary to uncover
these details and also to identify downstream genes that are impacted by free, lysine-less Ub
chains for both the Imd and Toll pathways. Based on increased nuclear levels of Relish and
phosphorylated-p65 proteins in flies and mammalian cells expressing Ub6-Stop-K0, there is good
reason to predict a genetic response to these transcription factors.
The extent of NF-κB component perturbation by linear Ub chains differed among
experiments in this work. For example, in figure 4.6C, glial expression of Ub6-Stop-K0 did not

93
induce dorsal mRNA expression to the magnitude shown in figure 4.4D. As mentioned above, we
have observed physiological effects from different fly media conditions, even using the same food
recipe. Flies used in figure 4.4 were reared on a lot of food that was different from those in figure
4.6, which might have been more prone to mold or bacterial growth and could have itself induced
background NF-κB signaling. We stress the importance of making comparisons only among flies
and their respective controls that were maintained on the same batch of food and monitored at
the same time. In our case, all flies from figure 4.4D were reared together and collected
independently of those in figure 4.6C, which were reared and collected as a separate cohort. But,
regardless of the observed experimental variation, the important point remains that the induction
of both dorsal and Relish mRNA was consistent among flies reared simultaneously: Ub6-Stop-K0
significantly increases their levels, whereas Ub6-Stop-K0-ile44a does not have the same impact.
Our work provides new insight into Ub biology more generally. The current model of Ub
utilization and recycling centers on the use of mono-Ub in a stepwise manner to generate polyUb and the disassembly of poly-Ub into mono-Ub before reuse (figure 4.8). We previously
described [70] and further evidence here the possibility of alternative routes for Ub use and
recycling, based on the notion that free Ub chains may not need to be disassembled into monoUb to be eliminated. They can be conjugated en bloc onto other proteins, or can be degraded
without the need of disassembly into their building blocks [70]. These routes can effectively
recycle untethered poly-Ub, which seems largely innocuous to an intact organism, except under
highly specific conditions, such as the ones in the current study. We propose that cells might
employ various types of Ub utilization, recycling and disposal routes, depending on homeostatic
needs (figure 4.8). For example, conjugation of free poly- Ub onto specific proteins without prior
disassembly might be beneficial under times of energy stress or proteotoxic pressure, where quick
and efficient removal of certain proteins might benefit from Ub chain “hopping”. These and other
possibilities deserve attention to understand Ub biology.
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Drosophila is an excellent model organism due its flexible genetics, easy and inexpensive
maintenance, low number of chromosomes, and short life cycle. Importantly, most genes and
pathways are conserved among Drosophila and vertebrates, allowing for reliable translation of
findings from flies to higher-order organisms [219]. It will be important to expand our findings in a
mammalian system to examine the role of endogenous, unanchored poly-Ub in various disease
models and stress responses. Free Ub chains are upregulated under certain stress conditions,
including inflammation [68] – what types of unanchored chains might we see in mammals with
inflammatory diseases? Are there tissue-specific differences? Are there disease-specific
variations? Diversity in unanchored Ub chain signaling – from chain length to composition to
available binding interfaces – will be important to consider when studying the effects of these
species going forward.
In summary, our results reinforce the notion that free Ub chains are not inherently
detrimental. Our investigations contribute to the overall understanding of Ub biology, recognize
the ile44-centereed hydrophobic patch of Ub as an important site for toxicity, and identify ways to
reduce and prevent deleterious effects from untethered Ub chains in vivo (figure 4.8). Continued
work is necessary to probe into these possibilities in different organisms and under various
physiological conditions.
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CHAPTER 5: FUTURE DIRECTIONS
The utility of novel the tools we have developed to study unanchored poly-Ub in Drosophila
is far from exhausted, as they can be used to probe lingering mysteries surrounding free Ub chain
toxicity, function, and regulation. For one, which E2s and E3s use preformed chains to ubiquitinate
substrates? Could there be DUBs that attempt to process the Ub6 chains we designed, whether
successfully or not? Our RNA-Seq studies identified transcriptional changes when conjugatable
Ub6-GG is expressed all throughout the fly (Chapter 3), but this approach does not address the
protein-protein interactions necessary for post-translational ubiquitination and deubiquitination.
Mass spectrometry studies could shed light on these interactions by identifying any DUBs that
associate with linear hexa-Ub, or the ubiquitination enzymes that use Ub6-GG to ubiquitinate en
bloc (figure 2.6).
Mass spectrometry studies using intact organisms will be especially beneficial for
identifying additional signaling capabilities of free poly-Ub. Our work in Drosophila has clarified
the importance of context in the study of unanchored chains, as they behave differently in vivo
than they do in in vitro proteasome assays and yeast (discussed in section 1.6). Exploratory
studies will be necessary to identify new pathways that involve free chains. NF- κB pathways are
well-studied, with many participating proteins already identified and a measurable transcriptional
output with the induction of immune and inflammatory response gene expression. Thus, studying
unanchored poly-Ub’s participation in these pathways is straightforward, compared to lesser
known pathways. Our RNA-seq studies in flies detected changes in the expression of many
orphan genes whose products have not yet been ascribed names or functions (Dataset S1) –
could the resultant proteins be effectors or products of additional signaling pathways that involve
free poly-Ub? Viewing this question through the lens of protein-protein interactions by performing
mass spectrometry will not only clear up questions around post-translational effects of
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unanchored chains – which may not be caught by RNA-Seq or in vitro experiments – but could
also illuminate details of more enigmatic signaling pathways that involve uncharacterized proteins.
Tissue-specific context is also important when considering the effects and handling of
unanchored chains, as neuronal and glial expression of Ub6-Stop-K0 or Ub6-Stop-K0-ile44a
reduced fly lifespans compared to their respective expression in muscles (figures 4.2, 4.6). Even
Ub6-Stop expression has a small but significant effect on lifespan when expressed in neurons,
but not when expressed in any other tissue (figure 4.2). It is possible that unanchored chains are
handled in distinct ways in different tissues, depending on the relative abundance of certain
proteins or the unique cellular demands in those tissues. These variations in toxicity represent an
ambitious and potentially lucrative research opportunity: delineating the intricacies of free polyUb function and toxicity in distinct cell types in the context of the whole organism. It is possible to
isolate specific populations of cells from Drosophila using techniques including magnetic beadbased cell sorting [220]. Using Gal4-UAS to express Ub6 transgenes in specific tissues, then
isolating Ub6-expressing cells to use in transcriptomics and proteomics studies would provide
tissue-specific profiles on the effects of unanchored, linear poly-Ub, moving us towards a better
understanding of how and when these chains are toxic, or how they affect the cellular landscape.
Even beyond that, these studies could point toward intercellular signaling affected by untethered
chains if they are also performed using non-Ub6-expressing cells from Ub6 flies (for example, are
there changes in neuronal cells when Ub6 is expressed only in glia?). Lifestage-dependent effects
are also evident from the developmental lethality with Ub6-Stop-K0 expression in various cell
types (figure 4.2). The behavior of free poly-Ub is clearly complicated and changes depending on
context, a fact that future studies will need to address in more detail.
Another question that unanchored ubiquitin research has not yet addressed is whether
there might be some circumstances in which it is beneficial to have pre-made, unconjugated Ub
chains ready for immediate use, such as when there is limited ATP to dedicate to chain elongation.
This is particularly interesting in light of our finding that Ub6 transgenes are robustly expressed in
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muscle cells compared to other tissues when using tissue-specific drivers (figures 2.3D, 4.1B).
Importantly, this robust expression does not seem to increase toxicity, as longevity is unaffected
by Mef2-driven (muscle cell-specific) Ub6-Stop or Ub6-Stop-K0-ile44a expression (figures 2.3F,
4.6A-B), and Ub6-Stop-K0 expression in muscle cells has a far smaller effect on longevity than its
expression in neurons, glia, or all cells (figure 4.2). It will be useful to decipher the handling of
these chains in muscle cells under different conditions, including exercise and hypoxia,
circumstances in which ATP stores are depleted. One interesting area to explore would be any
effects from unanchored chains in cardiac muscles, since Ub6 expression was so strong in
Drosophila muscle cells (figures 2.3D, 4.1B). There is evidence for the involvement of the
ubiquitin-proteasome system in many cardiovascular diseases. For example, it has been shown
that oxidative stress caused by heart disease, ischemia, and aging can lead to proteasomal
dysfunction and the buildup of aggregated proteins [221]. A contributing factor in some cases is
an increase in reactive oxygen species, which can inhibit certain DUBs including USP14 [221,
222], which notably creates untethered Ub chains at the proteasome by deubiquitinating poly-Ubed substrates en bloc [27, 223]. When USP14 cannot deubiquitinate substrates to recycle polyUb into mono-Ub, perhaps it necessitates the use of preformed chains for ubiquitination. Cardiac
studies in Drosophila and mammalian models could work toward understanding any involvement
of free chains in muscle function or dysfunction.
Finally, it will be necessary to tease out the details of unanchored poly-Ub inhibition of the
proteasome. In vitro proteasomal activity assays in the presence of different free chain species –
various lengths and linkage types – will help us understand which types of chains can inhibit the
proteasome, but conventional in vitro studies cannot provide a full picture. Not all proteasomal
degradation is Ub-dependent, and there are multiple binding sites for Ub at the proteasome [224].
Could some free poly-Ub species affect the turnover of only a subset of proteasomal substrates,
based on where the chains bind the proteasome? Is there any effect on Ub-independent turnover,
or do some chains simply outcompete degradation signals without affecting overall proteasomal
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function? One potential avenue to explore these questions involves the establishment of stable,
Ub6-expressing cell lines that can be used to assess proteasomal activity against a variety of
substrates present in cells. Assessing the turnover of known proteasomal substrates, either
engineered substrates in in vitro assays or endogenous proteins in the cells, would help determine
specific proteasomal effects. Similar studies can be performed in transgenic flies, but with more
difficulty due to the limited availability of quality fly antibodies.
In sum, ideas about untethered poly-Ub that have long been considered settled – that they
are toxic and require rapid disassembly to prevent proteasomal inhibition – are far more
complicated than previously understood. The complexities addressed throughout this dissertation
make it clear that the unanchored ubiquitin field is rife with novel research opportunities.
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APPENDIX
OUTLINE OF HOMOTYPIC UBIQUITIN LINKAGES
Linkage Type

Reported Cellular Processes

Mitochondrial Homeostasis

• Mitophagy delayed in cells with mutant Lys6 Ub1,2
• Involved with mitochondrial homeostasis1-4
Lysine-6 • Observed on ubiquitinated mitochondrial membrane proteins after mitochondrial depolarization3

DNA Damage Response

• Regulates DNA damage response with the E3 BRCA1/BARD15,6,7

Abundance
• Does not increase with
protease inhibition8,9
• Increases upon UV-based
genotoxic stress10
• Increases in response to
mitochondrial depolarization3

Predominant E2/E3s Reported
(Linkage-specific enzymes denoted in bold)

Predominant DUBs Reported
(Linkage-specific enzymes denoted in bold)

E2

• No specific E2s reported

E3
•
•
•
•

Bacterial HECT-like E311
N1eL12
BRCA1/BARD15,7
Parkin3,4

• USP30 (localized to
mitochondria)2,13,14

Cell Cycle Regulation
• Triggers proteasomal degradation of cell cycle regulators during mitosis15-22

Proteasomal Degradation

• Homotypic Lys11-linked chains are typically poor substrates for the proteasome16,19-23
• The E2 UBE2S and E3 APC/C construct branched chains comprising Lys11 that are strong
Lysine-11
proteasomal degradation signals, as well as heterotypic Lys11/Lys48-linked chains21,23,24

Other

• Implicated in cell-cycle-independent processes:
• Hif1(alpha) transcription factor25; ERAD26; innate immune response27; cellular adaptation to
hypoxia28,29,30

E2
• Increases in response to
proteasome inhibition8,26

• Ube2S15,17,20,24,32-34
• Ube2C15,35,36

• Increases in response to
mitochondrial depolarization3

E3

• Preferentially produced during
mitosis and G1 in cells16,21,31

•
•
•
•
•

APC/C15,17,24,32-34
Parkin3,4,37
UBR538,39
APEL140
AREL140,41

• Cezanne/OTUD7B29
• Cezanne2/OTUD7A29

DNA Damage Response

Lysine-27

• The E3 ligase RNF168 promotes ubiquitination of histone 2A, the major form of ubiquitination on
chromatin following DNA damage42
• Serves as scaffolding to recruit DNA damage response mediators42,43
• Lack of Lys27-linked chains prevents activation of DNA damage response42

Immune Response

• Associated with the host immune response in response to microbial DNA44,45
• Lys27-linked poly-Ub of STING acts as a scaffold for the recruitment and activation of the kinase
TBK144,45. This association triggers a cascade that leads the activation of transcription factor IRF-3 and
induction of type-1 interferons and pro-inflammatory cytokines44,45

E2
• Lys27-linked chains are the
major Ub chain type on
chromatin following DNA
damage42

Lysine-29

Repression of Wnt/β-Catenin Signaling

• Lys29-linked poly-Ub of Axin disrupts its interaction with co-receptors and represses Wnt/β signaling54

Parkin46,47
AMFR44,45
RNF16842
HACE148,49

• No specific DUBs reported

• No specific E2s reported
• TRABID

E2

• No specific E2s reported

• Implicated in regulating traffic through the post-Golgi network58
• Increases upon UV-based
genotoxic stress10

Other

•
•
•
•

• Increases upon inhibition of the
E3
proteasome8
• KIAA10/UBE3C39,40,52,55,56
• UBR538,39
• UFD457

Post-Golgi Membrane Trafficking
Lysine-33

E3

E2

Proteasomal Degradation

• Associates with the 26S proteasome and contributes to substrate turnover in the Ub-fusiondegradation pathway50-53

• No specific E2s reported

• Associated with negative regulation of T-cell antigen receptor59
• Associated with negative regulation of AMPK-related protein kinases60

E3

• TRABID

• CUL358
• APEL140
• AREL140,41

E2

Proteasomal Degradation

• Targets proteins to the 26S proteasome for degradation61-64
Lysine-48 Other
• Involved with Wnt signaling propagation65
• Indirectly regulates protein activity by signaling the degradation of various inhibitors66,67
• Can impair protein interactions without triggering degradation68

• Predominant linkage type in
cells, often >50% of all
linkages8,9,26,69,70
• Levels increase upon
proteasome inhibition26
• Increases in response to
mitochondrial depolarization3

•
•
•
•
•
•

Ube2K71-74
Ube2R173
Ube2G275
Ubc171,73,74
Cdc3473-76
Ube2D55,77

E3
•
•
•
•
•
•
•
•
•
•

BRCA1/BARD171,72 (46,48)
• OTUB1
SCF (Degradation specific)73
gp78 (Degradation specific)75,78
E6AP (Degradation
specific)55,77,79
KIAA10/UBE3C55
Bacterial HECT-like E311
Parkin46,47
N1eL12
APEL140
UFD280

Scaffolding to Facilitate Protein Interactions

• Acts as an interaction point for the formation and activation of various complexes and pathways:
‣ Activation of NF-kB transcription factor31,81,82
‣ DNA repair83-89
‣ Innate immune responses90
‣ Mitophagy1,2
‣ Protein sorting91,92
Lysine-63
‣ Assembly of protein complexes that drive mRNA splicing and translation93-96
‣ Propagation of Wnt signaling65

E2
• Second most abundant chain
type101
• Increases in response to
mitochondrial depolarization3

Lysosomal Degradation

• Targets substrate to the lysosome for degradation97-99
• Serves as an interaction point for adaptor molecules of autophagosomes and substrates en route to
lysosomal degradation100

• Ube2N-Uev1A71,72,102,103
• Ube2D77,104

E3
•
•
•
•

BRCA1/BARD171,72
CHIP102
RSP5/Nedd477,104,105
TRAF682,106

• CYLD107
• AMSH

NF-kB signaling

• Modifies the IKK complex subunit NEMO in order to allosterically activate IKK in the NF-kB
pathway108-113
Methionine-1

Other

signaling20

• Cytokine
• Regulation of interferon production114
• Control of Wnt signaling during blood vessel formation115

• Rapidly synthesized in
response to activation of
inflammatory signaling
cascades109,110,112,116

E2

• Ube2K108-112,116

E3

• CYLD107
• OTULIN

• LUBAC108-112,116,117

E2
Mediates Protein Interaction

• Can impair protein interactions:
‣ Mono-Ub of Smad4 blocks its association with Smad2118
‣ Blocks interactions of adaptor proteins to cargo in EGFR signaling119-121
Mono-Ub • Recruits enzymes to specific cellular locations in response to DNA damage89,122-130
‣ PCNA, FANCD2, and FANCI are all mono-Ub-d and also involved in DNA repair pathways89,122-130

Lysosomal Degradation

• Targets substrates to the lysosome for degradation97

•Reduced in response to
proteasome inhibition, most
likely in favor of polyubiquitin
chain formation131
•Varies among tissue, cell, and
model types but by far the most
abundant conjugated form of
ubiquitin and in some cases
rivals levels of free ubiquitin131

•
•
•
•
•

Ube2D132,133
UbcH5132,133
Rad689,134,135
Ube2W71,136-138
Ube2T136,137

E3
•
•
•
•
•
•
•

• No specific DUBs reported

BMI1-RING1132,133
Rad1889,134,135
FANCL136,137
BRCA1/BARD171,138
CHIP71,138
Parkin46,47
CUL3139,140

Table S1. Outline of the known homotypic ubiquitin linkages along with their reported functions, abundance,
and ubqiutin machinery associations. In addition to the primary literature cited in the table, the works of Komander
and Rape, 2012 (Komander, D., & Rape, M. (2012). The ubiquitin code. Annu Rev Biochem, 81, 203-229.
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doi:10.1146/annurev-biochem-060310-170328); Akutsu et al., 2016 (Akutsu, M., Dikic, I., & Bremm, A. (2016). Ubiquitin
chain diversity at a glance. J Cell Sci, 129(5), 875-880. doi:10.1242/jcs.183954); Yau and Rape, 2016 (Yau, R., & Rape,
M. (2016). The increasing complexity of the ubiquitin code. Nat Cell Biol, 18(6), 579-586. doi:10.1038/ncb3358); and
Swatek and Komander, 2016 (Swatek, K. N., & Komander, D. (2016). Ubiquitin modifications. Cell Res, 26(4), 399422. doi:10.1038/cr.2016.39) heavily influenced this table and deserve specific recognition. A separate list of sources
specifically for this table is included as a supplemental figure.
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Table S3.1. Effects of Ub6 expression throughout all tissues and stages, as previously published [79].

DAVID

•
•
Pros •

•
•
•

Drosophila-specific gene analysis
Groups functionally related genes and terms
into manageable number of biological
modules, helping to reduce redundancy
Gene-to-term and term-to-gene analysis
Improves “functional group” definition
Fuzziness feature, that allows one gene to
participate in more than one functional group
Global view with “fuzzy heat map” visualization

• Running criteria must be fine tuned to avoid
Cons

distortion
• “Orphan” terms, i.e. term exclusion because of
undefined fit into a specific function
• Fewer designer tools

IPA

•
•
•
•
•
•

Places data in the context of public sources
Canonical and overlapping pathways
Generates plausible signaling cascades
Builds interaction and regulatory networks
Multiple profiling tools
Pathway designer

•
•
•
•

Needs the most complete data set on file
Potential incongruence with GO terms
Many of our genes of interest lack human orthologs
Ignores our Drosophila-specific genes of interest

Table S3.2. Rationale for using DAVID analysis tool over IPA. Information was acquired through the databases
themselves, as well as reviews written on the subject of functional analysis tools [159, 160, 162-164].
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Gene Ontology: Biological Process
Term

Genes

Ub6-GG vs. Control
Upregulated

proteolysis
peptide catabolic process
mannose metabolic process
protein deglycosylation
melanin biosynthetic process from tyrosine

CG18493, CG31265, CG31266, CG4653, CG7025,
CG8299, CG9673, ZetaTry
CG31198, CG31343, CG42335, CG8773
LManIII, LManV, LManVI
LManIII, LManV, LManVI
yellow-f2, Y

Downregulated None detected
Ub6-Stop vs. Control
Upregulated

Downregulated

proteolysis
peptide catabolic process
transmembrane transport
carbohydrate metabolic process
folic acid-containing compound biosynthesis
process
tetrahydrofolate interconversion

CG11911, CG11912, CG14820, CG31198,
CG31343, CG42335, CG6048, CG7025, CG7631,
CG9673, Jon65Aii, zetaTry
CG31198, CG31343, CG42335
CG17751, CG32669, CG42825, CG4562, CG8785,
MFS1
Mal-A1, Mal-A6, Mal-A7, Nmdmc
Nmdmc, pug
CG3011, pug

de novo' IMP biosynthetic process
one-carbon metabolic process

AdSL, ade3
Nmdmc, pug

oxidation-reduction process

CG12766, Cyp4p2, Nmdmc, pug

Ub6-Stop vs. Ub6-GG
Upregulated None detected
Downregulated

carbohydrate metabolic process

Amy-d, Mal-A1, Mal-A4, Mal-A6, Mal-A7, MalA8, tobi

oxidation-reduction process

CG12766, CG18003, CG1944, CG31075

Table S3.3. Expansion of Table 3.1. Symbols of differentially expressed genes organized by biological process. “CG”
identifier denotes that the gene has not yet been named in Drosophila.
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Gene Ontology: Molecular Function
Term
Ub6-GG vs. Control
Upregulated

peptide binding
metalloaminopeptidase activity
alpha-mannosidase activity

CG31198, CG31343, CG42335, CG8773
CG31198, CG31343, CG42335, CG8773
LManIII, LManV, LManVI

metallopeptidase activity

CG31198, CG31343, CG42335, CG8773
CG1304, CG31265, CG31266, CG4653,
CG8299, CG9673, zetaTry

serine-type endopeptidase activity
carbohydrate binding
zinc ion binding
hydrolase activity
hydrolase activity, acting on C-N (not peptide)
bonds, in linear amides
Ub6-Stop vs. Control
Upregulated

peptide binding
metalloaminopeptidase activity
serine-type endopeptidase activity
metallopeptidase activity
hydrolase activity, acting on C-N (not peptide)
bonds, in linear amides

Downregulated

Genes

CG14499, LManIII, LManV, LManVI
CG31198, CG31343, CG42335, CG7025,
CG7631, CG8773, LManIII, LManV, LManVI
CG14120, CG31266, vanin-like, CG4653,
CG9673
CG32751, vanin-like
CG31198, CG31343, CG42335
CG31198, CG31343, CG42335
CG11911, CG11912, CG6048, CG9673,
Jon65Aii, zetaTry
CG31198, CG31343, CG42335
CG32751, vanin-like

catalytic activity
methenyltetrahydrofolate cyclohydrolase activity
methylenetetrahydrofolate dehydrogenase
(NADP+) activity
formate-tetrahydrofolate ligase activity
maltose alpha-glucosidase activity

CG5955, Mal-A1, Mal-A6, Mal-A7
Nmdmc, pug

alpha-1,4-glucosidase activity

Mal-A1, Mal-A7

Nmdmc, pug
Nmdmc, pug
Mal-A1, Mal-A7

Ub6-Stop vs. Ub6-GG
Upregulated
Downregulated

None detected
maltose alpha-glucosidase activity
alpha-1,4-glucosidase activity
catalytic activity

Mal-A1, Mal-A4, Mal-A7, Mal-A8, tobi
Mal-A1, Mal-A4, Mal-A7, Mal-A8, tobi
Amy-d, Mal-A1, Mal-A4, Mal-A6, Mal-A7,
Mal-A8

Table S3.4. Expansion of Table 3.2. Symbols of differentially expressed genes organized by molecular function. “CG”
identifier denotes that the gene has not yet been named in Drosophila.
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KEGG Pathway
Pathway

Genes

Ub6-GG vs. Control

Downregulated

Lysosome
Other glycan degradation
None detected

Ub6-Stop vs. Control
Upregulated
Downregulated

None detected
One carbon pool by folate

Upregulated

Ub6-Stop vs. Ub6-GG
Upregulated
Downregulated

CG6903, LMANIII, LMANV, LMANVI, Vha100-4,
Tsp29Fa
LMANIII, LMANV, LMANVI

Metabolic pathways

ade3, CG3011, Nmdmc, pug
ade, AdSL, CG11425, CG12766, CG13377,
CG17224, CG30016, CG3011, CG6903, Mal-A1,
Mal-A7, Nmdmc, pug, Ugt35b, vanin-like

Galactose metabolism

CG12766, Mal-A1, Mal-A7

None detected
Starch and sucrose metabolism
Galactose metabolism
Metabolic pathways

Amy-d, Mal-A1, Mal-A4, Mal-A7, Mal-A8, tobi
CG12766, Mal-A1, Mal-A4, Mal-A7, Mal-A8, tobi
Amy-d, CG11425, CG12766, CG18003, CG31075,
Mal-A1, Mal-A4, Mal-A7, Mal-A8, tobi

Glycerolipidmetabolism

CG11425, CG12766, CG31075

Table S3.5. Expansion of Table 3.3. Symbols of differentially expressed genes organized by KEGG pathway. “CG”
identifier denotes that the gene has not yet been named in Drosophila.
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Gene Ontology: Biological Process
Term

# of genes

p-value

Genes

Ub6-GG vs. Control
Upregulated

Downregulated

9
2
2
2
3

2.30E-05
7.30E-03
1.50E-02
2.90E-02
4.60E-02

ANPEP, CPB1, CFD, HPN, KLK9,
MEP1A, PRSS16, PRSS36, TPSD1
GBA, SMPD1
GBA, HPN
GBA, TTPA
BAIAP2, FMNL1, HPN

proteolysis *
pyrimidine nucleoside salvage
biotin metabolic process
folic acid metabolic process
purine nucleobase biosynthetic process
de novo IMP biosynthetic process
folic acid-containing compound
biosynthesis process
glycine metabolic process
tetrahydrofolate interconversion
tetrahydrofolate metabolic process
purine nucleotide biosynthetic process
purine ribonucleoside monophosphate
biosynthetic process

7
2
2
3
2
2

7.20E-04
2.60E-02
3.00E-02
1.30E-04
4.80E-03
5.70E-03

ANPEP, AZU1, CPA3, CPB1, HPN,
MEP1A, TPSD1
CDA, UPP1
BTD, SLC5A6
MTHFD1, MTHFD2, SHMT1
GART, SHMT1
AdSL, GART

2
2
2
2
2

5.70E-03
8.50E-03
9.50E-03
9.50E-03
1.10E-02

MTHFD2, MTHFD1
GART, SHMT1
MTHFD1, SHMT1
MTHFD2, SHMT1
ADSL, MTHFD1

2

1.20E-02

oxidation-reduction process
one-carbon metabolic process
amino acid transport
protein tetramerization

4
2
2
2

1.70E-02
2.80E-02
3.30E-02
3.70E-02

ADSL, GART
AKR1A1, CYP4B1, MTHFD1,
MTHFD2
MTHFD1, MTHFD2
SLC3A1, SLC36A1
ADSL, SHMT1

3

2.20E-03

ALDH2, AMY2B, SLC3A1

proteolysis *
termination of signal transduction
response to thyroid hormone
response to pH
regulation of cell shape
None detected

Ub6-Stop vs. Control
Upregulated

Downregulated

Ub6-Stop vs. Ub6-GG
Upregulated
Downregulated

None detected
carbohydrate metabolic process

Table S3.6. Enriched Biological Process Gene Ontology terms as determined by DAVID analysis. Differentially
expressed (Absolute Log2 Fold Change > 1, FDR < 0.05) RNA- Seq transcripts at each level of comparison (Ub6-GG
vs. Control, Ub6-Stop vs. Control, Ub6-Stop vs. Ub6-GG) were assigned human orthologues by FlyBase.org and
separated into lists of upregulated and downregulated genes for each condition. Each list was uploaded into DAVID’s
Functional Annotation tool (https://david.ncifcrf.gov, v. 6.8) as a gene list and submitted using the official gene symbol
as identifier and H. sapiens as background. The term BP_DIRECT was selected for chart creation within the Gene
Ontology category, and terms were included as enriched if p-value < 0.05. * indicates overlap in terms between Ub6GG vs. Control and Ub6-Stop vs. Control comparisons.
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Gene Ontology: Molecular Function
Term

# of genes

p-value

Genes

Ub6-GG vs. Control
Upregulated

serine-type peptidase activity
serine-type endopeptidase activity *

4
5

4.80E-04
3.30E-03

zinc ion binding *
apolipoprotein binding
mannose binding

8
2
2

2.10E-02
3.30E-02
4.70E-02

CFD, HPN, PRSS16, TPSD1
CFD, HPN, KLK9, PRSS36
TRAIP, ANPEP, CPB1, CDA,
ENPEP, MAN2B1, MEP1A,
SMPD1
CANX, CSARB1
CD207, MAN2B1

8
4

1.20E-02
1.80E-02

TRAIP, ANPEP, BNC2, CPA3,
CPB1, CDA, MEP1A
AZU1, HPN, TFPI, TPSD1

2

2.70E-03

MTHFD1, MTHFD2

2

3.50E-03

MTHFD1, MTHFD2

2
2
3

3.50E-03
3.50E-03
1.20E-02

MTHFD1, MTHFD2
MTHFD1, MTHFD2
ADSL, GART, SLC3A1

2

4.10E-02

SLC3A1, SLC36A1

3
2

2.00E-03
3.20E-02

ALDH2, AKR1A1, HAO2
ALDH2, AKR1A1

Downregulated

None detected

Ub6-Stop vs. Control
Upregulated

Downregulated

zinc ion binding *
serine-type endopeptidase activity *
methylenetetrahydrofolate
dehydrogenase
(NAD+)
activity
methylenetetrahydrofolate
dehydrogenase (NADP+) activity
methenyltetrahydrofolate cyclohydrolase
activity
formate-tetrahydrofolate ligase activity
catalytic activity
amino acid transmembrane transporter
activity

Ub6-Stop vs. Ub6-GG
Upregulated
Downregulated

None detected
oxidoreductase activity
electron carrier activity

Table S3.7. Enriched Molecular Function Gene Ontology terms as determined by DAVID analysis. Differentially
expressed (Absolute Log2 Fold Change > 1, FDR < 0.05) RNA- Seq transcripts at each level of comparison (Ub6-GG
vs. Control, Ub6-Stop vs. Control, Ub6-Stop vs. Ub6-GG) were assigned human orthologues by FlyBase.org and
separated into lists of upregulated and downregulated genes for each condition. Each list was uploaded into DAVID's
Functional Annotation tool (https://david.ncifcrf.gov, v. 6.8) as a gene list and submitted using the official gene symbol
as identifier and H. sapiens as background. The term MF_DIRECT was selected for chart creation within the Gene
Ontology category, and terms were included as enriched if p-value < 0.05. * indicates overlap in terms between Ub6GG vs. Control and Ub6-Stop vs. Control comparisons.

111

KEGG Pathway
Pathway

# of genes

p-value

Genes

5

1.00E-03

10

2.90E-02

3
3
4

7.00E-03
2.40E-02
4.50E-06

Metabolic pathways ^

9

2.40E-04

CDA, UGT2A3, UPP1
CPA3, CPB1, MEP1A
MTHFD2, MTHFD1, GART, SHMT1
ADSL, AKR1A1, CYP4F2, GART,
HGSNAT, MTHFD1, MTHFD2, PLPP1,
SHMT1

Biosynthesis of antibiotics +
Glycerolipid metabolism +

5
3

3.60E-04
4.40E-03

TGDS, ADSL, AKR1A1, GART, SHMT1
AKR1A1, LPL, PLPP1

6
3

8.90E-04
1.00E-03

ALDH2, AKR1A1, AMY2B, CYP4F2,
HAO2, PLPP1
ALDH2, AKR1A1, PLPP1

3

1.30E-02

ALDH2, AKR1A1, HAO2

Ub6-GG vs .Control
Upregulated Lysosome
Metabolic pathways ^
Downregulated

ATP6V0A4, CD63, GBA, MAN2B1,
SMPD1
ALPPL2, ANPEP, ATP6V0A1, BTD,
CDA, CHDH, CYP3A4, DPM3, GBA,
SMPD1

None detected

Ub6-Stop vs. Control
Upregulated Drug metabolism- other enzymes
Protein digestion and absorption
Downregulated One carbon pool by folate

Ub6-Stop vs. Ub6-GG
Upregulated

None detected

Downregulated Metabolic pathways ^
Glycerolipid metabolism +
Biosynthesis of antibiotics +

Table S3.8. Enriched KEGG Pathway terms as determined by DAVID analysis. Differentially expressed (Absolute
Log2 Fold Change > 1, FDR < 0.05) RNA-Seq transcripts at each level of comparison (Ub6-GG vs. Control, Ub6-Stop
vs. Control, Ub6- Stop vs. Ub6-GG) were assigned human orthologues by FlyBase.org and separated into lists of
upregulated and downregulated genes for each condition. Each list was uploaded into DAVID's Functional Annotation
tool (https://david.ncifcrf.gov, v. 6.8) as a gene list and submitted using the official gene symbol as identifier and H.
sapiens as background. The term KEGG_PATHWAY was selected for chart creation within the Pathway category, and
terms were included as enriched if p-value < 0.05. + indicates overlap in terms between Ub6-Stop vs. Control and Ub6Stop vs. Ub6-GG comparisons, ^ indicates overlap in terms across all comparisons.
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Gene Target

Forward primer 5′-3′

Reverse primer 5′-3′

Localization

Rp49

AGATCGTGAAGAAGCGCACCAAG

CACCAGGAACTTCTTGAATCCGG

Global

CG11911

GCCAACATGCCTTCCATTTAC

GCGATTTCGATCCTGGCTAATA

Midgut

CG1304

TCCACGAGGAGTATGGTAACT

GGTAGATCGATGGGCTGAATAC

Midgut

CG2650

GATGTCCAGCCGAAGATCAA

GAAGAACTCGTCGTAGGGAATG

Rectal pad and eye

CG32751

CGTATTCACCTGCTCTGGAAA

CTGCGGATATGTGACCCTAATC

Midgut and Spermatheca

CG4653

GGTGGTCCTGAATGCGAATA

TGGAGGACATGACTGAGAGA

Midgut, hindgut, and Malpighian tubules

CG7631

CGTATTCACCTGCTCTGGAAA

CTGCGGATATGTGACCCTAATC

Midgut

Drsl3

GGTGCAGATGATATTCCTGTTTG

GACCTCCGAAAGTTCCAGATAG

Midgut

LysE

GCTCGTTGGGCCTGTATT

GAAGATTCCGTAGTCGTTGGAG

Midgut and accessory glands

Mal-A7

GGCAAACGAATTGGACCTAAAG

CGTAGCCCTTCTCTCGATTTAC

Midgut

qin

CTGATCGCCAGACAAGTACAA

GACCGTAGACCGTCAAGTAATC

Testis, ovary, and eye

Takl1

TCCCTCCACAACTACCTCTATG

AGGCGATCTTGCACTTTACC

Midgut, hindut, and Malpighian tubules

Ubi-p5E

GGACGTCCGAGCAAGTAAAA

ATGGCTCAACCTCCAAAGTG

Global

Table S3.9. All primer sequences used for qRT-PCR and their corresponding genes' expression patterns in
Drosophila melanogaster. Localization according to FlyAtlas.org. “CG” identifier denotes that the gene has not yet
been named in Drosophila.

Sample
Name

RINe

28S/18S
(Area)

Conc.
(ng/uL)

GG-1

9.3

0.1

125

GG-2

7.6

N/A

37.4

GG-3

8.6

0.1

111

GG-4

8.9

0.1

95.3

Stop-1

6.9

N/A

42.2

Stop-2

6.2

N/A

41.4

Stop-3

8.4

0.2

141

Stop-4

8.4

0.2

167

Ctrl-1

6.0

0.2

76.3

Ctrl-2

7.5

0.3

199

Ctrl-3

8.0

0.1

65.1

Ctrl-4

7.8

0.2

101

Table S3.10. Overall RNA quality. Before RNA-Seq, an aliquot of the RNA was assessed by microfluidics using the
ScreenTape for the Agilent 2200 TapeStation. The electrophoretogram (not pictured), RNA Integrity Number (RIN),
and the ratio of the 28S:18S RNA bands are collectively examined to determine overall quality of the RNA.
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Dataset S1. All differentially expressed genes and their human orthologues. Only the top scoring orthologue
predictions from FlyBase.org are listed.

Ub6-GG vs. Ctrl
Gene Name (FlyBase)
CG32751
ETHR
CR42765
exex
CG5770
CG14499
CG3264
Cnx14D
CG32368
CG8299
ninaG
CG14419
CG33965
y
CG7631
CG31380
vanin-like
CG1304
TotC
CR44534
LManV
Gba1a
Takl1
LManIII
CG3588
CG12057
Alp2
CG4653
CG7968
LManVI
CG7025
CG42335
CG10345
CG15533
zetaTry
CG44252
CG31343
CG8773
CG10910
Vha100-4
CG2747
CG31266
CG9673
CG14120
CG8093
CG8083
Cyp6w1
CG7881
CG30427
IRSp53
Myo28B1
mwh
CG16743
CG15127
CG31265
CG31288
CG31198
Mur29B
CG8907
CG4839
CG32633
CG11878
CG18493
yellow-f2
Tsp29Fa
COX6AL
CG14974
CG5028
CR32661
eIF4E-3
CG43321
CG6903
dwg
MRE16
CG9072
CG12506
CR43157
CG15263
CG13946
CG7567
CG12519
qin
CG34283
mthl8
CG13947
CG43133

Ub6-Stop vs. Ub6-GG

Ub6-Stop vs. Ctrl
Log2 FC
6.28
5.10
4.66
4.21
4.06
4.01
3.79
3.73
3.53
3.43
3.42
3.42
3.39
3.18
3.11
3.03
2.93
2.88
2.85
2.85
2.79
2.76
2.75
2.74
2.70
2.69
2.58
2.54
2.49
2.48
2.37
2.34
2.33
2.27
2.11
2.10
2.05
2.04
2.01
1.98
1.97
1.96
1.93
1.90
1.89
1.86
1.83
1.83
1.77
1.76
1.75
1.72
1.69
1.64
1.60
1.56
1.56
1.54
1.53
1.52
1.50
1.50
1.40
1.38
1.24
-1.17
-1.30
-1.37
-1.39
-1.48
-1.60
-1.77
-1.89
-1.93
-2.02
-2.02
-2.03
-2.08
-2.25
-2.63
-2.72
-2.74
-2.89
-3.06
-3.18
-4.12

Human Orthologue(s)

Gene name (FlyBase)

BTD
TRHR
non-coding
MNX1

CG32751
CG9184
CR42765
CG10591
ImpL1
CG43829

ALPG
CANX

CG32368
Drsl3
LysE
CR44534
vanin-like
CG42825
MFS1
CG11671
CG12057
Cnx14D
CG31041
Npc2d
CG13377
CG11911
CG7631

PRSS36, PRSS53
CHDH
TTPAL
DPM3
MEP1A, MEP1B
BTD
CFD, GZMA, KLK9, KLK14, KLK15, TPSD1
non-coding
MAN2B1
GBA
MAP3K7
MAN2B1
ENAH, EVL, VASP
ALPG
KLK9, KLK14, TPSD1
MAN2B1
CPB1
ANPEP, LVRN, TRHDE
SCARB1, SCARB2
SMPD1
HPN, PRSS36, PRSS53
SLC27A4
ANPEP
ENPEP
CDA, MAGED1, MAGED2, MAGED4B, MAGED4, TRO
ATP6V0A4
HEATR5B
CFD, KLK7, KLK14, PRSS3
TPSD1
ENDOG
LIPM
SLC28A2
CYP3A4, TBXAS1
SLC17A1, SLC17A3, SLC17A4, SLC17A5
FAR1, FAR2
BAIAP2
MYO7A
FMNL1
PLAC8

ANPEP
EPS8L2
PRKG1
TRAIP
PRSS16
DPM3
CD63
COX6A1
IDH3G
non-coding
EIF4E
SMDT1
HGSNAT
MAZ
TBCA
non-coding

RNF17, TDRD1
GTSF1L
ADGRF3

sug
CG32564
CG31380
CG10910
CG9568
CG17751
CG3588
CG13102
CG11912
CG31343
CG42335
CG34301
CG32669
CG14820
Jon65Aii
Takl1
CG42397
CG7025
mwh
CG13912
CG10725
CG15155
CG8785
CG42807
CG15127
Cpr49Ag
CG32633
CG31515
CG9682
zetaTry
disco
CG6048
CG31198
CG15043
CG30016
CG10513
CG12290
Mur29B
CG4562
CG9673
Pat1
CG17841
CG17224
Ugt35b
Ubi-p5E
ade3
CG3011
AdSL
CG6903
MtnD
Cyp4p2
Akh
Nmdmc
dwg
CG11425
CG14075
Mal-A1
CG4363
pug
CG1139
Mal-A6
CG5955
CG10383
CG14245
Mal-A7
CG12766
DptA
CG2650
CG6283
CG15263
CG32335
CG13947
CG34040

Log2 FC
5.61
5.55
4.95
4.33
4.29
4.23
3.91
3.37
3.35
3.32
3.22
3.19
3.16
3.05
2.92
2.92
2.90
2.87
2.81
2.72
2.72
2.63
2.60
2.54
2.50
2.49
2.43
2.37
2.34
2.30
2.13
2.12
2.11
2.03
2.02
2.02
1.97
1.94
1.93
1.90
1.89
1.86
1.84
1.82
1.82
1.74
1.73
1.71
1.70
1.70
1.60
1.60
1.58
1.55
1.47
1.45
1.39
1.38
1.36
1.35
1.33
1.33
1.33
1.26
1.22
-1.26
-1.55
-1.58
-1.84
-1.87
-1.88
-1.92
-1.95
-1.95
-1.95
-2.01
-2.06
-2.11
-2.16
-2.19
-2.35
-2.37
-2.43
-2.49
-2.71
-2.95
-3.12
-3.42
-3.61
-3.75
-3.84
-3.86
-4.41
-4.63

Human Orthologue(s)

Gene name (FlyBase)

BTD

CG31813
CG9184
mthl8
Cpr49Ag
CG31075
Cyp4p2

4.43
3.67
3.53
2.07
-1.51
-1.89

CG18003
Akh
CG11425
CG12780
Mal-A8
Mal-A6
CG14075
Amy-d
Mal-A1
CG12766
Mal-A4
tobi
Mal-A7
CG34040
CG34316

-1.95
-2.23
-2.29
-2.34
-2.43
-2.48
-2.54
-2.65
-2.70
-2.82
-2.92
-2.99
-3.18
-3.88
-4.65

non-coding

LYZ
non-coding
BTD
SLC2A6, SLC2A8, SLC2A10, SLC2A12, SLC2A13
SLC17A5
C19orf12
CANX
NPC2
BDH1, HSD11B2, HSD17B2
AZU1, PRSS36, PRSS53, PRTN3
MEP1A, MEP1B
GLIS2
C1orf68, POU2AF1
CDA, MAGED1, MAGED2, MAGED4B, MAGED4, TRO
GPIHBP1, LY6D
SLC22A4, SLC22A5, SLC22A25
ENAH, EVL, VASP
AZU1, CTRB1, CTRB2, CTRL, PRSS38, PRTN3
ANPEP
ANPEP, LVRN, TRHDE
SLC5A6
CPA3, CPB1, CPO
MAP3K7
CPB1
FMNL1

GLYATL3
SLC36A1
PLAC8
TRAIP
TFPI, TFPI2
HPN, PRSS36, PRSS53
BNC2
AZU1, CFD, HABP2, KLK10, KLK14, PRSS55
ANPEP
TTR
ACAD10, ACAD11
HRH3, HRH4
ABCC4
TPSD1
APPBP2
FAM57B
UPP1
UGT2A3, UGT2B15
UBC
GART
SHMT1
ADSL
HGSNAT
CYP4B1, CYP4X1, CYP4Z1
MTHFD2
MAZ
PLPP1
SLCA1
LY6D
MTHFD1
SLC36A1, SLC36A2, SLC36A3, SLC36A4
SLC3A1
TGDS
SERAC1
SLC3A1
AKR1A1

LPL
C11orf54
LY6D, LYNX1

Log2 FC

Human Orthologue(s)

ADGRF3
ALDH2
CYP4F2, CYP4F3
HAO2
PLPP1
SLC3A1
SLC3A1
AMY2B
SLC3A1
AKR1A1
SLC3A1
MYORG
SLC3A1
LY6D, LYNX1

Drosophila gene names FlyBase; "CG" denotes an
unnamed gene
Human gene names – HGNC
Empty cells: no
ortholgues identified
on FlyBase.org
All results up-to date
as of January 11,
2019
Genes with multiple hits: all potential
orthologues had the same score on
FlyBase.org
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Ubiquitin is an 8.5 kDa post-translational modifier involved in essentially all eukaryotic
cellular processes. Through a process called ubiquitination, ubiquitinating enzymes chemically
attach ubiquitin to substrate proteins to control their fates, resulting in anything from their
recruitment into signaling pathways to their proteasomal degradation, with a plethora of
possibilities in between. Ubiquitin molecules can also be attached to one another, resulting in
poly-ubiquitin chains with various effects depending on the number of ubiquitin molecules and the
specific amino acid residues used to link them together. While most poly-ubiquitin in the cell exists
as conjugated species, there are also untethered poly-ubiquitin species that are not attached to
substrates. These unanchored ubiquitin chains have been previously classified as toxic
byproducts that interfere with proteasomal function in vitro and in yeast, and are thus believed to
be disassembled rapidly to avoid toxicity. Conversely, several studies have indicated a signaling
role for certain types of unanchored ubiquitin chains in innate immunity and stress responses.
Recent work from our lab that places untethered poly-ubiquitin in an in vivo setting, the fruit fly
Drosophila melanogaster, has established a more nuanced existence for these chains. By
manipulating the chemical properties of one type of untethered ubiquitin chain – linear polyubiquitin – we have shown that these chains are not always toxic in vivo. Under normal
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circumstances, they are innocuous, readily degraded by the proteasome, and used by
endogenous ubiquitination machinery that transfers them to substrates in toto. It is only under
certain conditions that they become noxious and elicit a cellular response; for example, when
unanchored, linear ubiquitin chains cannot be ubiquitinated, they induce aberrant NF-κB
signaling, resulting in premature death in flies. Our work invites a re-evaluation of the credence
that untethered poly-ubiquitin is always toxic, and more broadly points to untapped potential for
unanchored chain involvement in additional pathways in vivo.
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